| 1 |
Nambu R, Arai K, Kudo T, Murakoshi T, Kunisaki R, Mizuochi T, Kato S, Kumagai H, Inoue M, Ishige T, Saito T, Noguchi A, Yodoshi T, Hagiwara SI, Iwata N, Nishimata S, Kakuta F, Tajiri H, Hiejima E, Toita N, Mochizuki T, Shimizu H, Iwama I, Hirano Y, Shimizu T; JPIBD-R. Clinical outcome of ulcerative colitis with severe onset in children: a multicenter prospective cohort study. J Gastroenterol 2023. [PMID: 36884071 DOI: 10.1007/s00535-023-01972-1] [Reference Citation Analysis]
|
| 2 |
Boros KK, Veres G, Cseprekál O, Pintér HK, Richter É, Cseh Á, Dezsőfi-Gottl A, Arató A, Reusz G, Dohos D, Müller KE. Body composition, physical activity, and quality of life in pediatric patients with inflammatory bowel disease on anti-TNF therapy-an observational follow-up study. Eur J Clin Nutr 2023;77:380-5. [PMID: 36477672 DOI: 10.1038/s41430-022-01245-9] [Reference Citation Analysis]
|
| 3 |
Cenni S, Casertano M, Trani M, Pacella D, Martinelli M, Staiano A, Miele E, Strisciuglio C. The use of calgranulin-C (S100A12) and fecal zonulin as possible non-invasive markers in children with inflammatory bowel disease: a clinical study. Eur J Pediatr 2023;182:1299-308. [PMID: 36637538 DOI: 10.1007/s00431-022-04771-7] [Reference Citation Analysis]
|
| 4 |
Hagiwara S, Abe N, Hosoi K, Hara T, Ishige T, Shimizu H, Mizuochi T, Kakiuchi T, Kunisaki R, Matsuoka R, Kondou H, Kakuta F, Nakayama Y, Kimura T, Honma H, Hirano D, Saruta M, Yoshida T, Okayasu I, Etani Y, Maeyama T. Utility of a rapid assay for Prostaglandin E-major urinary metabolite as a biomarker in pediatric ulcerative colitis.. [DOI: 10.21203/rs.3.rs-2552506/v1] [Reference Citation Analysis]
|
| 5 |
Pivac VT, Herceg-Čavrak V, Hojsak I, Mišak Z, Jadrešin O, Kolaček S. Children with inflammatory bowel disease already have an altered arterial pulse wave. Eur J Pediatr 2023. [PMID: 36763192 DOI: 10.1007/s00431-023-04858-9] [Reference Citation Analysis]
|
| 6 |
Bronsky J, Copova I, Durilova M, Kazeka D, Kubat M, Lerchova T, Vlckova E, Mitrova K, Rataj M, Klocperk A, Sediva A, Hradsky O. Postvaccination Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine and Its Predictors in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2023;76:e36-44. [PMID: 36705698 DOI: 10.1097/MPG.0000000000003661] [Reference Citation Analysis]
|
| 7 |
Fabian O, Klocperk A, Lerchova T, Jencova P, Stolova L, Belhajova M, Voriskova D, Kazeka D, Vicha A, Hradsky O, Bronsky J. Serum and Mucosal CD30 in Pediatric Inflammatory Bowel Diseases: Useful Biomarker for Diagnosis and Disease Activity Monitoring? Dig Dis Sci 2023;68:460-70. [PMID: 36056999 DOI: 10.1007/s10620-022-07677-4] [Reference Citation Analysis]
|
| 8 |
Jeong J, Walters TD, Huynh HQ, Lawrence S, Mack DR, Deslandres C, Otley A, El-Matary W, Sherlock M, Griffiths AM, Wine E, Jacobson K, Church P, Carroll MW, Benchimol EI, Brill H, Critch J, Bax K, Jantchou P, Rashid M, Kaplan GG, Seow CH, Novak K, deBruyn JC; Canadian Children IBD Network. Inflammatory Bowel Disease Among Canadian Children: Comparison Between Children of Non-European Descent and Children of European Descent. Inflamm Bowel Dis 2023:izac276. [PMID: 36688453 DOI: 10.1093/ibd/izac276] [Reference Citation Analysis]
|
| 9 |
Atia O, Shavit-Brunschwig Z, Mould DR, Stein R, Matar M, Aloi M, Ledder O, Focht G, Urlep D, Hyams J, Broide E, Weiss B, Levine J, Russell RK, Turner D. Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study. Lancet Gastroenterol Hepatol 2023;8:31-42. [PMID: 36306803 DOI: 10.1016/S2468-1253(22)00307-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Ledder O, Turner D. Clinical Indices for Pediatric Inflammatory Bowel Disease Research. Pediatric Inflammatory Bowel Disease 2023. [DOI: 10.1007/978-3-031-14744-9_46] [Reference Citation Analysis]
|
| 11 |
Morita A, Imagawa K, Tagawa M, Sakamoto N, Takada H. Case report: Immunological characteristics of de novo ulcerative colitis in a child post COVID-19. Front Immunol 2023;14:1107808. [PMID: 36875135 DOI: 10.3389/fimmu.2023.1107808] [Reference Citation Analysis]
|
| 12 |
Kaplan JL, Winter HS. Treatment of Acute Severe Ulcerative Colitis. Pediatric Inflammatory Bowel Disease 2023. [DOI: 10.1007/978-3-031-14744-9_36] [Reference Citation Analysis]
|
| 13 |
Rintala RJ, Pakarinen MP. Inflammatory Bowel Disease. Pediatric Surgery 2023. [DOI: 10.1007/978-3-030-81488-5_76] [Reference Citation Analysis]
|
| 14 |
Hauer AC. Pediatric Inflammatory Bowel Disease Care in Low- and Middle-Income Countries. Pediatric Inflammatory Bowel Disease 2023. [DOI: 10.1007/978-3-031-14744-9_54] [Reference Citation Analysis]
|
| 15 |
Hart LM, Sherlock ME. Classification of Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2023. [DOI: 10.1007/978-3-031-14744-9_15] [Reference Citation Analysis]
|
| 16 |
Hommel KA, Ramsey RR, Gray WN, Denson LA. Digital Therapeutic Self-Management Intervention in Adolescents With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2023;76:38-42. [PMID: 36123761 DOI: 10.1097/MPG.0000000000003623] [Reference Citation Analysis]
|
| 17 |
Bouhuys M, Lexmond WS, van Rheenen PF. Pediatric Inflammatory Bowel Disease. Pediatrics 2023;151:e2022058037. [PMID: 36545774 DOI: 10.1542/peds.2022-058037] [Reference Citation Analysis]
|
| 18 |
Şimşek-Onat P, Hizarcioglu-Gulsen H, Ergen YM, Gumus E, Özen H, Demir H, Özen S, Saltık-Temizel İN. Neutrophil-to-Lymphocyte Ratio: An Easy Marker for the Diagnosis and Monitoring of Inflammatory Bowel Disease in Children. Dig Dis Sci 2023;68:233-9. [PMID: 35579794 DOI: 10.1007/s10620-022-07547-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 19 |
Fusillo S, Kastl AJ. The History and Physical Exam. Pediatric Inflammatory Bowel Disease 2023. [DOI: 10.1007/978-3-031-14744-9_16] [Reference Citation Analysis]
|
| 20 |
Krauthammer A, Weintraub I, Shaoul R, Lev-Tzion R, Broide E, Wilschanski M, Lerner A, Yerushalmi B, Shouval DS, Shamaly H, Haberman-Ziv Y, Weiss B. Infantile-onset inflammatory bowel disease has variable long-term outcomes. Front Pediatr 2023;11:1097779. [PMID: 36937967 DOI: 10.3389/fped.2023.1097779] [Reference Citation Analysis]
|
| 21 |
Bevers N, Van de Vijver E, Aliu A, Rezazadeh Ardabili A, Rosias P, Stapelbroek J, Bertrams Maartens IA, van de Feen C, Escher H, Oudshoorn A, Teklenburg S, Vande Velde S, Winkens B, Raijmakers M, Vreugdenhil A, Pierik MJ, van Rheenen PF. Ferric Carboxymaltose Versus Ferrous Fumarate in Anemic Children with Inflammatory Bowel Disease: The POPEYE Randomized Controlled Clinical Trial. J Pediatr 2022:S0022-3476(22)01134-9. [PMID: 36563900 DOI: 10.1016/j.jpeds.2022.12.016] [Reference Citation Analysis]
|
| 22 |
Marcovitch L, Focht G, Carmon N, Tersigni C, Ledder O, Lev-Tzion R, Church PC, Hyams JS, Baldassano RN, Bousvaros A, Mack DR, Hussey S, Otley A, Croft NM, Kappelman MD, Griffiths AM, Turner D. Development and Validation of the TUMMY-UC: A Patient-Reported Outcome for Pediatric Ulcerative Colitis. Gastroenterology 2022:S0016-5085(22)01390-7. [PMID: 36539016 DOI: 10.1053/j.gastro.2022.12.006] [Reference Citation Analysis]
|
| 23 |
Krawiec P, Pac-Kożuchowska E. Clinical Significance of Serum Elafin in Children with Inflammatory Bowel Disease. Biomedicines 2022;10. [PMID: 36552023 DOI: 10.3390/biomedicines10123267] [Reference Citation Analysis]
|
| 24 |
Kadenczki O, Dezsofi A, Cseh A, Szucs D, Vass N, Nemes E, Tarnok A, Szakos E, Guthy I, Kovacs M, Karoliny A, Czelecz J, Kiss C, Müller KE. Disease Activity Is Associated with Obesity in Newly Diagnosed Pediatric Patients with Ulcerative Colitis. Int J Environ Res Public Health 2022;19. [PMID: 36498163 DOI: 10.3390/ijerph192316091] [Reference Citation Analysis]
|
| 25 |
Parra-Izquierdo V, Flórez Sarmiento C, Frías-Ordoñez JS, Vargas M, Kock J, Lozano Escobar N, Márquez JR. Clinical and therapeutic characterisation of a multicentre cohort of patients with inflammatory bowel disease in Colombia. Gastroenterol Hepatol 2022:S0210-5705(22)00278-3. [PMID: 36464080 DOI: 10.1016/j.gastrohep.2022.11.006] [Reference Citation Analysis]
|
| 26 |
Kakiuchi T, Yoshiura M. Japanese pediatric patient with refractory steroid-resistant ulcerative colitis successfully treated with Tofacitinib: A case report. Medicine (Baltimore) 2022;101:e31757. [PMID: 36397383 DOI: 10.1097/MD.0000000000031757] [Reference Citation Analysis]
|
| 27 |
Lee GW, Chew KS, Wong SY, Chong SY, Ong SY, Lee WS. Quality of life in Malaysian children with inflammatory bowel disease: An understudied population. J Paediatr Child Health 2022;58:1972-9. [PMID: 35880617 DOI: 10.1111/jpc.16130] [Reference Citation Analysis]
|
| 28 |
Crowley E, Griffiths AM, Jairath V; pIBD CLINICAL TRIALS OUTCOME GROUP. Heterogeneity in Efficacy and Safety Endpoints for Pediatric Clinical Trials in Inflammatory Bowel Disease: A Need for Harmonization. Gastroenterology 2022;163:1137-44. [PMID: 35850191 DOI: 10.1053/j.gastro.2022.07.006] [Reference Citation Analysis]
|
| 29 |
Fedele F, Martinelli M, Strisciuglio C, Dolce P, Giugliano FP, Scarpato E, Staiano A, Miele E. Health-Related Quality of Life in Pediatric Inflammatory Bowel Disease During COVID-19 Pandemic: A Prospective Study. J Pediatr Gastroenterol Nutr 2022;75:595-600. [PMID: 35897141 DOI: 10.1097/MPG.0000000000003576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 30 |
Focht G, Cytter-Kuint R, Greer MC, Pratt LT, Castro DA, Church PC, Walters TD, Hyams J, Navon D, Martin de Carpi J, Ruemmele F, Russell RK, Gavish M, Griffiths AM, Turner D. Development, Validation, and Evaluation of the Pediatric Inflammatory Crohn's Magnetic Resonance Enterography Index From the ImageKids Study. Gastroenterology 2022;163:1306-20. [PMID: 35872072 DOI: 10.1053/j.gastro.2022.07.048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 31 |
Tokita K, Shimizu H, Takeuchi I, Shimizu T, Arai K. Long-Term Efficacy and Safety of Golimumab for Ulcerative Colitis in a Pediatric Inflammatory Bowel Disease Center in Japan. Pediatr Gastroenterol Hepatol Nutr 2022;25:461-72. [PMID: 36451693 DOI: 10.5223/pghn.2022.25.6.461] [Reference Citation Analysis]
|
| 32 |
Bąk-Drabik K, Malik M, Gwoździewicz K, Jarzumbek A, Krakowczyk H, Głowinkowska M, Adamczyk P. Pulmonary Function in Paediatric Patients with Inflammatory Bowel Disease. J Clin Med 2022;11. [PMID: 36294415 DOI: 10.3390/jcm11206095] [Reference Citation Analysis]
|
| 33 |
Elmaghrawy K, Fleming P, Fitzgerald K, Cooper S, Dominik A, Hussey S, Moran GP. The oral microbiome in treatment naïve paediatric IBD patients exhibits dysbiosis related to disease severity that resolves following therapy. J Crohns Colitis 2022:jjac155. [PMID: 36239621 DOI: 10.1093/ecco-jcc/jjac155] [Reference Citation Analysis]
|
| 34 |
Breugelmans T, Arras W, Boen LE, Borms E, Kamperdijk L, de Man J, van de Vijver E, van Gils A, de Winter BY, Moes N, Smet A. Aberrant Mucin Expression Profiles Associate With Pediatric Inflammatory Bowel Disease Presentation and Activity. Inflamm Bowel Dis 2022:izac217. [PMID: 36239641 DOI: 10.1093/ibd/izac217] [Reference Citation Analysis]
|
| 35 |
Vanhelst J, Beghin L, Coopman S, Labreuche J, Djeddi D, Gottrand F, Turck D, Ley D. Physical fitness in children and adolescents with inflammatory bowel disease: protocol for a case-control study. BMJ Open 2022;12:e063403. [PMID: 36220315 DOI: 10.1136/bmjopen-2022-063403] [Reference Citation Analysis]
|
| 36 |
Nyström N, Prast-Nielsen S, Correia M, Globisch D, Engstrand L, Schuppe Koistinen I, Halfvarson J. Mucosal and plasma metabolomes in new-onset paediatric inflammatory bowel disease: correlations with disease characteristics and plasma inflammation protein markers. J Crohns Colitis 2022:jjac149. [PMID: 36219554 DOI: 10.1093/ecco-jcc/jjac149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 37 |
S Akkelle B, Ertem D, Volkan B, Tutar E. Phenotypic Pattern of Early Versus Later-Onset Pediatric Inflammatory Bowel Disease in a Eurasian Country. J Pediatr Gastroenterol Nutr 2022;75:e61-6. [PMID: 35809240 DOI: 10.1097/MPG.0000000000003557] [Reference Citation Analysis]
|
| 38 |
Choi SY, Choi S, Kang B, Choe BH, Lee YJ, Park JH, Kim YB, Kim JY, Lee K, Lee KJ, Kang KS, Lee YM, Kim HJ, Kang Y, Jang HJ, Yi DY, Hong SJ, Choi YJ, Hong J, Kim SC. Epidemiological Trends of Pediatric Inflammatory Bowel Disease in Korea: A Multicenter Study of the Last 3 Years Including the COVID-19 Era. J Korean Med Sci 2022;37:e279. [PMID: 36163477 DOI: 10.3346/jkms.2022.37.e279] [Reference Citation Analysis]
|
| 39 |
Leiz M, Knorr M, Moon K, Tischler L, Sohrabi K, Cantez S, Däbritz J, de Laffolie J, Berg NVD. Can patient registries contribute to guideline-based healthcare? A retrospective analysis of the CEDATA-GPGE registry for pediatric inflammatory bowel disease.. [DOI: 10.21203/rs.3.rs-1901469/v1] [Reference Citation Analysis]
|
| 40 |
Penagini F, Calcaterra V, Dilillo D, Vandoni M, Gianolio L, Gatti A, Rendo G, Giuriato M, Cococcioni L, De Silvestri A, Zuccotti G. Self-Perceived Physical Level and Fitness Performance in Children and Adolescents with Inflammatory Bowel Disease. Children (Basel) 2022;9. [PMID: 36138708 DOI: 10.3390/children9091399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 41 |
Atia O, Pujol-Muncunill G, Navas-López VM, Orlanski-Meyer E, Ledder O, Lev-Tzion R, Focht G, Shteyer E, Stein R, Aloi M, Russell RK, Martin-de-Carpi J, Turner D. Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real-world patient mix. Aliment Pharmacol Ther 2022;56:794-801. [PMID: 35735987 DOI: 10.1111/apt.17092] [Reference Citation Analysis]
|
| 42 |
Whaley KG, Xiong Y, Karns R, Hyams JS, Kugathasan S, Boyle BM, Walters TD, Kelsen J, LeLeiko N, Shapiro J, Waddell A, Fox S, Bezold R, Bruns S, Widing R, Haberman Y, Collins MH, Mizuno T, Minar P, D'Haens GR, Denson LA, Vinks AA, Rosen MJ. Multicenter Cohort Study of Infliximab Pharmacokinetics and Therapy Response in Pediatric Acute Severe Ulcerative Colitis. Clin Gastroenterol Hepatol 2022:S1542-3565(22)00812-6. [PMID: 36031093 DOI: 10.1016/j.cgh.2022.08.016] [Reference Citation Analysis]
|
| 43 |
Pietrzak A, Banasiuk M, Szczepanik M, Borys-iwanicka A, Pytrus T, Walkowiak J, Banaszkiewicz A. Sodium Butyrate Effectiveness in Children and Adolescents with Newly Diagnosed Inflammatory Bowel Diseases—Randomized Placebo-Controlled Multicenter Trial. Nutrients 2022;14:3283. [DOI: 10.3390/nu14163283] [Reference Citation Analysis]
|
| 44 |
Lee KJ, Choi SY, Lee YM, Kim HW. Neutralizing Antibody Response, Safety, and Efficacy of mRNA COVID-19 Vaccines in Pediatric Patients with Inflammatory Bowel Disease: A Prospective Multicenter Case-Control Study. Vaccines (Basel) 2022;10:1265. [PMID: 36016153 DOI: 10.3390/vaccines10081265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 45 |
Jain A, Bricker J, Kappelman MD, Dotson JL; ImproveCareNow Pediatric IBD Learning Health System. Overweight and Obese Status Is Not Associated With Disease Activity for Children and Adolescents With Newly Diagnosed Inflammatory Bowel Disease. Am J Gastroenterol 2022;117:1146-53. [PMID: 35470288 DOI: 10.14309/ajg.0000000000001803] [Reference Citation Analysis]
|
| 46 |
Dellon ES, Khoury P, Muir AB, Liacouras CA, Safroneeva E, Atkins D, Collins MH, Gonsalves N, Falk GW, Spergel JM, Hirano I, Chehade M, Schoepfer AM, Menard-Katcher C, Katzka DA, Bonis PA, Bredenoord AJ, Geng B, Jensen ET, Pesek RD, Feuerstadt P, Gupta SK, Lucendo AJ, Genta RM, Hiremath G, McGowan EC, Moawad FJ, Peterson KA, Rothenberg ME, Straumann A, Furuta GT, Aceves SS. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. Gastroenterology 2022;163:59-76. [PMID: 35606197 DOI: 10.1053/j.gastro.2022.03.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 47 |
Klomberg RCW, Aardoom MA, Kemos P, Rizopoulos D, Ruemmele FM, Croft NM, de Ridder L, Neyt M; PIBD-SET Quality consortium. High Impact of Pediatric Inflammatory Bowel Disease on Caregivers' Work Productivity and Daily Activities: An International Prospective Study. J Pediatr 2022;246:95-102.e4. [PMID: 35429506 DOI: 10.1016/j.jpeds.2022.04.014] [Reference Citation Analysis]
|
| 48 |
Shao S, Huang M, Zhang H, Peng G, Song M, Liu J, Xu D. A Retrospective Analysis of Clinical Features and Treatment of the Inflammatory Bowel Disease in China. J Inflamm Res 2022;15:3587-97. [PMID: 35757458 DOI: 10.2147/JIR.S353329] [Reference Citation Analysis]
|
| 49 |
Attauabi M, Madsen GR, Bendtsen F, Wewer AV, Wilkens R, Ilvemark J, Vladimirova N, Jensen AB, Jensen FK, Hansen SB, Siebner HR, Nielsen YJW, Møller JM, Thomsen HS, Thomsen SF, Ingels HAS, Theede K, Boysen T, Bjerrum JT, Jakobsen C, Dorn-Rasmussen M, Jansson S, Yao Y, Burian EA, Møller FT, Fana V, Wiell C, Terslev L, Østergaard M, Bertl K, Stavropoulos A, Seidelin JB, Burisch J. Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study. BMJ Open 2022;12:e055779. [PMID: 35760545 DOI: 10.1136/bmjopen-2021-055779] [Reference Citation Analysis]
|
| 50 |
Curci D, Lucafò M, Parisse P, Decorti G, Bramuzzo M, Casalis L, Stocco G. Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease. J Pers Med 2022;12. [PMID: 35743733 DOI: 10.3390/jpm12060948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 51 |
Cesa KT, Cunningham CA, Noll RB, Kim SC. Parental Distress in Pediatric Inflammatory Bowel Diseases: Associations With Time From Diagnosis, Disease Activity, and Demographic Factors. Crohns Colitis 360 2022;4:otac019. [PMID: 35783219 DOI: 10.1093/crocol/otac019] [Reference Citation Analysis]
|
| 52 |
Chen Y, Xiao F, Wang Y, Sun M, Teng X. Analysis of the Clinical Efficacy of Infliximab in the Treatment of Steroid-Refractory Ulcerative Colitis in Children. Iran J Pediatr 2022;32. [DOI: 10.5812/ijp-119605] [Reference Citation Analysis]
|
| 53 |
Kaplan HC, Opipari-Arrigan L, Yang J, Schmid CH, Schuler CL, Saeed SA, Braly KL, Chang F, Murphy L, Dodds CM, Nuding M, Liu H, Pilley S, Stone J, Woodward G, Yokois N, Goyal A, Lee D, Yeh AM, Lee P, Gold BD, Molle-Rios Z, Zwiener RJ, Ali S, Chavannes M, Linville T, Patel A, Ayers T, Bassett M, Boyle B, Palomo P, Verstraete S, Dorsey J, Kaplan JL, Steiner SJ, Nguyen K, Burgis J, Suskind DL; ImproveCareNow Pediatric IBD Learning Health System. Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease: A Series of N-of-1 Diet Trials. Am J Gastroenterol 2022;117:902-17. [PMID: 35442220 DOI: 10.14309/ajg.0000000000001800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 54 |
Ishihara J, Arai K, Kudo T, Nambu R, Tajiri H, Aomatsu T, Abe N, Kakiuchi T, Hashimoto K, Sogo T, Takahashi M, Etani Y, Yasuda R, Sakaguchi H, Konishi KI, Obara H, Kakuma T, Yamashita Y, Mizuochi T. Serum Zinc and Selenium in Children with Inflammatory Bowel Disease: A Multicenter Study in Japan. Dig Dis Sci 2022;67:2485-91. [PMID: 34101059 DOI: 10.1007/s10620-021-07078-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 55 |
Bollegala N, Barwick M, Fu N, Griffiths AM, Keefer L, Kohut SA, Kroeker KI, Lawrence S, Lee K, Mack DR, Walters TD, de Guzman J, Tersigni C, Miatello A, Benchimol EI. Multimodal intervention to improve the transition of patients with inflammatory bowel disease from pediatric to adult care: protocol for a randomized controlled trial. BMC Gastroenterol 2022;22:251. [PMID: 35585484 DOI: 10.1186/s12876-022-02307-9] [Reference Citation Analysis]
|
| 56 |
Krawiec P, Opoka-winiarska V, Pac-kożuchowska E. Is It Inflammatory Bowel Disease Flare or Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19? JCM 2022;11:2765. [DOI: 10.3390/jcm11102765] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 57 |
Ninh G, Kallemose T, Wewer V, Jakobsen C. Incidence, Disease Course, and Medical Treatment of a Danish Population-Based Cohort of Very Early-Onset Inflammatory Bowel Disease. GastroHep 2022;2022:1-11. [DOI: 10.1155/2022/3507028] [Reference Citation Analysis]
|
| 58 |
Dellon ES, Khoury P, Muir AB, Liacouras CA, Safroneeva E, Atkins D, Collins MH, Gonsalves N, Falk GW, Spergel JM, Hirano I, Chehade M, Schoepfer AM, Menard-katcher C, Katzka DA, Bonis PA, Bredenoord AJ, Geng B, Jensen ET, Pesek RD, Feuerstadt P, Gupta SK, Lucendo AJ, Genta RM, Hiremath G, Mcgowan EC, Moawad FJ, Peterson KA, Rothenberg ME, Straumann A, Furuta GT, Aceves SS. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. Journal of Allergy and Clinical Immunology 2022. [DOI: 10.1016/j.jaci.2022.03.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 59 |
Dilillo A, Del Giudice E, Cucchiara S, Viola F, Maliardo S, Isoldi S, Lorfida D, Bloise S, Marcellino A, Martucci V, Sanseviero M, De Luca E, Protano C, Marotta D, Ventriglia F, Lubrano R. Evaluation of Risk for Thromboembolic Events in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2022;74:599-604. [PMID: 35129153 DOI: 10.1097/MPG.0000000000003398] [Reference Citation Analysis]
|
| 60 |
Légeret C, Furlano R, Köhler H. Therapy Strategies for Children Suffering from Inflammatory Bowel Disease (IBD)—A Narrative Review. Children 2022;9:617. [DOI: 10.3390/children9050617] [Reference Citation Analysis]
|
| 61 |
Gordon RJ, Wells R, Johansen C, Liu S, Dahlberg SE, Snapper SB, Rufo PA. Efficacy and Safety of High-dose Cholecalciferol in Patients With Inflammatory Bowel Disease Receiving Infliximab. J Pediatr Gastroenterol Nutr 2022;74:476-83. [PMID: 35045559 DOI: 10.1097/MPG.0000000000003386] [Reference Citation Analysis]
|
| 62 |
Xia H, Li S, He Y, Ren Q, Qin S. Long non-coding RNA ANRIL serves as a potential marker of disease risk, inflammation, and disease activity of pediatric inflammatory bowel disease. Clin Res Hepatol Gastroenterol 2022;46:101895. [PMID: 35227955 DOI: 10.1016/j.clinre.2022.101895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 63 |
Le Berre C, Ricciuto A, Peyrin-Biroulet L, Turner D. Evolving Short- and Long-Term Goals of Management of Inflammatory Bowel Diseases: Getting It Right, Making It Last. Gastroenterology 2022;162:1424-38. [PMID: 34995529 DOI: 10.1053/j.gastro.2021.09.076] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 64 |
von Graffenried T, Schoepfer AM, Rossel J, Greuter T, Safroneeva E, Godat S, Henchoz S, Vavricka SR, Sokollik C, Spalinger J, Braegger CP, Nydegger A, on behalf of the Swiss IBD Cohort Study Group. Impact of Overweight and Obesity on Disease Outcome in the Pediatric Swiss Inflammatory Bowel Disease Cohort. JPGN Reports 2022;3:e193. [DOI: 10.1097/pg9.0000000000000193] [Reference Citation Analysis]
|
| 65 |
Bouazzi M, Bak NF, Agnholt J, Wewer V, Malham M, Bendix M. Paediatric Crohn’s Disease Patients Have Increased Inflammatory Markers Compared to Adult Patients prior to Biological Treatment. GastroHep 2022;2022:1-11. [DOI: 10.1155/2022/9550908] [Reference Citation Analysis]
|
| 66 |
Kuloglu Z, Çetin F, Urgancı N, Önal Z, Sarı S, Yüksekkaya H, Çaltepe G, Kutluk G, Dumlupinar E; Turkish Inflammatory Bowel Disease Study Group. Nutritional characteristic of children with inflammatory bowel disease in the nationwide inflammatory bowel disease registry from the Mediterranean region. Eur J Clin Nutr 2022. [PMID: 35173290 DOI: 10.1038/s41430-022-01094-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 67 |
Venkateswaran S, Somineni HK, Matthews JD, Kilaru V, Hyams JS, Denson LA, Kellamayer R, Gibson G, Cutler DJ, Conneely KN, Smith AK, Kugathasan S. Longitudinal DNA Methylation Profiling of the Rectal Mucosa Identifies Cell-specific Signatures of Disease Status, Severity and Clinical Outcomes in Ulcerative Colitis.. [DOI: 10.1101/2022.01.28.22269598] [Reference Citation Analysis]
|
| 68 |
Panova I, FSBEI (Federal state budget educational institution) HE (higher education) «Rostov state medical university» Ministry of Health of the Russian Federation, Dombayan SK, Letifov GM, FSBEI (Federal state budget educational institution) HE (higher education) «Rostov state medical university» Ministry of Health of the Russian Federation, FSBEI (Federal state budget educational institution) HE (higher education) «Rostov state medical university» Ministry of Health of the Russian Federation. Regional features of the course of ulcerative colitis: clinical observations (on the example of Rostov-on-Don). General Physician 2022. [DOI: 10.33920/med-12-2202-05] [Reference Citation Analysis]
|
| 69 |
Shentova-eneva R, Yankov I. Pediatric Ulcerative Colitis. Ulcerative Colitis [Working Title] 2022. [DOI: 10.5772/intechopen.102226] [Reference Citation Analysis]
|
| 70 |
Labriola F, Marcato C, Zarbo C, Betti L, Catelli A, Valerii MC, Spisni E, Alvisi P. Dietary Habits of a Group of Children with Crohn’s Disease Compared to Healthy Subjects: Assessment of Risk of Nutritional Deficiencies through a Bromatological Analysis. Nutrients 2022;14:499. [DOI: 10.3390/nu14030499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 71 |
Bousvaros A. Management of Pediatric Patients Hospitalized with Ulcerative. Management of Inpatient Inflammatory Bowel Disease 2022. [DOI: 10.1007/978-1-0716-1987-2_11] [Reference Citation Analysis]
|
| 72 |
Krishnakumar C, Ananthakrishnan AN, Boyle BM, Griffiths AM, LeLeiko NS, Mack DR, Markowitz JF, Rosh JR, Sauer CG, Walters TD, Bonkowski E, Denson LA, Hyams JS, Kugathasan S. Early Change in Fecal Calprotectin Predicts One-Year Outcome in Children Newly Diagnosed With Ulcerative Colitis. J Pediatr Gastroenterol Nutr 2022;74:72-8. [PMID: 34433783 DOI: 10.1097/MPG.0000000000003291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 73 |
Rao A, Gokhale R. Ulcerative Colitis. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition 2022. [DOI: 10.1007/978-3-030-80068-0_30] [Reference Citation Analysis]
|
| 74 |
Choi SY, Kang B. Adalimumab in Pediatric Inflammatory Bowel Disease. Front Pediatr 2022;10:852580. [PMID: 35498800 DOI: 10.3389/fped.2022.852580] [Reference Citation Analysis]
|
| 75 |
Brar MS, Macrae H. IBD Diagnosis and Evaluation. The ASCRS Textbook of Colon and Rectal Surgery 2022. [DOI: 10.1007/978-3-030-66049-9_44] [Reference Citation Analysis]
|
| 76 |
Kishi M, Hirai F, Takatsu N, Hisabe T, Takada Y, Beppu T, Takeuchi K, Naganuma M, Ohtsuka K, Watanabe K, Matsumoto T, Esaki M, Koganei K, Sugita A, Hata K, Futami K, Ajioka Y, Tanabe H, Iwashita A, Shimizu H, Arai K, Suzuki Y, Hisamatsu T. A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation. J Gastroenterol 2022;57:246-66. [PMID: 35235037 DOI: 10.1007/s00535-022-01862-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 77 |
van Hoeve K, Seyed Tabib NS, Dreesen E, Tops S, Hoffman I, Gils A, Ferrante M, Vermeire S. Infliximab Concentrations during Induction Are Predictive for Endoscopic Remission in Pediatric Patients with Inflammatory Bowel Disease under Combination Therapy. J Pediatr 2022;240:150-157.e4. [PMID: 34481805 DOI: 10.1016/j.jpeds.2021.08.079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 78 |
Bosa L, Di Chiara C, Gaio P, Cosma C, Padoan A, Cozzani S, Perilongo G, Plebani M, Giaquinto C, Donà D, Cananzi M. Protective SARS-CoV-2 Antibody Response in Children With Inflammatory Bowel Disease. Front Pediatr 2022;10:815857. [PMID: 35223697 DOI: 10.3389/fped.2022.815857] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 79 |
Oba J, Sobrado CW, Damião AOMC, Azevedo M, Carlos A, Queiroz N, Len CA, Toma RK, Deboni M, Ozaki MJ, Carrilho FJ, Nahas S, Silva CA. HEALTH-RELATED QUALITY OF LIFE IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH REDUCTION IN SCHOOL AND WORK PRODUCTIVITY RATHER THAN PHYSICAL IMPAIRMENT: A MULTIDISCIPLINARY STUDY. Arq Gastroenterol 2021;58:541-7. [PMID: 34909863 DOI: 10.1590/S0004-2803.202100000-96] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 80 |
Bayrak NA, Polat E, Erdogan F. Cytomegalovirus Colitis in Immunocompetent and Immunocompromised Children: A 2-Center Study. Pediatr Infect Dis J 2021;40:1101-7. [PMID: 34609104 DOI: 10.1097/INF.0000000000003339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 81 |
van de Guchte M, Mondot S, Doré J. Dynamic Properties of the Intestinal Ecosystem Call for Combination Therapies, Targeting Inflammation and Microbiota, in Ulcerative Colitis. Gastroenterology 2021;161:1969-1981.e12. [PMID: 34508776 DOI: 10.1053/j.gastro.2021.08.057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 82 |
Jang HJ, Suh HR, Choi S, Hong SJ, Cho SM, Choi KH, Choe BH, Kang B; Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD). Severe Disease Activity Based on the Paris Classification Is Associated with the Development of Extraintestinal Manifestations in Korean Children and Adolescents with Ulcerative Colitis. J Korean Med Sci 2021;36:e278. [PMID: 34783212 DOI: 10.3346/jkms.2021.36.e278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 83 |
Bouhuys M, Lexmond WS, Dijkstra G, Lobatón T, Louis E, van Biervliet S, Groen H, Guardiola J, Rheenen PV. Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study): protocol for a partially randomised patient preference trial. BMJ Open 2021;11:e054154. [PMID: 34732500 DOI: 10.1136/bmjopen-2021-054154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 84 |
Acar B, Gümüş E, Özcan-Bulut S, Özşin-Özler C, Boyraz MS, Tan Ç, Yaz I, Özbek B, Cagdas D, Saltık-Temizel İN, Demir H, Özen H, Karabulut E, Tezcan İ, Yüce A, Berker E. Cytokine profile in serum and gingival crevicular fluid of children with inflammatory bowel disease: A case-control study. J Periodontol 2021. [PMID: 34730850 DOI: 10.1002/JPER.21-0514] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 85 |
Story E, Bijelic V, Penney C, Benchimol EI, Halton J, Mack DR. Safety of Venous Thromboprophylaxis With Low-molecular-weight Heparin in Children With Ulcerative Colitis. J Pediatr Gastroenterol Nutr 2021;73:604-9. [PMID: 34676833 DOI: 10.1097/MPG.0000000000003231] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 86 |
Li H, Zhang X, Chen R, Cheng K, Ning Z, Li J, Twine S, Stintzi A, Mack D, Figeys D. Elevated colonic microbiota-associated paucimannosidic and truncated N-glycans in pediatric ulcerative colitis. J Proteomics 2021;249:104369. [PMID: 34481999 DOI: 10.1016/j.jprot.2021.104369] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 87 |
Sherlock ME, Zachos M, Issenman RM, Mulder DJ. Clinical and Laboratory Characteristics Are Associated With Biologic Therapy Use in Pediatric Inflammatory Bowel Disease: A Retrospective Cohort Study. J Can Assoc Gastroenterol 2021;4:e92-e100. [PMID: 34617006 DOI: 10.1093/jcag/gwaa033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 88 |
Ricciuto A, Carman N, Benchimol EI, Siddiqui I, Putra J, Khanna R, Griffiths AM, Walters TD, Church PC. Prospective Evaluation of Endoscopic and Histologic Indices in Pediatric Ulcerative Colitis Using Centralized Review. Am J Gastroenterol 2021;116:2052-9. [PMID: 34388139 DOI: 10.14309/ajg.0000000000001400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 89 |
Rubalcava NS, Gadepalli SK, Criss CN, Moreno NA, Adler J, Geiger JD. Single-stage restorative proctocolectomy for ulcerative colitis in pediatric patients: a safe alternative. Pediatr Surg Int 2021;37:1453-9. [PMID: 34143272 DOI: 10.1007/s00383-021-04943-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 90 |
Vanhelst J, Béghin L, Turck D, Labreuche J, Coopman S, Gottrand F, Ley D. Daily physical activity patterns in children and adolescents with inflammatory bowel disease. Pediatr Res 2021;90:847-52. [PMID: 33469176 DOI: 10.1038/s41390-020-01313-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 91 |
Lipstein EA, Brinkman WB, Zhang Y, Hommel KA, Ittenbach RF, Liu C, Denson LA. Decision making about anti-TNF therapy: A pilot trial of a shared decision-making intervention. Patient Educ Couns 2021:S0738-3991(21)00639-X. [PMID: 34629231 DOI: 10.1016/j.pec.2021.09.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 92 |
Ricciuto A, Lamb CA, Benchimol EI, Walker GJ, Kennedy NA, Kuenzig ME, Kaplan GG, Kappelman MD, Ungaro RC, Colombel JF, Brenner EJ, Agrawal M, Reinisch W, Griffiths AM, Sebastian S. Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients. J Crohns Colitis 2022;16:591-600. [PMID: 34570886 DOI: 10.1093/ecco-jcc/jjab172] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 93 |
Alhalabi M, Eddin KA, Cheha K, Abbas A. Subcutaneous golimumab induced and maintained clinical response in a child with a biological-experienced steroid-refractory flare of ulcerative colitis: A case report. Medicine (Baltimore) 2021;100:e27283. [PMID: 34559136 DOI: 10.1097/MD.0000000000027283] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 94 |
Shentova-eneva R, Kofinova D, Hadzhiyski P, Yaneva P, Lazarova E, Baycheva M. Anemia in Newly Diagnosed Pediatric Patients with Inflammatory Bowel Disease. Gastroenterology Insights 2021;12:376-83. [DOI: 10.3390/gastroent12040036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 95 |
Gatti S, Del Baldo G, Catassi G, Faragalli A, Aloi M, Bramuzzo M, D'Arcangelo G, Felici E, Fuoti M, Lega S, Panceri R, Pastore M, Penagini F, Gesuita R, Catassi C. Factors associated with quality of life in Italian children and adolescents with IBD. Sci Rep 2021;11:18076. [PMID: 34508152 DOI: 10.1038/s41598-021-97661-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 96 |
Starr AE, Deeke SA, Ning Z, de Nanassy J, Singleton R, Benchimol EI, Mack DR, Stintzi A, Figeys D. Associations between Cellular Energy and Pediatric Inflammatory Bowel Disease Patient Response to Treatment. J Proteome Res 2021;20:4393-404. [PMID: 34424714 DOI: 10.1021/acs.jproteome.1c00341] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 97 |
Moore H, Dubes L, Fusillo S, Baldassano R, Stein R. Tofacitinib Therapy in Children and Young Adults With Pediatric-onset Medically Refractory Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2021;73:e57-62. [PMID: 34091545 DOI: 10.1097/MPG.0000000000003190] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 98 |
Ezirike Ladipo J, He Z, Chikwava K, Robbins K, Beri J, Molle-Rios Z. Oncostatin-M Does Not Predict Treatment Response in Inflammatory Bowel Disease in a Pediatric Cohort. J Pediatr Gastroenterol Nutr 2021;73:352-7. [PMID: 34117193 DOI: 10.1097/MPG.0000000000003201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 99 |
Chien MM, Chang MH, Chang KC, Chiu YC, Chen HL, Hsu HY, Wu JF. The characteristics of pediatric ulcerative colitis with primary sclerosing cholangitis: A single-center study in Taiwan. Pediatr Neonatol 2021;62:483-90. [PMID: 34074613 DOI: 10.1016/j.pedneo.2021.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 100 |
Atia O, Gupta A, Travis S, Turner D, Koslowsky B. The pediatric ulcerative colitis activity index (PUCAI) predicts steroid-failure in adults with acute severe colitis. Scand J Gastroenterol 2021;56:1049-55. [PMID: 34261387 DOI: 10.1080/00365521.2021.1947368] [Reference Citation Analysis]
|
| 101 |
Kudo T, Fujii T, Maisawa SI, Sasaki M, Uchida K, Ida S, Kagimoto S, Yoden A, Shimizu T. A Multicenter Prospective Survey on Early-Onset Inflammatory Bowel Disease in Japan. Digestion 2021;102:368-76. [PMID: 32422640 DOI: 10.1159/000507570] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 102 |
Dhaliwal J, Carroll MW, deBruyn JC, Ricciuto A, Benchimol EI, Lawrence S, Sherlock M, El-Matary W, Brill H, Church P, Wine E, Carman N, Muise A, Huynh H, Mack DR, Walters TD, Griffiths AM, Jacobson K. The Phenotypic Spectrum of New-onset IBD in Canadian Children of South Asian Ethnicity: A Prospective Multi-Centre Comparative Study. J Crohns Colitis 2022;16:216-23. [PMID: 34379117 DOI: 10.1093/ecco-jcc/jjab143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 103 |
Rubalcava NS, Gadepalli SK. Inflammatory Bowel Disease in Children and Adolescents. Adv Pediatr 2021;68:121-42. [PMID: 34243849 DOI: 10.1016/j.yapd.2021.05.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 104 |
O'Connor E, Sugarman I, Patel Y, Jaffray B. Severity of complications following restorative proctocolectomy in children is related to staging not diagnosis. J Pediatr Surg 2021;56:1330-4. [PMID: 32972742 DOI: 10.1016/j.jpedsurg.2020.08.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 105 |
Jasielska M, Grzybowska-Chlebowczyk U. Hypocalcemia and Vitamin D Deficiency in Children with Inflammatory Bowel Diseases and Lactose Intolerance. Nutrients 2021;13:2583. [PMID: 34444743 DOI: 10.3390/nu13082583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 106 |
Holbein CE, Plevinsky J, Patel T, Conrad MC, Kelsen JR. Pediatric Global Health in Children with Very Early-Onset Inflammatory Bowel Disease. J Pediatr Psychol 2021:jsab035. [PMID: 34313785 DOI: 10.1093/jpepsy/jsab035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 107 |
Sicilia B, García-López S, González-Lama Y, Zabana Y, Hinojosa J, Gomollón F; Grupo Español de Trabajo de Enfermedad de Crohn., Colitis Ulcerosa o Spanish Group for Working on Crohn's Disease and Ulcerative Colitis (GETECCU). GETECCU 2020 guidelines for the treatment of ulcerative colitis. Developed using the GRADE approach. Gastroenterol Hepatol 2020;43 Suppl 1:1-57. [PMID: 32807301 DOI: 10.1016/j.gastrohep.2020.07.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 108 |
Ono S, Takeshita K, Kiridoshi Y, Kato M, Kamiya T, Hoshino A, Yanagimachi M, Arai K, Takeuchi I, Toita N, Imamura T, Sasahara Y, Sugita J, Hamamoto K, Takeuchi M, Saito S, Onuma M, Tsujimoto H, Yasui M, Taga T, Arakawa Y, Mitani Y, Yamamoto N, Imai K, Suda W, Hattori M, Ohara O, Morio T, Honda K, Kanegane H. Hematopoietic Cell Transplantation Rescues Inflammatory Bowel Disease and Dysbiosis of Gut Microbiota in XIAP Deficiency. J Allergy Clin Immunol Pract 2021:S2213-2198(21)00765-0. [PMID: 34246792 DOI: 10.1016/j.jaip.2021.05.045] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 109 |
Brenner EJ, Long MD, Mann CM, Lin L, Chen W, Reyes C, Bahnson KM, Reeve BB, Kappelman MD. Validity and Responsiveness of the Patient-reported Outcomes Measurement Information System in Children With Ulcerative Colitis. J Pediatr Gastroenterol Nutr 2021;73:67-72. [PMID: 33633083 DOI: 10.1097/MPG.0000000000003101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 110 |
Ito N, Takeuchi I, Kyodo R, Hirano Y, Sato T, Usami M, Shimizu H, Shimizu T, Arai K. Features and Outcomes of Children with Ulcerative Colitis who Undergo a Diagnostic Change: A Single-Center Experience. Pediatr Gastroenterol Hepatol Nutr 2021;24:357-65. [PMID: 34316470 DOI: 10.5223/pghn.2021.24.4.357] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 111 |
Batra SK, Rahman S, Rana MS, Chaisson E, Moya D, Sebastian T. Postoperative Complications in Pediatric IBD Patients on Biologic Therapy Undergoing Intra-abdominal Surgery. SN Compr Clin Med 2021;3:1544-1550. [DOI: 10.1007/s42399-021-00919-y] [Reference Citation Analysis]
|
| 112 |
Reed B, Rea KE, Claar RL, van Tilburg MAL, Levy RL. Passive Coping Associations With Self-Esteem and Health-Related Quality of Life in Youth With Inflammatory Bowel Disease. Front Psychol 2021;12:670902. [PMID: 34248766 DOI: 10.3389/fpsyg.2021.670902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 113 |
Ashton JJ, Marino LV, Johnson MJ, Newell C, Price G, Dewar H, Brampton R, Ennis S, Griffiths M, Coelho T, Batra A, Afzal N, Beattie RM. Bioelectrical spectroscopy impedance phase angle is not associated with nutritional status in a stable cohort of paediatric inflammatory bowel disease patients. Clin Nutr ESPEN 2021;44:276-81. [PMID: 34330479 DOI: 10.1016/j.clnesp.2021.06.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 114 |
Hajjat TM, Mosha M, Whaley KG, Rosen MJ, Suppa C, Markowitz J, Dufour L, Sauer C, Shukla-Udawatta M, Boyle B, Gibson M, Shapiro J, Sams D, Sylvester F, Hunter G, Perez ME, Hyams JS. Vedolizumab Experience in Children and Adolescents With Inflammatory Bowel Disease: A Multicenter Observational Study. Crohns Colitis 360 2021;3:otab039. [PMID: 36776669 DOI: 10.1093/crocol/otab039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 115 |
Fisher K, Byham-Gray L, Rothpletz-Puglia P. Characterizing the Parental Perspective of Food-Related Quality of Life in Families After Pediatric Inflammatory Bowel Disease Diagnosis. Gastroenterol Nurs 2021;44:E69-77. [PMID: 34149042 DOI: 10.1097/SGA.0000000000000616] [Reference Citation Analysis]
|
| 116 |
Ballesio A, Zagaria A, Baccini F, Micheli F, Di Nardo G, Lombardo C. A meta-analysis on sleep quality in inflammatory bowel disease. Sleep Med Rev 2021;60:101518. [PMID: 34214847 DOI: 10.1016/j.smrv.2021.101518] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 117 |
Rubalcava NS, Moreno NA, Adler J, Geiger JD, Hirschl RB, Gadepalli SK. Does the timing of pouch creation in 2-stage operations for pediatric patients with ulcerative colitis matter? J Pediatr Surg 2021;56:1203-7. [PMID: 33741179 DOI: 10.1016/j.jpedsurg.2021.02.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 118 |
Mizuochi T, Arai K, Kudo T, Nambu R, Tajiri H, Aomatsu T, Abe N, Kakiuchi T, Hashimoto K, Sogo T, Takahashi M, Etani Y, Takaki Y, Konishi KI, Ishihara J, Obara H, Kakuma T, Kurei S, Yamashita Y, Mitsuyama K. Diagnostic accuracy of serum proteinase 3 antineutrophil cytoplasmic antibodies in children with ulcerative colitis. J Gastroenterol Hepatol 2021;36:1538-44. [PMID: 33047817 DOI: 10.1111/jgh.15296] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 119 |
Dhaliwal J, McKay HE, Deslandres C, Debruyn J, Wine E, Wu A, Huynh H, Carman N, Crowley E, Church PC, Walters TD, Ricciuto A, Griffiths AM; Canadian Children IBD Network. One-year outcomes with ustekinumab therapy in infliximab-refractory paediatric ulcerative colitis: a multicentre prospective study. Aliment Pharmacol Ther 2021;53:1300-8. [PMID: 33909911 DOI: 10.1111/apt.16388] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 120 |
Atlan L, Cohen S, Shiran S, Sira LB, Pratt LT, Yerushalmy-Feler A. Sarcopenia is a Predictor for Adverse Clinical Outcome in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2021;72:883-8. [PMID: 33720095 DOI: 10.1097/MPG.0000000000003091] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 121 |
Li H, Zhang X, Chen R, Cheng K, Ning Z, Li J, Twine S, Stintzi A, Mack D, Figeys D. Elevated colonic microbiota-associated paucimannosidic and truncated N-glycans in pediatric ulcerative colitis.. [DOI: 10.1101/2021.05.27.446002] [Reference Citation Analysis]
|
| 122 |
Stapersma L, van den Brink G, van der Ende J, Szigethy EM, Groeneweg M, de Bruijne FH, Hillegers MHJ, Escher JC, Utens EMWJ. Psychological Outcomes of a Cognitive Behavioral Therapy for Youth with Inflammatory Bowel Disease: Results of the HAPPY-IBD Randomized Controlled Trial at 6- and 12-Month Follow-Up. J Clin Psychol Med Settings 2020;27:490-506. [PMID: 31506853 DOI: 10.1007/s10880-019-09649-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 123 |
Somineni HK, Weitzner JH, Venkateswaran S, Dodd A, Prince J, Karikaran A, Sauer CG, Abramowicz S, Zwick ME, Cutler DJ, Okou DT, Chopra P, Kugathasan S. Site- and Taxa-Specific Disease-Associated Oral Microbial Structures Distinguish Inflammatory Bowel Diseases. Inflamm Bowel Dis 2021;27:1889-900. [PMID: 34002220 DOI: 10.1093/ibd/izab082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 124 |
Click B, Barnes EL, Cohen BL, Sands BE, Hanson JS, Regueiro M, Rubin DT, Dubinsky MC, Gazis DR, Dalfonso L, Hildebrand JS, Crawford JM, Long MD. Methodology and Initial Results From a Real-World Observational Cohort of Patients With Inflammatory Bowel Disease: TARGET-IBD. Crohns Colitis 360 2021;3:otab023. [PMID: 36776639 DOI: 10.1093/crocol/otab023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 125 |
Carlsen K, Frederiksen NW, Wewer V. Integration of eHealth Into Pediatric Inflammatory Bowel Disease Care is Safe: 3 Years of Follow-up of Daily Care. J Pediatr Gastroenterol Nutr 2021;72:723-7. [PMID: 33470751 DOI: 10.1097/MPG.0000000000003053] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 126 |
Corrêa FF, Sdepanian VL. BODY IRON STATUS INDICATORS AND INFLAMMATION INDICATORS DURING INFLAMMATORY BOWEL DISEASE THERAPY IN CHILDREN AND ADOLESCENTES. Arq Gastroenterol 2021;58:48-54. [PMID: 33909796 DOI: 10.1590/S0004-2803.202100000-09] [Reference Citation Analysis]
|
| 127 |
Hyams JS, Brimacombe M, Haberman Y, Walters T, Gibson G, Mo A, Mack D, Griffiths A, Boyle B, LeLeiko N, Markowitz J, Rosh J, Patel A, Shah S, Baldassano R, Pfefferkorn M, Sauer C, Dailey J, Venkateswaran S, Kugathasan S, Denson LA. Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis. Inflamm Bowel Dis 2022;28:151-60. [PMID: 33904583 DOI: 10.1093/ibd/izab061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 128 |
Murphy LK, de la Vega R, Kohut SA, Kawamura JS, Levy RL, Palermo TM. Systematic Review: Psychosocial Correlates of Pain in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:697-710. [PMID: 32458966 DOI: 10.1093/ibd/izaa115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 129 |
Dembiński Ł, Stelmaszczyk-Emmel A, Sznurkowska K, Szlagatys-Sidorkiewicz A, Radzikowski A, Banaszkiewicz A. Immunogenicity of cholera vaccination in children with inflammatory bowel disease. Hum Vaccin Immunother 2021;17:2586-92. [PMID: 33794737 DOI: 10.1080/21645515.2021.1884475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 130 |
Cohen ME, Deepak P, Khanna G, Samson CM. Evaluation of Nonalcoholic Fatty Liver Disease in Pediatric Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2021;72:574-8. [PMID: 33346578 DOI: 10.1097/MPG.0000000000003023] [Reference Citation Analysis]
|
| 131 |
Turner D, Ricciuto A, Lewis A, D'Amico F, Dhaliwal J, Griffiths AM, Bettenworth D, Sandborn WJ, Sands BE, Reinisch W, Schölmerich J, Bemelman W, Danese S, Mary JY, Rubin D, Colombel JF, Peyrin-Biroulet L, Dotan I, Abreu MT, Dignass A; International Organization for the Study of IBD. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology 2021;160:1570-83. [PMID: 33359090 DOI: 10.1053/j.gastro.2020.12.031] [Cited by in Crossref: 473] [Cited by in F6Publishing: 458] [Article Influence: 236.5] [Reference Citation Analysis]
|
| 132 |
Sarbagili-Shabat C, Weiner D, Wardi J, Abramas L, Yaakov M, Levine A. Moderate-to-severe Endoscopic Inflammation is Frequent After Clinical Remission in Pediatric Ulcerative Colitis. J Pediatr Gastroenterol Nutr 2021;72:569-73. [PMID: 33346576 DOI: 10.1097/MPG.0000000000003018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 133 |
Vernon-roberts A, Gearry RB, Day AS. Overview of Self-Management Skills and Associated Assessment Tools for Children with Inflammatory Bowel Disease. GastrointestDisord 2021;3:61-77. [DOI: 10.3390/gidisord3020007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 134 |
Tsvetkova VS, Potapov AS, Semikina EL, Fisenko AP, Lokhmatov MM, Surkov AN, Anushenko AO, Kopyltsova EA, Budkina TN, Akulova SS. Noninvasive assessment of ulcerative colitis activity in children. RPJ 2021;24:12-19. [DOI: 10.46563/1560-9561-2021-24-1-12-19] [Reference Citation Analysis]
|
| 135 |
Aloi M, Bramuzzo M, Norsa L, Arrigo S, Distante M, Miele E, Romano C, Giobbi C, Panceri R, Cucchiara S, Alvisi P; SIGENP IBD Working Group. IBD Working group. Disease Activity Patterns in the First 5 Years After Diagnosis in Children With Ulcerative Colitis: A Population-Based Study. J Crohns Colitis 2021;15:367-74. [PMID: 33022055 DOI: 10.1093/ecco-jcc/jjaa203] [Reference Citation Analysis]
|
| 136 |
Villemonteix J, Guérin-El Khourouj V, Hugot JP, Giardini C, Carcelain G, Martinez-Vinson C. Comparison of three immunoassays for infliximab trough level monitoring in paediatric inflammatory bowel diseases. Biologicals 2021;70:17-21. [PMID: 33676831 DOI: 10.1016/j.biologicals.2021.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 137 |
Malham M, James JP, Jakobsen C, Hoegdall E, Holmstroem K, Wewer V, Nielsen BS, Riis LB. Mucosal microRNAs relate to age and severity of disease in ulcerative colitis. Aging (Albany NY) 2021;13:6359-74. [PMID: 33647883 DOI: 10.18632/aging.202715] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 138 |
Cortez RV, Moreira LN, Padilha M, Bibas MD, Toma RK, Porta G, Taddei CR. Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis. Front Immunol 2020;11:598152. [PMID: 33613519 DOI: 10.3389/fimmu.2020.598152] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 139 |
Berkovitch G, Cohen S, Lubetzky R, Singer D, Yerushalmy-Feler A. Biologic therapy is associated with a mild decrease in the rate of hospitalizations in pediatric IBD. BMC Pediatr 2021;21:63. [PMID: 33541320 DOI: 10.1186/s12887-021-02526-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 140 |
Ahola Kohut S, Stinson J, Jelen A, Ruskin D. Feasibility and Acceptability of a Mindfulness-Based Group Intervention for Adolescents with Inflammatory Bowel Disease. J Clin Psychol Med Settings 2020;27:68-78. [PMID: 31065861 DOI: 10.1007/s10880-019-09622-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 141 |
Arrigo S, Alvisi P, Banzato C, Bramuzzo M, Civitelli F, Corsello A, D'Arcangelo G, Dilillo A, Dipasquale V, Felici E, Fuoti M, Gatti S, Giusti Z, Knafelz D, Lionetti P, Mario F, Marseglia A, Martelossi S, Moretti C, Norsa L, Nuti F, Panceri R, Rampado S, Renzo S, Romano C, Romeo E, Strisciuglio C, Martinelli M. Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group. Dig Liver Dis 2021;53:183-9. [PMID: 33132063 DOI: 10.1016/j.dld.2020.10.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 142 |
Krawiec P, Pac-Kożuchowska E. Cathelicidin - A Novel Potential Marker of Pediatric Inflammatory Bowel Disease. J Inflamm Res 2021;14:163-74. [PMID: 33519224 DOI: 10.2147/JIR.S288742] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 143 |
Wittmann Dayagi T, Werner L, Pinsker M, Salamon N, Barschak I, Weiss B, Shouval DS. Mucosal IL-10 and IL-10 receptor expression patterns in paediatric patients with ulcerative colitis. Int J Exp Pathol 2021;102:4-10. [PMID: 33405352 DOI: 10.1111/iep.12382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 144 |
Gupta V, Mohsen W, Chapman TP, Satsangi J. Predicting Outcome in Acute Severe Colitis-Controversies in Clinical Practice in 2021. J Crohns Colitis 2021;15:1211-21. [PMID: 33388777 DOI: 10.1093/ecco-jcc/jjaa265] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 145 |
Bitton S, Markowitz JF. Ulcerative Colitis in Children and Adolescents. Pediatric Gastrointestinal and Liver Disease 2021. [DOI: 10.1016/b978-0-323-67293-1.00043-8] [Reference Citation Analysis]
|
| 146 |
Shimizu H, Arai K, Takeuchi I, Minowa K, Hosoi K, Sato M, Oka I, Kaburaki Y, Shimizu T. Long-Term Durability of Infliximab for Pediatric Ulcerative Colitis: A Retrospective Data Review in a Tertiary Children's Hospital in Japan. Pediatr Gastroenterol Hepatol Nutr 2021;24:7-18. [PMID: 33505889 DOI: 10.5223/pghn.2021.24.1.7] [Reference Citation Analysis]
|
| 147 |
Colman RJ, Dhaliwal J, Rosen MJ. Predicting Therapeutic Response in Pediatric Ulcerative Colitis-A Journey Towards Precision Medicine. Front Pediatr 2021;9:634739. [PMID: 33681110 DOI: 10.3389/fped.2021.634739] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 148 |
Rintala RJ, Pakarinen MP, Koivusalo A. Ulcerative Colitis. Pediatric Surgery 2021. [DOI: 10.1007/978-3-662-43559-5_106] [Reference Citation Analysis]
|
| 149 |
Gasparetto M, Payne F, Nayak K, Kraiczy J, Glemas C, Philip-McKenzie Y, Ross A, Edgar RD, Zerbino DR, Salvestrini C, Torrente F, Ventham NT, Kalla R, Satsangi J, Sarkies P, Heuschkel R, Zilbauer M. Transcription and DNA Methylation Patterns of Blood-Derived CD8(+) T Cells Are Associated With Age and Inflammatory Bowel Disease But Do Not Predict Prognosis. Gastroenterology 2021;160:232-244.e7. [PMID: 32814113 DOI: 10.1053/j.gastro.2020.08.017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 150 |
Lucafò M, Curci D, Bramuzzo M, Alvisi P, Martelossi S, Silvestri T, Guastalla V, Labriola F, Stocco G, Decorti G. Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease. Front Pediatr 2021;9:646671. [PMID: 34017806 DOI: 10.3389/fped.2021.646671] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 151 |
King S. Inflammatory Bowel Disease. Pearls and Tricks in Pediatric Surgery 2021. [DOI: 10.1007/978-3-030-51067-1_32] [Reference Citation Analysis]
|
| 152 |
Shaoul R, Day AS. An Overview of Tools to Score Severity in Pediatric Inflammatory Bowel Disease. Front Pediatr 2021;9:615216. [PMID: 33912519 DOI: 10.3389/fped.2021.615216] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 153 |
Scheffers LE, Helbing WA, Utens EMWJ, Dieleman GC, Dulfer K, Noske J, van den Broek EA, Walet S, Olieman JF, Escher JC, Pijnenburg MW, van der Ploeg AT, van den Berg LE. Study Protocol of the Exercise Study: Unraveling Limitations for Physical Activity in Children With Chronic Diseases in Order to Target Them With Tailored Interventions-A Randomized Cross Over Trial. Front Pediatr 2021;9:791701. [PMID: 35118031 DOI: 10.3389/fped.2021.791701] [Reference Citation Analysis]
|
| 154 |
deBruyn JCC, Jacobson K, El-Matary W, Wine E, Carroll MW, Goedhart C, Panaccione R, Wrobel IT, Huynh HQ. Early Serum Infliximab Levels in Pediatric Ulcerative Colitis. Front Pediatr 2021;9:668978. [PMID: 34395336 DOI: 10.3389/fped.2021.668978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 155 |
Koniushevska AA, Sydorenko NV, Vaizer NV, Kramarenko IE, Yakovenko DV, Bokholdin YО. NON-SPECIFIC ULCER COLITIS IN THE PRACTICE OF A PEDIATRICIAN: ETIOLOGY, PATHOGENESIS, CLASSIFICATION, DIAGNOSIS, TREATMENT (REVIEW OF LITERATURE AND OWN OBSERVATION). VPBM 2021;1:278. [DOI: 10.29254/2077-4214-2021-1-159-278-286] [Reference Citation Analysis]
|
| 156 |
Shearer JL, Perry S, Lidyard N, Apperson-Hensen C, DeLozier S, Burkhart K, Katz J, Moses J. Evaluating a Standardized Transition of Care Process for Pediatric Inflammatory Bowel Disease Patients. Children (Basel) 2020;7:E271. [PMID: 33291611 DOI: 10.3390/children7120271] [Reference Citation Analysis]
|
| 157 |
El-Matary W, Carroll MW, Debruyn JC, Huynh H, Wine E, Lawrence S, Chandrakumar A, Morel T, Jacobson K. Discontinuation of Immunosuppressive Medications in Children With Inflammatory Bowel Disease on Combination Therapy. J Pediatr Gastroenterol Nutr 2020;71:740-3. [PMID: 32740529 DOI: 10.1097/MPG.0000000000002857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 158 |
Murphy LK, Suskind DL, Qu P, Zhou C, Gashi K, Kawamura JS, Palermo TM; ImproveCareNow Pediatric IBD Learning Health System, as stipulated by ICN. Abdominal Pain After Pediatric Inflammatory Bowel Disease Diagnosis: Results From the ImproveCareNow Network. J Pediatr Gastroenterol Nutr 2020;71:749-54. [PMID: 32910089 DOI: 10.1097/MPG.0000000000002933] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 159 |
Kucharzik T, Dignass AU, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengießer K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:. Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline. Z Gastroenterol 2020;58:e241-326. [PMID: 33260237 DOI: 10.1055/a-1296-3444] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 160 |
Sznurkowska K, Luty J, Bryl E, Witkowski JM, Hermann-Okoniewska B, Landowski P, Kosek M, Szlagatys-Sidorkiewicz A. Enhancement of Circulating and Intestinal T Regulatory Cells and Their Expression of Helios and Neuropilin-1 in Children with Inflammatory Bowel Disease. J Inflamm Res 2020;13:995-1005. [PMID: 33273840 DOI: 10.2147/JIR.S268484] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 161 |
Banerjee R, Pal P, Nabi Z, Shava U, Ganesh G, Reddy DN. Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset disease. Intest Res 2021;19:398-407. [PMID: 33207854 DOI: 10.5217/ir.2020.00107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 162 |
Gupta N, Liu C, King E, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Colletti R; ImproveCareNow Network. Continued Statural Growth in Older Adolescents and Young Adults With Crohn's Disease and Ulcerative Colitis Beyond the Time of Expected Growth Plate Closure. Inflamm Bowel Dis 2020;26:1880-9. [PMID: 31968095 DOI: 10.1093/ibd/izz334] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 163 |
Seitel T, Cagol L, Prelog M, Frivolt K, Krahl A, Trenkel S, Speth F, Mayer B, Almanzar G, Koletzko S, Debatin KM, Mertens T, Posovszky C. Varicella-zoster-virus vaccination of immunosuppressed children with inflammatory bowel disease or autoimmune hepatitis: A prospective observational study. Vaccine 2020;38:8024-31. [PMID: 33160754 DOI: 10.1016/j.vaccine.2020.10.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 164 |
Grover Z, Alex G. Management of inflammatory bowel disease in children: It is time for an individualised approach. J Paediatr Child Health 2020;56:1677-84. [PMID: 31613039 DOI: 10.1111/jpc.14652] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 165 |
Ivković L, Hojsak I, Trivić I, Sila S, Hrabač P, Konjik V, Senečić-Čala I, Palčevski G, Despot R, Žaja O, Kolaček S. Incidence and Geographical Variability of Pediatric Inflammatory Bowel Disease in Croatia: Data From the Croatian National Registry for Children With Inflammatory Bowel Disease. Clin Pediatr (Phila) 2020;59:1182-90. [PMID: 32674589 DOI: 10.1177/0009922820941202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 166 |
Dhingani N, Guo C, Pan J, Li Q, Warner N, Jardine S, Leung G, Kotlarz D, Gonzaga-Jauregui C, Klein C, Snapper SB, Navas-López VM, Muise AM. The E3 ubiquitin ligase UBR5 interacts with TTC7A and may be associated with very early onset inflammatory bowel disease. Sci Rep 2020;10:18648. [PMID: 33122718 DOI: 10.1038/s41598-020-73482-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 167 |
Turner D, Bishai J, Reshef L, Abitbol G, Focht G, Marcus D, Ledder O, Lev-Tzion R, Orlanski-Meyer E, Yerushalmi B, Aloi M, Griffiths AM, Albenberg L, Kolho KL, Assa A, Cohen S, Gophna U, Vlamakis H, Lurz E, Levine A. Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial. Inflamm Bowel Dis 2020;26:1733-42. [PMID: 31833543 DOI: 10.1093/ibd/izz298] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 168 |
Polat E, Çınar Z, Keskindemirci G, Yiğit Ö, Kutluk G, Türe M, Akça T, Alkaya E. Assessment of Hearing Function in Children with Inflammatory Bowel Disease. J Int Adv Otol 2020;16:362-6. [PMID: 33136017 DOI: 10.5152/iao.2020.6035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 169 |
Ikeuchi A, Kakiuchi T, Ibi A, Matsuo M. A pediatric case of moderate active ulcerative colitis successfully treated with vedolizumab in Japan. Clin J Gastroenterol 2021;14:146-51. [PMID: 33040281 DOI: 10.1007/s12328-020-01260-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 170 |
Erős A, Dohos D, Veres G, Tárnok A, Vincze Á, Tészás A, Zádori N, Gede N, Hegyi P, Sarlós P. Effect of joint transition visits on quality of life in adolescents with inflammatory bowel diseases: a protocol for a prospective, randomised, multicentre, controlled trial (TRANS-IBD). BMJ Open 2020;10:e038410. [PMID: 33028560 DOI: 10.1136/bmjopen-2020-038410] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 171 |
D'Arcangelo G, Aloi M. Treat-to-Target in Pediatric Inflammatory Bowel Disease: What Does the Evidence Say? Paediatr Drugs 2020;22:463-72. [PMID: 32572841 DOI: 10.1007/s40272-020-00406-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 172 |
Grossman A, Mauer E, Gerber LM, Long MD, Kappelman MD, Gupta N. Black/African American Patients with Pediatric Crohn's Disease Report Less Anxiety and Fatigue than White Patients. J Pediatr 2020;225:146-51. [PMID: 32544479 DOI: 10.1016/j.jpeds.2020.05.042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 173 |
Meredith J, Khedim CA, Henderson P, Wilson DC, Russell RK. Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 [PIMS-TS] in a Patient Receiving Infliximab Therapy for Inflammatory Bowel Disease. J Crohns Colitis 2021;15:687-91. [PMID: 32997749 DOI: 10.1093/ecco-jcc/jjaa201] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 174 |
Mack DR, Saul B, Boyle B, Griffiths A, Sauer C, Markowitz J, LeLeiko N, Keljo D, Rosh JR, Baker SS, Steiner S, Heyman MB, Patel AS, Baldassano R, Noe J, Rufo P, Kugathasan S, Walters T, Marquis A, Thomas SM, Denson L, Hyams J; PROTECT STUDY GROUP. Analysis of Using the Total White Blood Cell Count to Define Severe New-onset Ulcerative Colitis in Children. J Pediatr Gastroenterol Nutr 2020;71:354-60. [PMID: 32520830 DOI: 10.1097/MPG.0000000000002797] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 175 |
Iwańczak B, Ruczka M, Matusiewicz M, Pytrus T, Matusiewicz K, Krzesiek E. Correlation between biomarkers (calprotectin, seromucoid, metalloproteinase-3 and CRP) and clinical and endoscopic activity of ulcerative colitis in children. Adv Med Sci 2020;65:259-64. [PMID: 32361483 DOI: 10.1016/j.advms.2020.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 176 |
Medina Carbonell FR, Choyudhry Chandan O. Body Mass Index at Presentation of Inflammatory Bowel Disease in Children. Pediatr Gastroenterol Hepatol Nutr 2020;23:439-46. [PMID: 32953639 DOI: 10.5223/pghn.2020.23.5.439] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 177 |
Stawowczyk E, Kawalec P, Kowalska-Duplaga K, Mossakowska M. Productivity Loss Among Parents of Children With Inflammatory Bowel Diseases in Relation to Disease Activity and Patient's Quality of Life. J Pediatr Gastroenterol Nutr 2020;71:340-5. [PMID: 32459743 DOI: 10.1097/MPG.0000000000002801] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 178 |
Martinelli M, Giugliano FP, Strisciuglio C, Urbonas V, Serban DE, Banaszkiewicz A, Assa A, Hojsak I, Lerchova T, Navas-López VM, Romano C, Sladek M, Veres G, Aloi M, Kucinskiene R, Miele E. Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN. Inflamm Bowel Dis 2020;26:1407-14. [PMID: 31689349 DOI: 10.1093/ibd/izz264] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 179 |
Bushman FD, Conrad M, Ren Y, Zhao C, Gu C, Petucci C, Kim MS, Abbas A, Downes KJ, Devas N, Mattei LM, Breton J, Kelsen J, Marakos S, Galgano A, Kachelries K, Erlichman J, Hart JL, Moraskie M, Kim D, Zhang H, Hofstaedter CE, Wu GD, Lewis JD, Zackular JP, Li H, Bittinger K, Baldassano R. Multi-omic Analysis of the Interaction between Clostridioides difficile Infection and Pediatric Inflammatory Bowel Disease. Cell Host Microbe 2020;28:422-433.e7. [PMID: 32822584 DOI: 10.1016/j.chom.2020.07.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 180 |
Arai K, Kunisaki R, Kakuta F, Hagiwara SI, Murakoshi T, Yanagi T, Shimizu T, Kato S, Ishige T, Aomatsu T, Inoue M, Saito T, Iwama I, Kawashima H, Kumagai H, Tajiri H, Iwata N, Mochizuki T, Noguchi A, Kashiwabara T, Shimizu H, Suzuki Y, Hirano Y, Fujiwara T. Phenotypic characteristics of pediatric inflammatory bowel disease in Japan: results from a multicenter registry. Intest Res 2020;18:412-20. [PMID: 32806870 DOI: 10.5217/ir.2019.00130] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 181 |
Batra SK, Heier CR, Diaz-Calderon L, Tully CB, Fiorillo AA, van den Anker J, Conklin LS. Serum miRNAs Are Pharmacodynamic Biomarkers Associated With Therapeutic Response in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:1597-606. [PMID: 32793975 DOI: 10.1093/ibd/izaa209] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 182 |
Hyams JS, O'Brien CD, Padgett L, Rosh JR, Turner D, Veereman G, Griffiths AM, Heyman MB, Wahbeh G, Adedokun OJ, Strauss RS, Lynch JP, Chan D. Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study Results. Crohns Colitis 360 2020;2:otaa063. [PMID: 36777743 DOI: 10.1093/crocol/otaa063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 183 |
Senbanjo I, Akinola A, Kumolu-Johnson T, Igbekoyi O, Oshikoya K. Inflammatory bowel disease in Nigerian children: case series and management challenges. Paediatr Int Child Health 2020;40:143-7. [PMID: 31495301 DOI: 10.1080/20469047.2019.1662658] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 184 |
Claytor JD, Kochar B, Kappelman MD, Long MD. Body Image Dissatisfaction among Pediatric Patients with Inflammatory Bowel Disease. J Pediatr 2020;223:68-72.e1. [PMID: 32711754 DOI: 10.1016/j.jpeds.2020.04.045] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 185 |
Navas-López VM, Martel LC, Martín-Masot R, Rubio MN, Santana NR, López MH, Frías Arjona A, Merino Valero VM, Ortega Doltz V, Ramos-Cózar SN, Alcaín Martínez G. The Effect of the Inflammatory Bowel Disease Classroom in Nature on the Quality of Life of Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;71:243-5. [PMID: 32304559 DOI: 10.1097/MPG.0000000000002746] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 186 |
Negroni A, Fiaschini N, Palone F, Vitali R, Colantoni E, Laudadio I, Oliva S, Aloi M, Cucchiara S, Stronati L. Intestinal Inflammation Alters the Expression of Hepatic Bile Acid Receptors Causing Liver Impairment. J Pediatr Gastroenterol Nutr 2020;71:189-96. [PMID: 32404746 DOI: 10.1097/MPG.0000000000002759] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 187 |
Krawiec P, Pac-Kożuchowska E. Serum interleukin 17A and interleukin 17F in children with inflammatory bowel disease. Sci Rep 2020;10:12617. [PMID: 32724117 DOI: 10.1038/s41598-020-69567-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 188 |
Grossi V, Hyams JS, Glidden NC, Knight BE, Young EE. Characterizing Clinical Features and Creating a Gene Expression Profile Associated With Pain Burden in Children With Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:1283-90. [PMID: 31627210 DOI: 10.1093/ibd/izz240] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 189 |
Scarallo L, Maniscalco V, Paci M, Renzo S, Naldini S, Barp J, Tasciotti L, Lionetti P. Bowel Ultrasound Scan Predicts Corticosteroid Failure in Children With Acute Severe Colitis. J Pediatr Gastroenterol Nutr 2020;71:46-51. [PMID: 32102087 DOI: 10.1097/MPG.0000000000002677] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 190 |
Aardoom MA, Kemos P, Tindemans I, Aloi M, Koletzko S, Levine A, Turner D, Veereman G, Neyt M, Russell RK, Walters TD, Ruemmele FM, Samsom JN, Croft NM, de Ridder L; PIBD-SETQuality consortium and PIBD-NET. International prospective observational study investigating the disease course and heterogeneity of paediatric-onset inflammatory bowel disease: the protocol of the PIBD-SETQuality inception cohort study. BMJ Open 2020;10:e035538. [PMID: 32611739 DOI: 10.1136/bmjopen-2019-035538] [Reference Citation Analysis]
|
| 191 |
Dhaliwal J, Martincevic I, Williams B, Frost K, Uusoue K, Arpino V, Church P, Walters TD, Griffiths AM, Mouzaki M. Body Composition Using Air Displacement Plethysmography in Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;71:52-8. [PMID: 32141991 DOI: 10.1097/MPG.0000000000002683] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 192 |
Choe YH. Precision medicine for pediatric inflammatory bowel disease: a perspective. Precis Future Med 2020;4:43-52. [DOI: 10.23838/pfm.2020.00058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 193 |
Reliability and Measurement Error. Evidence-Based Diagnosis 2020. [DOI: 10.1017/9781108500111.006] [Reference Citation Analysis]
|
| 194 |
Hart L, Farbod Y, Szamosi JC, Yamamoto M, Britz-McKibbin P, Halgren C, Zachos M, Pai N. Effect of Exclusive Enteral Nutrition and Corticosteroid Induction Therapy on the Gut Microbiota of Pediatric Patients with Inflammatory Bowel Disease. Nutrients 2020;12:E1691. [PMID: 32517036 DOI: 10.3390/nu12061691] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 195 |
Atia O, Ledder O, Ben-Moshe T, Lev-Tzion R, Rachmen Y, Meyer EO, Beeri R, Renbaum P, Shamasneh I, Shteyer E, Turner D. Role of Thiopurines in Pediatric Inflammatory Bowel Diseases: A Real-Life Prospective Cohort Study. J Pediatr Gastroenterol Nutr 2020;70:825-32. [PMID: 32443042 DOI: 10.1097/MPG.0000000000002566] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 196 |
Ricciuto A, Hansen BE, Ngo B, Aloi M, Walters TD, Church PC, Mazurek A, Khan M, Carman N, Siddiqui I, Nguyen GC, Kamath BM, Griffiths AM. Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases Is Associated With Milder Clinical Activity But More Frequent Subclinical Inflammation and Growth Impairment. Clin Gastroenterol Hepatol 2020;18:1509-1517.e7. [PMID: 31493578 DOI: 10.1016/j.cgh.2019.08.048] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 197 |
Vanhelst J, Coopman S, Labreuche J, Dupont C, Bertrand V, Djeddi D, Turck D, Ley D. Protocol of a randomised controlled trial assessing the impact of physical activity on bone health in children with inflammatory bowel disease. BMJ Open. 2020;10:e036400. [PMID: 32430452 DOI: 10.1136/bmjopen-2019-036400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 198 |
Chandrakumar A, Wang A, Grover K, El-Matary W. Obesity Is More Common in Children Newly Diagnosed With Ulcerative Colitis as Compared to Those With Crohn Disease. J Pediatr Gastroenterol Nutr 2020;70:593-7. [PMID: 31977953 DOI: 10.1097/MPG.0000000000002639] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 199 |
Dhaliwal J, Walters TD, Mack DR, Huynh HQ, Jacobson K, Otley AR, Debruyn J, El-Matary W, Deslandres C, Sherlock ME, Critch JN, Bax K, Seidman E, Jantchou P, Ricciuto A, Rashid M, Muise AM, Wine E, Carroll M, Lawrence S, Van Limbergen J, Benchimol EI, Church P, Griffiths AM. Phenotypic Variation in Paediatric Inflammatory Bowel Disease by Age: A Multicentre Prospective Inception Cohort Study of the Canadian Children IBD Network. J Crohns Colitis 2020;14:445-54. [PMID: 31136648 DOI: 10.1093/ecco-jcc/jjz106] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 200 |
Silva LC, Seixas RBPM, de Carvalho E. Quality of Life in Children and Adolescents with Inflammatory Bowel Disease: Impact and Predictive Factors. Pediatr Gastroenterol Hepatol Nutr 2020;23:286-96. [PMID: 32483550 DOI: 10.5223/pghn.2020.23.3.286] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 201 |
Mizuochi T, Arai K, Kudo T, Nambu R, Tajiri H, Aomatsu T, Abe N, Kakiuchi T, Hashimoto K, Sogo T, Takahashi M, Etani Y, Takaki Y, Konishi KI, Ishihara J, Obara H, Kakuma T, Kurei S, Yamashita Y, Mitsuyama K. Antibodies to Crohn's disease peptide 353 as a diagnostic marker for pediatric Crohn's disease: a prospective multicenter study in Japan. J Gastroenterol 2020;55:515-22. [PMID: 31980893 DOI: 10.1007/s00535-019-01661-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 202 |
Kim DR, Kim D, Choi S, Suh YL, Yoo SY, Kim MJ, Choe YH, Kim YJ. Myositis as an Initial Presentation of Ulcerative Colitis before Gastrointestinal Symptoms. Pediatr Gastroenterol Hepatol Nutr 2020;23:297-303. [PMID: 32483551 DOI: 10.5223/pghn.2020.23.3.297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 203 |
Eissa N, Mujawar Q, Alabdoulsalam T, Zohni S, El-Matary W. The immune-sleep crosstalk in inflammatory bowel disease. Sleep Med 2020;73:38-46. [PMID: 32769031 DOI: 10.1016/j.sleep.2020.04.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 204 |
Haverman L, van Oers HA, van Muilekom MM, Grootenhuis MA. Options for the Interpretation of and Recommendations for Acting on Different PROMs in Daily Clinical Practice Using KLIK. Med Care 2019;57 Suppl 5 Suppl 1:S52-8. [PMID: 30985597 DOI: 10.1097/MLR.0000000000001061] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 205 |
Sila S, Jelić M, Trivić I, Tambić Andrašević A, Hojsak I, Kolaček S. Altered Gut Microbiota Is Present in Newly Diagnosed Pediatric Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;70:497-502. [PMID: 31899727 DOI: 10.1097/MPG.0000000000002611] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 206 |
Takeuchi I, Kaburaki Y, Arai K, Shimizu H, Hirano Y, Nagata S, Shimizu T. Infliximab for very early-onset inflammatory bowel disease: A tertiary center experience in Japan. J Gastroenterol Hepatol 2020;35:593-600. [PMID: 31425641 DOI: 10.1111/jgh.14836] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 207 |
Gasparetto M, Payne F, Nayak K, Kraiczy J, Glemas C, Philip-mckenzie Y, Ross A, Edgar R, Zerbino D, Salvestrini C, Torrente F, Sarkies P, Heuschkel R, Zilbauer M. CD8+ T-cell transcription and DNA methylation show age specific differences and lack correlation with clinical outcome in pediatric Inflammatory Bowel Disease.. [DOI: 10.1101/2020.03.30.015446] [Reference Citation Analysis]
|
| 208 |
Moore H, Dolce P, Devas N, Baldassano R, Martinelli M. Post-induction infliximab trough levels and disease activity in the clinical evolution of pediatric ulcerative colitis. United European Gastroenterol J 2020;8:425-35. [PMID: 32213038 DOI: 10.1177/2050640620912877] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 209 |
Erolu E, Polat E. Cardiac functions and aortic elasticity in children with inflammatory bowel disease: effect of age at disease onset. Cardiol Young 2020;30:313-7. [PMID: 31964454 DOI: 10.1017/S1047951119002932] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 210 |
Piercy J, Stinson J, Church PC, Walters TD, Frost K, Ahola Kohut S. Trait Perfectionism and Psychosocial Outcomes in Adolescents With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;70:318-23. [PMID: 31821232 DOI: 10.1097/MPG.0000000000002586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 211 |
Krishna M, Britto S, Qian J, Ihekweazu F, Rodriguez JR, Kellermayer R. Diagnostic delay and colectomy risk in pediatric ulcerative colitis. J Pediatr Surg 2020;55:403-5. [PMID: 30992148 DOI: 10.1016/j.jpedsurg.2019.03.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 212 |
Däbritz J. Besonderheiten der Therapie chronisch-entzündlicher Darmerkrankungen im Kindes- und Jugendalter. Monatsschr Kinderheilkd 2020;168:344-51. [DOI: 10.1007/s00112-020-00855-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 213 |
Jiménez Treviño S, Pujol Muncunill G, Martín-Masot R, Rodríguez Martínez A, Segarra Cantón O, Peña Quintana L, Armas Ramos H, Eizaguirre Arocena FJ, Barrio Torres J, García Burriel JI, Ortigosa Castillo L, Donat Aliaga E, Crujeiras Martínez V, Barros García P, Botija Arcos G, Bartolomé Porro JM, Juste Ruiz M, Ochoa Sangrador C, García Casales Z, Galicia Poblet G, Oliver Goicolea P, Lorenzo Garrido H, García Romero R, La Orden Izquierdo E, Pérez Solis D, Navas-López VM, Díaz Martin JJ, Martín de Carpi J. Spanish Pediatric Inflammatory Bowel Disease Diagnostic Delay Registry: SPIDER Study From Sociedad Española de Gastroenterología, Hepatología y Nutrición Pediátrica. Front Pediatr 2020;8:584278. [PMID: 33178654 DOI: 10.3389/fped.2020.584278] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 214 |
Shentova R, Baycheva M, Hadjiiski P, Kofinova D, Yaneva P. Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis. Gastroenterología y Hepatología (English Edition) 2020;43:57-61. [DOI: 10.1016/j.gastre.2019.08.005] [Reference Citation Analysis]
|
| 215 |
Rogler G, Biedermann L. Klassifikationen, Indizes, Aktivitätsbeurteilung. Chronisch-entzündliche Darmerkrankungen 2020. [DOI: 10.1007/978-3-662-59104-8_8] [Reference Citation Analysis]
|
| 216 |
Yerushalmy-Feler A, Singer D, Berkovitch G, Lubetzky R, Dotan I, Ziv-Baran T, Cohen S. Predictors for poor outcome of hospitalized children with inflammatory bowel disease. Eur J Pediatr 2020;179:157-64. [PMID: 31709474 DOI: 10.1007/s00431-019-03491-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 217 |
Rintala RJ, Pakarinen MP, Koivusalo A. Ulcerative Colitis (General Pediatric Surgery of Abdomen). Pediatric Surgery 2020. [DOI: 10.1007/978-3-642-38482-0_106-1] [Reference Citation Analysis]
|
| 218 |
Keller K. Medikamentöse Therapie der CED bei Kindern und Jugendlichen. Chronisch-entzündliche Darmerkrankungen 2020. [DOI: 10.1007/978-3-662-59104-8_28] [Reference Citation Analysis]
|
| 219 |
Kim S, Park S, Kang Y, Koh H. Combining faecal calprotectin and sigmoidoscopy can predict mucosal healing in paediatric ulcerative colitis. Eur J Gastroenterol Hepatol 2020;32:17-21. [PMID: 31651657 DOI: 10.1097/MEG.0000000000001550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 220 |
Krauthammer A, Tzivinikos C, Assa A, Miele E, Strisciuglio C, Urlep D, Serban ED, Singh A, Winter HS, Russell RK, Hojsak I, Malham M, Navas-López VM, Croft NM, Lee HM, Ledder O, Shamasneh I, Hussey S, Huynh HQ, Wine E, Shah N, Sladek M, de Meij TG, Romano C, Dipasquale V, Lionetti P, Afzal NA, Aloi M, Lee K, Martín-de-Carpi J, Yerushalmy-Feler A, Subramanian S, Weiss B, Shouval DS. Long-term Outcomes of Paediatric Patients Admitted With Acute Severe Colitis- A Multicentre Study From the Paediatric IBD Porto Group of ESPGHAN. J Crohns Colitis 2019;13:1518-26. [PMID: 31120524 DOI: 10.1093/ecco-jcc/jjz092] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 221 |
Franca R, Stocco G, Favretto D, Giurici N, Del Rizzo I, Locatelli F, Vinti L, Biondi A, Colombini A, Fagioli F, Barisone E, Pelin M, Martellossi S, Ventura A, Decorti G, Rabusin M. PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients.Pharmacogenomics J. 2020;20:415-425. [PMID: 31792371 DOI: 10.1038/s41397-019-0130-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 222 |
Jasielska M, Grzybowska-Chlebowczyk U. Lactose Malabsorption and Lactose Intolerance in Children with Inflammatory Bowel Diseases. Gastroenterol Res Pract 2019;2019:2507242. [PMID: 31871445 DOI: 10.1155/2019/2507242] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 223 |
Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H, Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB; IBD guidelines eDelphi consensus group. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019;68:s1-s106. [PMID: 31562236 DOI: 10.1136/gutjnl-2019-318484] [Cited by in Crossref: 860] [Cited by in F6Publishing: 863] [Article Influence: 215.0] [Reference Citation Analysis]
|
| 224 |
van den Brink G, Stapersma L, Bom AS, Rizopolous D, van der Woude CJ, Stuyt RJL, Hendriks DM, van der Burg JAT, Beukers R, Korpershoek TA, Theuns-Valks SDM, Utens EMWJ, Escher JC. Effect of Cognitive Behavioral Therapy on Clinical Disease Course in Adolescents and Young Adults With Inflammatory Bowel Disease and Subclinical Anxiety and/or Depression: Results of a Randomized Trial. Inflamm Bowel Dis 2019;25:1945-56. [PMID: 31050763 DOI: 10.1093/ibd/izz073] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 225 |
Kelay A, Tullie L, Stanton M. Surgery and paediatric inflammatory bowel disease. Transl Pediatr 2019;8:436-48. [PMID: 31993358 DOI: 10.21037/tp.2019.09.01] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 226 |
Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H, Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB; IBD guidelines eDelphi consensus group. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019;68:s1-s106. [PMID: 31562236 DOI: 10.1136/gutjnl-2019-318484] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 227 |
Pai N, Popov J, Hill L, Hartung E. Protocol for a double-blind, randomised, placebo-controlled pilot study for assessing the feasibility and efficacy of faecal microbiota transplant in a paediatric Crohn's disease population: PediCRaFT Trial. BMJ Open 2019;9:e030120. [PMID: 31784432 DOI: 10.1136/bmjopen-2019-030120] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
|
| 228 |
Shentova R, Baycheva M, Hadjiiski P, Kofinova D, Yaneva P. Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis. Gastroenterol Hepatol 2020;43:57-61. [PMID: 31733888 DOI: 10.1016/j.gastrohep.2019.08.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 229 |
Stapersma L, van den Brink G, van der Ende J, Szigethy EM, Beukers R, Korpershoek TA, Theuns-Valks SDM, Hillegers MHJ, Escher JC, Utens EMWJ. Effectiveness of Disease-Specific Cognitive Behavioral Therapy on Anxiety, Depression, and Quality of Life in Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial. J Pediatr Psychol 2018;43:967-80. [PMID: 29850915 DOI: 10.1093/jpepsy/jsy029] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 230 |
Danko I, Weidkamp M, Eickhoff JC. Improvement of Health-Related Quality of Life in Children with Inflammatory Bowel Disease Receiving Routine Intravenous Iron Supplementation. J Pediatr Pharmacol Ther 2019;24:517-27. [PMID: 31719814 DOI: 10.5863/1551-6776-24.6.517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 231 |
Vaz KKH, Carmody JK, Zhang Y, Denson LA, Hommel KA. Evaluation of a Novel Educational Tool in Adolescents With Inflammatory Bowel Disease: The NEAT Study. J Pediatr Gastroenterol Nutr 2019;69:564-9. [PMID: 31261247 DOI: 10.1097/MPG.0000000000002431] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 232 |
Newton L, Randall JA, Hunter T, Keith S, Symonds T, Secrest RJ, Komocsar WJ, Curtis SE, Abetz-Webb L, Kappelman M, Naegeli AN. A qualitative study exploring the health-related quality of life and symptomatic experiences of adults and adolescents with ulcerative colitis. J Patient Rep Outcomes 2019;3:66. [PMID: 31667633 DOI: 10.1186/s41687-019-0154-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 233 |
Lucafò M, Pugnetti L, Bramuzzo M, Curci D, Di Silvestre A, Marcuzzi A, Bergamo A, Martelossi S, Villanacci V, Bozzola A, Cadei M, De Iudicibus S, Decorti G, Stocco G. Long Non-Coding RNA GAS5 and Intestinal MMP2 and MMP9 Expression: A Translational Study in Pediatric Patients with IBD. Int J Mol Sci 2019;20:E5280. [PMID: 31652976 DOI: 10.3390/ijms20215280] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 234 |
Bolia R, Rajanayagam J, Hardikar W, Alex G. Impact of Changing Treatment Strategies on Outcomes in Pediatric Ulcerative Colitis. Inflamm Bowel Dis 2019;25:1838-44. [PMID: 31002341 DOI: 10.1093/ibd/izz072] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 235 |
El Manouni El Hassani S, Bosch S, Lemmen JPM, Brizzio Brentar M, Ayada I, Wicaksono AN, Covington JA, Benninga MA, de Boer NKH, de Meij TGJ. Simultaneous Assessment of Urinary and Fecal Volatile Organic Compound Analysis in De Novo Pediatric IBD. Sensors (Basel) 2019;19:E4496. [PMID: 31623289 DOI: 10.3390/s19204496] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 236 |
Palmer NP, Silvester JA, Lee JJ, Beam AL, Fried I, Valtchinov VI, Rahimov F, Kong SW, Ghodoussipour S, Hood HC, Bousvaros A, Grand RJ, Kunkel LM, Kohane IS. Concordance between gene expression in peripheral whole blood and colonic tissue in children with inflammatory bowel disease. PLoS One 2019;14:e0222952. [PMID: 31618209 DOI: 10.1371/journal.pone.0222952] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 237 |
Tajiri H, Arai K, Kagimoto S, Kunisaki R, Hida N, Sato N, Yamada H, Nagano M, Susuta Y, Ozaki K, Kondo K, Hibi T. Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan. BMC Pediatr 2019;19:351. [PMID: 31607268 DOI: 10.1186/s12887-019-1739-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 238 |
Fabian O, Hradsky O, Lerchova T, Mikus F, Zamecnik J, Bronsky J. Limited clinical significance of tissue calprotectin levels in bowel mucosa for the prediction of complicated course of the disease in children with ulcerative colitis. Pathol Res Pract 2019;215:152689. [PMID: 31679791 DOI: 10.1016/j.prp.2019.152689] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 239 |
Malham M, Carlsen K, Riis L, Paerregaard A, Vind I, Fenger M, Wewer V. Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative Colitis. Scand J Gastroenterol 2019;54:1214-9. [PMID: 31526273 DOI: 10.1080/00365521.2019.1665097] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 240 |
Haisma SM, Verkade HJ, Scheenstra R, van der Doef HPJ, Bodewes FAJA, van Rheenen PF. Time-to-reach Target Calprotectin Level in Newly Diagnosed Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;69:466-73. [PMID: 31365486 DOI: 10.1097/MPG.0000000000002458] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 241 |
Sila S, Trivić I, Pavić AM, Niseteo T, Kolaček S, Hojsak I. Nutritional status and food intake in pediatric patients with inflammatory bowel disease at diagnosis significantly differs from healthy controls. Eur J Pediatr 2019;178:1519-27. [PMID: 31422462 DOI: 10.1007/s00431-019-03443-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 242 |
Carmody JK, Plevinsky J, Peugh JL, Denson LA, Hyams JS, Lobato D, LeLeiko NS, Hommel KA. Longitudinal non-adherence predicts treatment escalation in paediatric ulcerative colitis. Aliment Pharmacol Ther 2019;50:911-8. [PMID: 31373712 DOI: 10.1111/apt.15445] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 243 |
Pratt J, Jeffers D, King EC, Kappelman MD, Collins J, Margolis P, Baron H, Bass JA, Bassett MD, Beasley GL, Benkov KJ, Bornstein JA, Cabrera JM, Crandall W, Dancel LD, Garin-Laflam MP, Grunow JE, Hirsch BZ, Hoffenberg E, Israel E, Jester TW, Kiparissi F, Lakhole A, Lapsia SP, Minar P, Navarro FA, Neef H, Park KT, Pashankar DS, Patel AS, Pineiro VM, Samson CM, Sandberg KC, Steiner SJ, Strople JA, Sudel B, Sullivan JS, Suskind DL, Uppal V, Wali PD. Implementing a Novel Quality Improvement-Based Approach to Data Quality Monitoring and Enhancement in a Multipurpose Clinical Registry. EGEMS (Wash DC) 2019;7:51. [PMID: 31646151 DOI: 10.5334/egems.262] [Reference Citation Analysis]
|
| 244 |
Reed-Knight B, van Tilburg MAL, Levy RL, Langer SL, Romano JM, Murphy TB, DuPen MM, Feld AD. Maladaptive Coping and Depressive Symptoms Partially Explain the Association Between Family Stress and Pain-Related Distress in Youth With IBD. J Pediatr Psychol 2018;43:94-103. [PMID: 28541526 DOI: 10.1093/jpepsy/jsx082] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 245 |
Agin M, Yucel A, Gumus M, Yuksekkaya HA, Tumgor G. The Effect of Enteral Nutrition Support Rich in TGF-β in the Treatment of Inflammatory Bowel Disease in Childhood. Medicina (Kaunas) 2019;55:E620. [PMID: 31546703 DOI: 10.3390/medicina55100620] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 246 |
Schuler CL, Dodds C, Hommel KA, Ittenbach RF, Denson LA, Lipstein EA. Shared decision making in IBD: A novel approach to trial consent and timing. Contemp Clin Trials Commun 2019;16:100447. [PMID: 31538130 DOI: 10.1016/j.conctc.2019.100447] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 247 |
Grez C, Ossa JC. ENFERMEDAD INFLAMATORIA INTESTINAL EN PEDIATRÍA, UNA REVISIÓN. Revista Médica Clínica Las Condes 2019;30:372-382. [DOI: 10.1016/j.rmclc.2019.06.009] [Reference Citation Analysis]
|
| 248 |
Breton J, Kastl A, Hoffmann N, Rogers R, Grossman AB, Mamula P, Kelsen JR, Baldassano RN, Albenberg L. Efficacy of Combination Antibiotic Therapy for Refractory Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1586-93. [PMID: 30715364 DOI: 10.1093/ibd/izz006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 249 |
Andreozzi M, Giugliano FP, Strisciuglio T, Pirozzi E, Papparella A, Caprio AM, Miele E, Strisciuglio C, Perrone Filardi P. The Role of Inflammation in the Endothelial Dysfunction in a Cohort of Pediatric Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;69:330-5. [PMID: 31169657 DOI: 10.1097/MPG.0000000000002374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 250 |
Yanagi T, Ushijima K, Koga H, Tomomasa T, Tajiri H, Kunisaki R, Isihige T, Yamada H, Arai K, Yoden A, Aomatsu T, Nagata S, Uchida K, Ohtsuka Y, Shimizu T. Tacrolimus for ulcerative colitis in children: a multicenter survey in Japan. Intest Res 2019;17:476-85. [PMID: 31454858 DOI: 10.5217/ir.2019.00027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 251 |
Black DD, Mack C, Kerkar N, Miloh T, Sundaram SS, Anand R, Gupta A, Alonso E, Arnon R, Bulut P, Karpen S, Lin CH, Rosenthal P, Ryan M, Squires RH, Valentino P, Elsea SH, Shneider BL. A Prospective Trial of Withdrawal and Reinstitution of Ursodeoxycholic Acid in Pediatric Primary Sclerosing Cholangitis. Hepatol Commun 2019;3:1482-95. [PMID: 31701072 DOI: 10.1002/hep4.1421] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 252 |
Church PC, Ho S, Sharma A, Tomalty D, Frost K, Muise A, Walters TD, Griffiths AM. Intensified Infliximab Induction is Associated with Improved Response and Decreased Colectomy in Steroid-Refractory Paediatric Ulcerative Colitis. J Crohns Colitis 2019;13:982-9. [PMID: 30715240 DOI: 10.1093/ecco-jcc/jjz019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 253 |
Cohen S, Padlipsky J, Yerushalmy-Feler A. Risk factors associated with extraintestinal manifestations in children with inflammatory bowel disease. Eur J Clin Nutr 2020;74:691-7. [PMID: 31395971 DOI: 10.1038/s41430-019-0490-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 254 |
Wang Y, Li H. Complex Chemical Process Evaluation Methods Using a New Analytic Hierarchy Process Model Integrating Deep Residual Network with Multiway Principal Component Analysis. Ind Eng Chem Res 2019;58:13889-99. [DOI: 10.1021/acs.iecr.9b02857] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 255 |
Courbette O, Aupiais C, Viala J, Hugot JP, Louveau B, Chatenoud L, Bourrat E, Martinez-Vinson C. Infliximab Paradoxical Psoriasis in a Cohort of Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;69:189-93. [PMID: 30921262 DOI: 10.1097/MPG.0000000000002349] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 256 |
Gray WN, Holbrook E, Dykes D, Morgan PJ, Saeed SA, Denson LA. Improving IBD Transition, Self-management, and Disease Outcomes With an In-clinic Transition Coordinator. J Pediatr Gastroenterol Nutr 2019;69:194-9. [PMID: 30964817 DOI: 10.1097/MPG.0000000000002350] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 257 |
Vanhelst J, Vidal F, Turck D, Drumez E, Djeddi D, Devouge E, Spyckerelle C, Zandzou SG, Legrand C, Michaud L, Béghin L, Gottrand F, Coopman S, Ley D. Physical activity is associated with improved bone health in children with inflammatory bowel disease. Clin Nutr 2020;39:1793-8. [PMID: 31427183 DOI: 10.1016/j.clnu.2019.07.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 258 |
Ayers TD, Leonard-puppa E, Kader HA, Waddell J, Watkins RD, Blanchard SS, Safta AM, Rawal N. Oral Vancomycin as an Adjuvant Treatment in IBD. Crohn's & Colitis 360 2019;1. [DOI: 10.1093/crocol/otz015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 259 |
Deva Rajoo G, Tan L, Lopez A, Lewindon P, Grover Z. Early Response to Corticosteroid and Baseline C-Reactive Protein Predicts Outcomes in Children with Moderate to Severe Ulcerative Colitis. Dig Dis Sci 2019;64:1929-37. [PMID: 30734233 DOI: 10.1007/s10620-019-05486-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 260 |
Vernon-Roberts A, Lopez RN, Frampton C, Gearry RB, Lemberg DA, Day AS. A Symptom Self-report Tool for Children With Inflammatory Bowel Disease (IBDnow). J Pediatr Gastroenterol Nutr 2019;69:e7-e12. [PMID: 30921259 DOI: 10.1097/MPG.0000000000002329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 261 |
Goldstein-Leever A, Bass JA, Goyal A, Maddux MH. Health-Related Quality of Life Predicts Psychology Referral in Youth with Inflammatory Bowel Disease. J Pediatr Nurs 2019;47:73-7. [PMID: 31054370 DOI: 10.1016/j.pedn.2019.04.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 262 |
Takaki Y, Mizuochi T, Eda K, Ishihara J, Yamashita Y. Laboratory values in Japanese children with newly diagnosed inflammatory bowel disease. Pediatr Int 2019;61:720-5. [PMID: 31102555 DOI: 10.1111/ped.13892] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 263 |
Loy L, Roda G, Fiorino G, Allocca M, Furfaro F, Argollo M, Peyrin-Biroulet L, Danese S. Detection and management of early stage inflammatory bowel disease: an update for clinicians. Expert Rev Gastroenterol Hepatol 2019;13:547-55. [PMID: 31007098 DOI: 10.1080/17474124.2019.1605291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 264 |
van Hoeve K, Dreesen E, Hoffman I, Van Assche G, Ferrante M, Gils A, Vermeire S. Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel Disease. Therapeutic Drug Monitoring 2019;41:317-24. [DOI: 10.1097/ftd.0000000000000601] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 265 |
van Hoeve K, Dreesen E, Hoffman I, Van Assche G, Ferrante M, Gils A, Vermeire S. Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;68:847-53. [PMID: 30633108 DOI: 10.1097/MPG.0000000000002265] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 266 |
Restellini S, Chao CY, Martel M, Barkun A, Kherad O, Seidman E, Wild G, Bitton A, Afif W, Bessissow T, Lakatos PL. Clinical Parameters Correlate With Endoscopic Activity of Ulcerative Colitis: A Systematic Review. Clin Gastroenterol Hepatol 2019;17:1265-1275.e8. [PMID: 30583048 DOI: 10.1016/j.cgh.2018.12.021] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 267 |
Turner D. Particularities of IBD Trials in Children. CPD 2019;25:69-72. [DOI: 10.2174/1381612825666190307125511] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 268 |
Carlsen K, Malham M, Hansen LF, Petersen JJH, Paerregaard A, Houen G, Wewer V. Serum Calprotectin in Adolescents With Inflammatory Bowel Disease-A Pilot Investigation. J Pediatr Gastroenterol Nutr 2019;68:669-75. [PMID: 30628981 DOI: 10.1097/MPG.0000000000002244] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 269 |
Bronsky J, de Ridder L, Ruemmele FM, Griffiths A, Buderus S, Hradsky O, Hauer AC. Diagnostic and Therapeutic Approach in Paediatric Inflammatory Bowel Diseases: Results from a Clinical Practice Survey. J Pediatr Gastroenterol Nutr 2019;68:676-83. [PMID: 30664566 DOI: 10.1097/MPG.0000000000002233] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 270 |
Carlsen K, Hald M, Dubinsky MC, Keefer L, Wewer V. A Personalized eHealth Transition Concept for Adolescents With Inflammatory Bowel Disease: Design of Intervention. JMIR Pediatr Parent 2019;2:e12258. [PMID: 31518331 DOI: 10.2196/12258] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 271 |
Lucafò M, Stocco G, Martelossi S, Favretto D, Franca R, Malusà N, Lora A, Bramuzzo M, Naviglio S, Cecchin E, Toffoli G, Ventura A, Decorti G. Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants. Genes (Basel) 2019;10:E277. [PMID: 30987408 DOI: 10.3390/genes10040277] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 272 |
Testa A, Giannetti E, Rispo A, Rea M, Miele E, Scarpato E, Opramolla A, Nardone OM, Imperatore N, Di Luna I, Staiano A, Castiglione F. Successful outcome of the transitional process of inflammatory bowel disease from pediatric to adult age: A five years experience. Dig Liver Dis 2019;51:524-8. [PMID: 30704905 DOI: 10.1016/j.dld.2018.11.034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 273 |
Cohen JS, Lyons JS, Benchimol EI, Carman N, Guertin C, Mack DR. The pediatric inflammatory bowel disease INTERMED: A new clinical tool to assess psychosocial needs. J Psychosom Res 2019;119:26-33. [PMID: 30947814 DOI: 10.1016/j.jpsychores.2019.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 274 |
Hyams JS, Davis Thomas S, Gotman N, Haberman Y, Karns R, Schirmer M, Mo A, Mack DR, Boyle B, Griffiths AM, LeLeiko NS, Sauer CG, Keljo DJ, Markowitz J, Baker SS, Rosh J, Baldassano RN, Patel A, Pfefferkorn M, Otley A, Heyman M, Noe J, Oliva-Hemker M, Rufo PA, Strople J, Ziring D, Guthery SL, Sudel B, Benkov K, Wali P, Moulton D, Evans J, Kappelman MD, Marquis MA, Sylvester FA, Collins MH, Venkateswaran S, Dubinsky M, Tangpricha V, Spada KL, Saul B, Wang J, Serrano J, Hommel K, Marigorta UM, Gibson G, Xavier RJ, Kugathasan S, Walters T, Denson LA. Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study. Lancet. 2019;393:1708-1720. [PMID: 30935734 DOI: 10.1016/s0140-6736(18)32592-3] [Cited by in Crossref: 79] [Cited by in F6Publishing: 79] [Article Influence: 19.8] [Reference Citation Analysis]
|
| 275 |
Sturm A, Maaser C, Calabrese E, Annese V, Fiorino G, Kucharzik T, Vavricka SR, Verstockt B, van Rheenen P, Tolan D, Taylor SA, Rimola J, Rieder F, Limdi JK, Laghi A, Krustiņš E, Kotze PG, Kopylov U, Katsanos K, Halligan S, Gordon H, González Lama Y, Ellul P, Eliakim R, Castiglione F, Burisch J, Borralho Nunes P, Bettenworth D, Baumgart DC, Stoker J; European Crohn’s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR]. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects. J Crohns Colitis 2019;13:273-84. [PMID: 30137278 DOI: 10.1093/ecco-jcc/jjy114] [Cited by in Crossref: 166] [Cited by in F6Publishing: 172] [Article Influence: 41.5] [Reference Citation Analysis]
|
| 276 |
Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol 2019;114:384-413. [PMID: 30840605 DOI: 10.14309/ajg.0000000000000152] [Cited by in Crossref: 612] [Cited by in F6Publishing: 559] [Article Influence: 153.0] [Reference Citation Analysis]
|
| 277 |
Venturieri MO, Komati JTS, Lopes LHC, Sdepanian VL. Treatment with Noripurum EV(®) is effective and safe in pediatric patients with inflammatory bowel disease and iron deficiency anemia. Scand J Gastroenterol 2019;54:198-204. [PMID: 30782036 DOI: 10.1080/00365521.2019.1570326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 278 |
Dalzell AM, Ba'Ath ME. Paediatric inflammatory bowel disease: review with a focus on practice in low- to middle-income countries. Paediatr Int Child Health 2019;39:48-58. [PMID: 30900526 DOI: 10.1080/20469047.2019.1575056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 279 |
Carman N, Tomalty D, Church PC, Mack DR, Benchimol EI, Otley AR, Jacobson K, Huynh HQ, DeBruyn JC, El-Matary W, Sherlock M, Van Limbergen J, Griffiths AM, Walters TD; Canadian Children Inflammatory Bowel Disease Network: A Joint Partnership of Canadian Institutes of Health Research and the Children with Intestinal and Liver Disorders Foundation. Clinical disease activity and endoscopic severity correlate poorly in children newly diagnosed with Crohn's disease. Gastrointest Endosc 2019;89:364-72. [PMID: 30273592 DOI: 10.1016/j.gie.2018.09.025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 280 |
Moon JS. Clinical aspects and treatments for pediatric inflammatory bowel disease. Intest Res 2019;17:17-23. [PMID: 30625263 DOI: 10.5217/ir.2018.00139] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 281 |
Naviglio S, Lacorte D, Lucafò M, Cifù A, Favretto D, Cuzzoni E, Silvestri T, Pozzi Mucelli M, Radillo O, Decorti G, Fabris M, Bramuzzo M, Taddio A, Stocco G, Alvisi P, Ventura A, Martelossi S. Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study. J Pediatr Gastroenterol Nutr 2019;68:37-44. [PMID: 30211845 DOI: 10.1097/MPG.0000000000002112] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 282 |
Moon JS. Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases. Pediatr Gastroenterol Hepatol Nutr 2019;22:50-6. [PMID: 30671373 DOI: 10.5223/pghn.2019.22.1.50] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 283 |
Grover Z. Predicting and preventing complications in children with inflammatory bowel disease. Transl Pediatr 2019;8:70-6. [PMID: 30881900 DOI: 10.21037/tp.2019.01.03] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 284 |
Whaley KG, Rosen MJ. Contemporary Medical Management of Acute Severe Ulcerative Colitis. Inflamm Bowel Dis 2019;25:56-66. [PMID: 29889235 DOI: 10.1093/ibd/izy208] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 285 |
Schirmer M, Denson L, Vlamakis H, Franzosa EA, Thomas S, Gotman NM, Rufo P, Baker SS, Sauer C, Markowitz J, Pfefferkorn M, Oliva-Hemker M, Rosh J, Otley A, Boyle B, Mack D, Baldassano R, Keljo D, LeLeiko N, Heyman M, Griffiths A, Patel AS, Noe J, Kugathasan S, Walters T, Huttenhower C, Hyams J, Xavier RJ. Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course. Cell Host Microbe 2018; 24: 600-610. e4. [PMID: 30308161 DOI: 10.1016/j.chom.2018.09.009] [Cited by in Crossref: 114] [Cited by in F6Publishing: 90] [Article Influence: 22.8] [Reference Citation Analysis]
|
| 286 |
Ouahed J, Gordon W, Canavan JB, Zhou H, Du S, von Schack D, Phillips K, Wang L, Dunn WA 3rd, Field M, Friel S, Griffith A, Evans S, Tollefson S, Carrellas M, Cao B, Merker A, Bousvaros A, Shouval DS, Hung K, Lepsy C, Afzelius L, Korzenik JR, Snapper SB; BCH IBD Center, BWH Crohn’s and Colitis Center. Mucosal Gene Expression in Pediatric and Adult Patients With Ulcerative Colitis Permits Modeling of Ideal Biopsy Collection Strategy for Transcriptomic Analysis. Inflamm Bowel Dis 2018;24:2565-78. [PMID: 30085215 DOI: 10.1093/ibd/izy242] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 287 |
Arruda JM, Bogetz AL, Vellanki S, Wren A, Yeh AM. Yoga as adjunct therapy for adolescents with inflammatory bowel disease: A pilot clinical trial. Complementary Therapies in Medicine 2018;41:99-104. [DOI: 10.1016/j.ctim.2018.09.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 288 |
Gervais L, McLean LL, Wilson ML, Cameron C, Curtis L, Garrick V, Armstrong K, Tayler R, Henderson P, Hansen R, Chalmers I, Wilson DC, Russell RK. Switching From Originator to Biosimilar Infliximab in Paediatric Inflammatory Bowel Disease Is Feasible and Uneventful. J Pediatr Gastroenterol Nutr 2018;67:745-8. [PMID: 29985877 DOI: 10.1097/MPG.0000000000002091] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 289 |
van Hoeve K, Dreesen E, Hoffman I, Van Assche G, Ferrante M, Gils A, Vermeire S. Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease. J Crohns Colitis 2018;12:1316-25. [PMID: 30239644 DOI: 10.1093/ecco-jcc/jjy111] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 290 |
Däbritz J, Gerner P, Enninger A, Claßen M, Radke M. Inflammatory Bowel Disease in Childhood and Adolescence. Dtsch Arztebl Int 2017;114:331-8. [PMID: 28597827 DOI: 10.3238/arztebl.2017.0331] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 291 |
Henderson EJ, Morgan GS, Amin J, Gaunt DM, Ben-Shlomo Y. The minimum clinically important difference (MCID) for a falls intervention in Parkinson's: A delphi study. Parkinsonism Relat Disord 2019;61:106-10. [PMID: 30455158 DOI: 10.1016/j.parkreldis.2018.11.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 292 |
Strisciuglio C, Cenni S, Giugliano FP, Miele E, Cirillo G, Martinelli M, Vitale A, Tolone C, Staiano A, Miraglia Del Giudice E, Perrone L. The Role of Inflammation on Vitamin D Levels in a Cohort of Pediatric Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2018;67:501-6. [PMID: 29877900 DOI: 10.1097/MPG.0000000000002049] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 293 |
Ungar B, Glidai Y, Yavzori M, Picard O, Fudim E, Lahad A, Haberman Y, Shouval DS, Weintraub I, Eliakim R, Ben-Horin S, Weiss B. Association Between Infliximab Drug and Antibody Levels and Therapy Outcome in Pediatric Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr 2018;67:507-12. [PMID: 29901557 DOI: 10.1097/MPG.0000000000002051] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 294 |
Chanchlani N, Mortier K, Williams LJ, Muhammed R, Auth MKH, Cosgrove M, Fagbemi A, Fell J, Chong S, Zamvar V, Hyer W, Bisset WM, Morris MA, Rodrigues A, Mitton SG, Bunn S, Beattie RM, Willmott A, Wilson DC, Russell RK. Use of Infliximab Biosimilar Versus Originator in a Pediatric United Kingdom Inflammatory Bowel Disease Induction Cohort. J Pediatr Gastroenterol Nutr 2018;67:513-9. [PMID: 29697550 DOI: 10.1097/MPG.0000000000002011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 295 |
Schneider AM, Weghuber D, Hetzer B, Entenmann A, Müller T, Zimmermann G, Schütz S, Huber WD, Pichler J. Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease. BMC Gastroenterol 2018;18:140. [PMID: 30219028 DOI: 10.1186/s12876-018-0868-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 296 |
Ruskin D, Campbell L, Stinson J, Ahola Kohut S. Changes in Parent Psychological Flexibility after a One-Time Mindfulness-Based Intervention for Parents of Adolescents with Persistent Pain Conditions. Children (Basel) 2018;5:E121. [PMID: 30177644 DOI: 10.3390/children5090121] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 297 |
Gottlieb Y, Elhasid R, Berger-Achituv S, Brazowski E, Yerushalmy-Feler A, Cohen S. Neutrophil extracellular traps in pediatric inflammatory bowel disease. Pathol Int. 2018;68:517-523. [PMID: 30133056 DOI: 10.1111/pin.12715] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 298 |
Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M, Strisciuglio C, Braegger CP, Assa A, Romano C, Hussey S, Stanton M, Pakarinen M, de Ridder L, Katsanos KH, Croft N, Navas-López VM, Wilson DC, Lawrence S, Russell RK. Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis-An Evidence-based Consensus Guideline From the European Crohn's and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018;67:292-310. [PMID: 30044358 DOI: 10.1097/MPG.0000000000002036] [Cited by in Crossref: 107] [Cited by in F6Publishing: 87] [Article Influence: 21.4] [Reference Citation Analysis]
|
| 299 |
Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M, Strisciuglio C, Braegger CP, Assa A, Romano C, Hussey S, Stanton M, Pakarinen M, de Ridder L, Katsanos K, Croft N, Navas-López V, Wilson DC, Lawrence S, Russell RK. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018;67:257-91. [PMID: 30044357 DOI: 10.1097/MPG.0000000000002035] [Cited by in Crossref: 188] [Cited by in F6Publishing: 157] [Article Influence: 37.6] [Reference Citation Analysis]
|
| 300 |
Gasparetto M, Wong-Spracklen V, Torrente F, Howell K, Brennan M, Noble-Jamieson G, Heuschkel R, Zilbauer M. Early Treatment Response Predicts Outcome in Paediatric Ulcerative Colitis: GASTROENTEROLOGY: INFLAMMATORY BOWEL DISEASE. J Pediatr Gastroenterol Nutr 2018;67:217-20. [PMID: 30044356 DOI: 10.1097/MPG.0000000000001941] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 301 |
El-Matary W, Stefanovici C, Van Caeseele P, Deora V, McCurdy J. Detection of Cytomegalovirus in Colonic Mucosa of Children With Inflammatory Bowel Disease: Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2018;67:221-4. [PMID: 29601437 DOI: 10.1097/MPG.0000000000001976] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 302 |
van den Brink G, Stapersma L, Vlug LE, Rizopolous D, Bodelier AG, van Wering H, Hurkmans PCWM, Stuyt RJL, Hendriks DM, van der Burg JAT, Utens EMWJ, Escher JC. Clinical disease activity is associated with anxiety and depressive symptoms in adolescents and young adults with inflammatory bowel disease. Aliment Pharmacol Ther 2018;48:358-69. [PMID: 29897134 DOI: 10.1111/apt.14832] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 303 |
Zhang X, Deeke SA, Ning Z, Starr AE, Butcher J, Li J, Mayne J, Cheng K, Liao B, Li L, Singleton R, Mack D, Stintzi A, Figeys D. Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel disease. Nat Commun 2018;9:2873. [PMID: 30030445 DOI: 10.1038/s41467-018-05357-4] [Cited by in Crossref: 129] [Cited by in F6Publishing: 138] [Article Influence: 25.8] [Reference Citation Analysis]
|
| 304 |
Diederen K, Krom H, Koole JCD, Benninga MA, Kindermann A. Diet and Anthropometrics of Children With Inflammatory Bowel Disease: A Comparison With the General Population. Inflamm Bowel Dis 2018;24:1632-40. [PMID: 29697827 DOI: 10.1093/ibd/izy027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 305 |
Ricciuto A, Fish J, Carman N, Walters TD, Church PC, Hansen BE, Crowley E, Siddiqui I, Nguyen GC, Kamath BM, Griffiths AM. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Clin Gastroenterol Hepatol 2018;16:1098-1105.e1. [PMID: 29378308 DOI: 10.1016/j.cgh.2018.01.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 306 |
Picoraro JA, Lee D, Heller CA, Weaver A, Hyams JS, Conklin LS, Otley A, Ziring D, Kugathasan S, Rosh JR, Mulberg A, Denson LA, Kappelman MD, Grossman AB, Bousvaros A, Park KT. Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn's & Colitis Foundation: Charting the Future of Pediatric IBD. Inflamm Bowel Dis 2019;25:27-32. [PMID: 29931102 DOI: 10.1093/ibd/izy205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 307 |
Tun GS, Harris A, Lobo AJ. Ulcerative colitis: management in adults, children and young people - concise guidance . Clin Med (Lond) 2017;17:429-33. [PMID: 28974592 DOI: 10.7861/clinmedicine.17-5-429] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 308 |
Bosch S, El Manouni El Hassani S, Covington JA, Wicaksono AN, Bomers MK, Benninga MA, Mulder CJJ, de Boer NKH, de Meij TGJ. Optimized Sampling Conditions for Fecal Volatile Organic Compound Analysis by Means of Field Asymmetric Ion Mobility Spectrometry. Anal Chem 2018;90:7972-81. [PMID: 29860824 DOI: 10.1021/acs.analchem.8b00688] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 309 |
Grzybowska-Chlebowczyk U, Wysocka-Wojakiewicz P, Jasielska M, Cukrowska B, Więcek S, Kniażewska M, Chudek J. Oxidative and Antioxidative Stress Status in Children with Inflammatory Bowel Disease as a Result of a Chronic Inflammatory Process. Mediators Inflamm 2018;2018:4120973. [PMID: 30116148 DOI: 10.1155/2018/4120973] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 310 |
Auth MK, Bunn SK, Protheroe AL, Williams LJ, Fell JM, Muhammed R, Croft NM, Beattie RM, Willmott A, Spray C, Vadamalayan B, Rodrigues A, Puntis J, Pigott AJ, Wilson DC, Mitton S, Furman M, Charlton C, Chong SKF, Russell RK; BSPGHAN IBD working group, BSPGHAN IBD site leads. Improved Medical Treatment and Surgical Surveillance of Children and Adolescents with Ulcerative Colitis in the United Kingdom. Inflamm Bowel Dis 2018;24:1520-30. [PMID: 29668982 DOI: 10.1093/ibd/izy042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 311 |
Aloi M, Bramuzzo M, Arrigo S, Romano C, D'Arcangelo G, Lacorte D, Gatti S, Illiceto MT, Zucconi F, Dilillo D, Zuin G, Knafelz D, Ravelli A, Cucchiara S, Alvisi P; SIGENP IBD Working Group. Efficacy and Safety of Adalimumab in Pediatric Ulcerative Colitis: A Real-life Experience from the SIGENP-IBD Registry. J Pediatr Gastroenterol Nutr 2018;66:920-5. [PMID: 29315163 DOI: 10.1097/MPG.0000000000001883] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 312 |
Yerushalmy-Feler A, Ben-Tov A, Weintraub Y, Amir A, Galai T, Moran-Lev H, Cohen S. High and low body mass index may predict severe disease course in children with inflammatory bowel disease. Scand J Gastroenterol 2018;53:708-13. [PMID: 29688090 DOI: 10.1080/00365521.2018.1464595] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 313 |
Spencer EA, Davis SM, Mack DR, Boyle BM, Griffiths AM, LeLeiko NS, Sauer CG, Keljo DJ, Markowitz JF, Baker SS, Rosh JR, Baldassano RN, Oliva-Hemker M, Pfefferkorn MD, Otley AR, Heyman MB, Noe JD, Patel AS, Rufo PA, Alison Marquis M, Walters TD, Collins MH, Kugathasan S, Denson LA, Hyams JS, Dubinsky MC; PROTECT Study Group. Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children. Inflamm Bowel Dis 2018;24:1335-43. [PMID: 29718391 DOI: 10.1093/ibd/izy009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 314 |
Barber JL, Zambrano-Perez A, Olsen ØE, Kiparissi F, Baycheva M, Knaflez D, Shah N, Watson TA. Detecting inflammation in inflammatory bowel disease - how does ultrasound compare to magnetic resonance enterography using standardised scoring systems? Pediatr Radiol 2018;48:843-51. [PMID: 29651607 DOI: 10.1007/s00247-018-4084-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 315 |
Suh JH, Degagné É, Gleghorn EE, Setty M, Rodriguez A, Park KT, Verstraete SG, Heyman MB, Patel AS, Irek M, Gildengorin GL, Hubbard NE, Borowsky AD, Saba JD. Sphingosine-1-Phosphate Signaling and Metabolism Gene Signature in Pediatric Inflammatory Bowel Disease: A Matched-case Control Pilot Study. Inflamm Bowel Dis 2018;24:1321-34. [PMID: 29788359 DOI: 10.1093/ibd/izy007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 316 |
Martinelli M, Giugliano FP, Russo M, Giannetti E, Andreozzi M, Bruzzese D, Perrone L, Staiano A, Miraglia Del Giudice E, Miele E, Marzuillo P, Strisciuglio C. The Changing Face of Pediatric Ulcerative Colitis: A Population-based Cohort Study. J Pediatr Gastroenterol Nutr 2018;66:903-8. [PMID: 29135823 DOI: 10.1097/MPG.0000000000001833] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 317 |
Ferrari F, Ranucci G, Aloi M, Della Volpe L, Viola F, Miele E, Cucchiara S, Iorio R. A promising medium-term follow-up of pediatric sclerosing cholangitis: Mild phenotype or early diagnosis? Hepatol Res 2018;48:556-65. [PMID: 29316057 DOI: 10.1111/hepr.13059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 318 |
Strisciuglio C, Bellini G, Miele E, Martinelli M, Cenni S, Tortora C, Tolone C, Miraglia Del Giudice E, Rossi F. Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease. J Clin Gastroenterol 2018;52:e37-43. [PMID: 27875353 DOI: 10.1097/MCG.0000000000000755] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 319 |
Deeke SA, Starr AE, Ning Z, Ahmadi S, Zhang X, Mayne J, Chiang CK, Singleton R, Benchimol EI, Mack DR, Stintzi A, Figeys D. Mucosal-luminal interface proteomics reveals biomarkers of pediatric inflammatory bowel disease-associated colitis. Am J Gastroenterol 2018;113:713-24. [PMID: 29531307 DOI: 10.1038/s41395-018-0024-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 320 |
Pituch-Zdanowska A, Albrecht P, Banasiuk M, Banaszkiewicz A. Dietary Fiber Intake in Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2018;66:624-9. [PMID: 28922258 DOI: 10.1097/MPG.0000000000001736] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 321 |
Rolandsdotter H, Jönsson-Videsäter K, L Fagerberg U, Eberhardson M, Finkel Y. Mucosal Cytokine Profiles After Induction Therapy With Granulocyte/Monocyte Apheresis in New-onset Inflammatory Colitis. J Pediatr Gastroenterol Nutr 2018;66:e103-7. [PMID: 28891831 DOI: 10.1097/MPG.0000000000001735] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 322 |
Ricciuto A, Fish JR, Tomalty DE, Carman N, Crowley E, Popalis C, Muise A, Walters TD, Griffiths AM, Church PC. Diagnostic delay in Canadian children with inflammatory bowel disease is more common in Crohn's disease and associated with decreased height. Arch Dis Child 2018;103:319-26. [PMID: 28794097 DOI: 10.1136/archdischild-2017-313060] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 323 |
Diederen K, Haverman L, Grootenhuis MA, Benninga MA, Kindermann A. Parental Distress and Quality of Life in Pediatric Inflammatory Bowel Disease: Implications for the Outpatient Clinic. J Pediatr Gastroenterol Nutr 2018;66:630-6. [PMID: 28953528 DOI: 10.1097/MPG.0000000000001756] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 324 |
Heida A, Dijkstra A, Muller Kobold A, Rossen JW, Kindermann A, Kokke F, de Meij T, Norbruis O, Weersma RK, Wessels M, Hummel T, Escher J, van Wering H, Hendriks D, Mearin L, Groen H, Verkade HJ, van Rheenen PF. Efficacy of Home Telemonitoring versus Conventional Follow-up: A Randomized Controlled Trial among Teenagers with Inflammatory Bowel Disease. J Crohns Colitis 2018;12:432-41. [PMID: 29228230 DOI: 10.1093/ecco-jcc/jjx169] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 325 |
Diederen K, Gerritsma JJ, Koot BGP, Tabbers MM, Benninga MA, Kindermann A. Do Children and Adolescents With Inflammatory Bowel Disease Complete Clinical Disease Indices Similar to Physicians? J Pediatr Gastroenterol Nutr 2018;66:410-6. [PMID: 28832362 DOI: 10.1097/MPG.0000000000001712] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 326 |
Giugliano FP, Strisciuglio C, Martinelli M, Andreozzi M, Cenni S, Campione S, D'Armiento M, Staiano A, Miele E. Does Azathioprine induce endoscopic and histologic healing in pediatric inflammatory bowel disease? A prospective, observational study. Dig Liver Dis 2018;50:240-6. [PMID: 29174208 DOI: 10.1016/j.dld.2017.10.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 327 |
Dipasquale V, Romano C. Pharmacological treatments and infectious diseases in pediatric inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2018;12:237-47. [PMID: 28994306 DOI: 10.1080/17474124.2018.1391091] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 328 |
Cabrera JM, Sato TT. Medical and Surgical Management of Pediatric Ulcerative Colitis. Clin Colon Rectal Surg 2018;31:71-9. [PMID: 29487489 DOI: 10.1055/s-0037-1609021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 329 |
Barned C, Dobson J, Stintzi A, Mack D, O'doherty KC. Children's perspectives on the benefits and burdens of research participation. AJOB Empirical Bioethics 2017;9:19-28. [DOI: 10.1080/23294515.2018.1430709] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 330 |
Archer R, Tappenden P, Ren S, Martyn-St James M, Harvey R, Basarir H, Stevens J, Carroll C, Cantrell A, Lobo A, Hoque S. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model. Health Technol Assess 2016;20:1-326. [PMID: 27220829 DOI: 10.3310/hta20390] [Cited by in Crossref: 28] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 331 |
Suskind DL, Cohen SA, Brittnacher MJ, Wahbeh G, Lee D, Shaffer ML, Braly K, Hayden HS, Klein J, Gold B, Giefer M, Stallworth A, Miller SI. Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease. J Clin Gastroenterol 2018;52:155-63. [PMID: 28030510 DOI: 10.1097/MCG.0000000000000772] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 15.4] [Reference Citation Analysis]
|
| 332 |
Mager DR, Carroll MW, Wine E, Siminoski K, Macdonald K, Kluthe CL, Medvedev P, Chen M, Wu J, Turner JM, Huynh HQ. Vitamin D status and risk for sarcopenia in youth with inflammatory bowel diseases. Eur J Clin Nutr 2018;72:623-6. [DOI: 10.1038/s41430-018-0105-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 333 |
Uggla C, Lindh V, Lind T, Lindkvist M. IMPACT-III is a valid and reliable questionnaire for assessing health-related quality of life in Swedish children with inflammatory bowel disease. Acta Paediatr 2018;107:347-53. [PMID: 29032599 DOI: 10.1111/apa.14119] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 334 |
Goyal A, Yeh A, Bush BR, Firek BA, Siebold LM, Rogers MB, Kufen AD, Morowitz MJ. Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease. Inflamm Bowel Dis 2018;24:410-21. [PMID: 29361092 DOI: 10.1093/ibd/izx035] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 15.4] [Reference Citation Analysis]
|
| 335 |
Rolandsdotter H, Eberhardson M, Fagerberg UL, Finkel Y. Granulocyte and Monocyte Apheresis for Induction of Remission in Children With New-Onset Inflammatory Bowel Colitis. J Pediatr Gastroenterol Nutr 2018;66:84-9. [PMID: 28604509 DOI: 10.1097/MPG.0000000000001641] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 336 |
Richmond L, Curtis L, Garrick V, Rogers P, Wilson M, Tayler R, Henderson P, Hansen R, Wilson DC, Russell RK. Biosimilar infliximab use in paediatric IBD. Arch Dis Child 2018;103:89-91. [PMID: 28988215 DOI: 10.1136/archdischild-2017-313404] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 337 |
de Laffolie J, Laass MW, Scholz D, Zimmer KP, Buderus S; CEDATA-GPGE Study Group . Prevalence of Anemia in Pediatric IBD Patients and Impact on Disease Severity: Results of the Pediatric IBD-Registry CEDATA-GPGE®. Gastroenterol Res Pract 2017;2017:8424628. [PMID: 29358946 DOI: 10.1155/2017/8424628] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 338 |
Siow VS, Bhatt R, Mollen KP. Management of acute severe ulcerative colitis in children. Semin Pediatr Surg 2017;26:367-72. [PMID: 29126505 DOI: 10.1053/j.sempedsurg.2017.10.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 339 |
Hyams JS, Chan D, Adedokun OJ, Padgett L, Turner D, Griffiths A, Veereman G, Heyman MB, Rosh JR, Wahbeh G, Strauss R. Subcutaneous Golimumab in Pediatric Ulcerative Colitis: Pharmacokinetics and Clinical Benefit. Inflamm Bowel Dis 2017;23:2227-37. [PMID: 29140944 DOI: 10.1097/MIB.0000000000001262] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 340 |
Yu YR, Rodriguez JR. Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes. Semin Pediatr Surg 2017;26:349-55. [PMID: 29126502 DOI: 10.1053/j.sempedsurg.2017.10.003] [Cited by in Crossref: 135] [Cited by in F6Publishing: 139] [Article Influence: 22.5] [Reference Citation Analysis]
|
| 341 |
Greenley RN, Reed-knight B, Wojtowicz AA, Plevinsky JM, Lewis JD, Kahn SA. A bitter pill to swallow: Medication adherence barriers in adolescents and young adults with inflammatory bowel diseases. Children's Health Care 2018;47:416-31. [DOI: 10.1080/02739615.2017.1383911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 342 |
Carlsen K, Jakobsen C, Kallemose T, Paerregaard A, Riis LB, Munkholm P, Wewer V. F-calprotectin and Blood Markers Correlate to Quality of Life in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2017;65:539-45. [PMID: 28169974 DOI: 10.1097/MPG.0000000000001540] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 343 |
Negroni A, Colantoni E, Pierdomenico M, Palone F, Costanzo M, Oliva S, Tiberti A, Cucchiara S, Stronati L. RIP3 AND pMLKL promote necroptosis-induced inflammation and alter membrane permeability in intestinal epithelial cells. Dig Liver Dis 2017;49:1201-10. [PMID: 28844856 DOI: 10.1016/j.dld.2017.08.017] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 344 |
Boyle B, Collins MH, Wang Z, Mack D, Griffiths A, Sauer C, Markowitz J, LeLeiko N, Keljo D, Rosh J, Baker SS, Pfefferkorn M, Heyman M, Patel A, Baldassano R, Noe J, Rufo P, Kugathasan S, Walters T, Denson L, Hyams J; PROTECT Study Group. Histologic Correlates of Clinical and Endoscopic Severity in Children Newly Diagnosed With Ulcerative Colitis. Am J Surg Pathol 2017;41:1491-8. [PMID: 28863076 DOI: 10.1097/PAS.0000000000000939] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 345 |
Reigada LC, Moore MT, Martin CF, Kappelman MD. Psychometric Evaluation of the IBD-Specific Anxiety Scale: A Novel Measure of Disease-Related Anxiety for Adolescents With IBD. Journal of Pediatric Psychology 2018;43:413-22. [DOI: 10.1093/jpepsy/jsx121] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 346 |
Rinawi F, Assa A, Eliakim R, Mozer-Glassberg Y, Nachmias-Friedler V, Niv Y, Rosenbach Y, Silbermintz A, Zevit N, Shamir R. Risk of Colectomy in Patients With Pediatric-onset Ulcerative Colitis. J Pediatr Gastroenterol Nutr 2017;65:410-5. [PMID: 28207474 DOI: 10.1097/MPG.0000000000001545] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 347 |
Maratova K, Hradsky O, Matyskova J, Copova I, Soucek O, Sumnik Z, Bronsky J. Musculoskeletal system in children and adolescents with inflammatory bowel disease: normal muscle force, decreased trabecular bone mineral density and low prevalence of vertebral fractures. Eur J Pediatr 2017;176:1355-63. [PMID: 28840427 DOI: 10.1007/s00431-017-2988-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 348 |
Flood E, Silberg DG, Romero B, Beusterien K, Erder MH, Cuffari C. Development of the pediatric daily ulcerative colitis signs and symptoms scale (DUCS): qualitative research findings. BMC Res Notes 2017;10:491. [PMID: 28946891 DOI: 10.1186/s13104-017-2814-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 349 |
Hyams JS, Davis S, Mack DR, Boyle B, Griffiths AM, LeLeiko NS, Sauer CG, Keljo DJ, Markowitz J, Baker SS, Rosh J, Baldassano RN, Patel A, Pfefferkorn M, Otley A, Heyman M, Noe J, Oliva-Hemker M, Rufo P, Strople J, Ziring D, Guthery SL, Sudel B, Benkov K, Wali P, Moulton D, Evans J, Kappelman MD, Marquis A, Sylvester FA, Collins MH, Venkateswaran S, Dubinsky M, Tangpricha V, Spada KL, Britt A, Saul B, Gotman N, Wang J, Serrano J, Kugathasan S, Walters T, Denson LA. Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study. Lancet Gastroenterol Hepatol 2017;2:855-68. [PMID: 28939374 DOI: 10.1016/S2468-1253(17)30252-2] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 350 |
Nakazawa Y, Kawai T, Arai K, Tamura E, Uchiyama T, Onodera M. Fecal Calprotectin Rise in Chronic Granulomatous Disease-Associated Colitis. J Clin Immunol 2017;37:741-3. [PMID: 28879453 DOI: 10.1007/s10875-017-0441-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 351 |
Starr AE, Deeke SA, Ning Z, Chiang CK, Zhang X, Mottawea W, Singleton R, Benchimol EI, Wen M, Mack DR, Stintzi A, Figeys D. Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UC. Gut 2017;66:1573-83. [PMID: 27216938 DOI: 10.1136/gutjnl-2015-310705] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 352 |
Carlsen K, Houen G, Jakobsen C, Kallemose T, Paerregaard A, Riis LB, Munkholm P, Wewer V. Individualized Infliximab Treatment Guided by Patient-managed eHealth in Children and Adolescents with Inflammatory Bowel Disease. Inflamm Bowel Dis 2017;23:1473-82. [PMID: 28617758 DOI: 10.1097/MIB.0000000000001170] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 353 |
Lazzerini M, Villanacci V, Pellegrin MC, Martelossi S, Magazzù G, Pellegrino S, Lucanto MC, Barabino A, Calvi A, Arrigo S, Lionetti P, Fontana M, Zuin G, Maggiore G, Bramuzzo M, Maschio M, Salemme M, Manenti S, Lorenzi L, Decorti G, Montico M, Ventura A. Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide. Clin Gastroenterol Hepatol 2017;15:1382-1389.e1. [PMID: 28286192 DOI: 10.1016/j.cgh.2017.02.029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 354 |
Maxwell EC, Dawany N, Baldassano RN, Mamula P, Mattei P, Albenberg L, Kelsen JR. Diverting Ileostomy for the Treatment of Severe, Refractory, Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2017;65:299-305. [PMID: 28045769 DOI: 10.1097/MPG.0000000000001498] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 355 |
Zaidi D, Churchill L, Huynh HQ, Carroll MW, Persad R, Wine E. Capillary Flow Rates in the Duodenum of Pediatric Ulcerative Colitis Patients Are Increased and Unrelated to Inflammation. J Pediatr Gastroenterol Nutr 2017;65:306-10. [PMID: 28045777 DOI: 10.1097/MPG.0000000000001495] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 356 |
Rinawi F, Assa A, Eliakim R, Mozer Glassberg Y, Nachmias Friedler V, Niv Y, Rosenbach Y, Silbermintz A, Zevit N, Shamir R. Predictors of pouchitis after ileal pouch-anal anastomosis in pediatric-onset ulcerative colitis. Eur J Gastroenterol Hepatol 2017;29:1079-85. [PMID: 28542114 DOI: 10.1097/MEG.0000000000000914] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 357 |
Monasta L, Pierobon C, Princivalle A, Martelossi S, Marcuzzi A, Pasini F, Perbellini L. Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry. PLoS One 2017;12:e0184118. [PMID: 28859138 DOI: 10.1371/journal.pone.0184118] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 358 |
Pai N, Popov J. Protocol for a randomised, placebo-controlled pilot study for assessing feasibility and efficacy of faecal microbiota transplantation in a paediatric ulcerative colitis population: PediFETCh trial. BMJ Open. 2017;7:e016698. [PMID: 28827258 DOI: 10.1136/bmjopen-2017-016698] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 359 |
Rinawi F, Assa A, Bashir H, Peleg S, Shamir R. Clinical and Phenotypic Differences in Inflammatory Bowel Disease Among Arab and Jewish Children in Israel. Dig Dis Sci 2017;62:2095-101. [PMID: 28547648 DOI: 10.1007/s10620-017-4623-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 360 |
Turner D, Carle A, Steiner SJ, Margolis PA, Colletti RB, Russell RK, Levine A, Kolho KL, Ruemmele FM; ImproveCareNow Network. Quality Items Required for Running a Paediatric Inflammatory Bowel Disease Centre: An ECCO Paper. J Crohns Colitis 2017;11:981-7. [PMID: 28789473 DOI: 10.1093/ecco-jcc/jjx036] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 361 |
Watson KL Jr, Kim SC, Boyle BM, Saps M. Prevalence and Impact of Functional Abdominal Pain Disorders in Children With Inflammatory Bowel Diseases (IBD-FAPD). J Pediatr Gastroenterol Nutr 2017;65:212-7. [PMID: 27906801 DOI: 10.1097/MPG.0000000000001479] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 362 |
Levine A, Yerushalmi B, Kori M, Broide E, Mozer-Glassberg Y, Shaoul R, Kolho KL, Shteyer E, Shamaly H, Ledder O, Cohen S, Peleg S, Shabat CS, Focht G, Shachmon E, Boaz M, On A, Turner D. Mesalamine Enemas for Induction of Remission in Oral Mesalamine-refractory Pediatric Ulcerative Colitis: A Prospective Cohort Study. J Crohns Colitis 2017;11:970-4. [PMID: 28369299 DOI: 10.1093/ecco-jcc/jjx042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 363 |
Misof BM, Roschger P, Klaushofer K, Rauch F, Ma J, Mack DR, Ward LM. Increased bone matrix mineralization in treatment-naïve children with inflammatory bowel disease. Bone 2017;105:50-6. [PMID: 28705682 DOI: 10.1016/j.bone.2017.07.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 364 |
Yerushalmy-Feler A, Ron Y, Barnea E, Nachum A, Matalon S, Dali-Levy M, Dotan I, Cohen S. Adolescent transition clinic in inflammatory bowel disease: quantitative assessment of self-efficacy skills. Eur J Gastroenterol Hepatol 2017;29:831-7. [PMID: 28230561 DOI: 10.1097/MEG.0000000000000864] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 365 |
Lee HJ, Cheon JH. Optimal diagnosis and disease activity monitoring of intestinal Behçet's disease. Intest Res 2017;15:311-7. [PMID: 28670227 DOI: 10.5217/ir.2017.15.3.311] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 366 |
Hensel KO, Abellan Schneyder FE, Wilke L, Heusch A, Wirth S, Jenke AC. Speckle Tracking Stress Echocardiography Uncovers Early Subclinical Cardiac Involvement in Pediatric Patients with Inflammatory Bowel Diseases. Sci Rep 2017;7:2966. [PMID: 28592829 DOI: 10.1038/s41598-017-03255-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 367 |
Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, Burisch J, Gecse KB, Hart AL, Hindryckx P, Langner C, Limdi JK, Pellino G, Zagórowicz E, Raine T, Harbord M, Rieder F; European Crohn’s and Colitis Organisation [ECCO]. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis 2017;11:649-70. [PMID: 28158501 DOI: 10.1093/ecco-jcc/jjx008] [Cited by in Crossref: 1024] [Cited by in F6Publishing: 1019] [Article Influence: 170.7] [Reference Citation Analysis]
|
| 368 |
Coughlan A, Wylde R, Lafferty L, Quinn S, Broderick A, Bourke B, Hussey S; DOCHAS Study. A rising incidence and poorer male outcomes characterise early onset paediatric inflammatory bowel disease. Aliment Pharmacol Ther 2017;45:1534-41. [PMID: 28449214 DOI: 10.1111/apt.14070] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 369 |
Hagiwara SI, Okayasu I, Fujiwara M, Matsuura M, Ohnishi H, Ito S, Kishimoto H, Nambu R, Kagimoto S. Prostaglandin E-major Urinary Metabolite as a Biomarker for Pediatric Ulcerative Colitis Activity. J Pediatr Gastroenterol Nutr 2017;64:955-61. [PMID: 27906804 DOI: 10.1097/MPG.0000000000001477] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 370 |
Heida A, Park KT, van Rheenen PF. Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide. Inflamm Bowel Dis 2017;23:894-902. [PMID: 28511198 DOI: 10.1097/MIB.0000000000001082] [Cited by in Crossref: 87] [Cited by in F6Publishing: 75] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 371 |
Oliveira SB, Monteiro IM. Diagnosis and management of inflammatory bowel disease in children. BMJ. 2017;357:j2083. [PMID: 28566467 DOI: 10.1136/bmj.j2083] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 372 |
Martin FP, Su MM, Xie GX, Guiraud SP, Kussmann M, Godin JP, Jia W, Nydegger A. Urinary metabolic insights into host-gut microbial interactions in healthy and IBD children. World J Gastroenterol 2017; 23(20): 3643-3654 [PMID: 28611517 DOI: 10.3748/wjg.v23.i20.3643] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 373 |
Soriano RA, Ramos-Soriano AG. Clinical and Pathologic Remission of Pediatric Ulcerative Colitis with Serum-Derived Bovine Immunoglobulin Added to the Standard Treatment Regimen. Case Rep Gastroenterol 2017;11:335-43. [PMID: 28626380 DOI: 10.1159/000475923] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 374 |
Kerur B, Litman HJ, Stern JB, Weber S, Lightdale JR, Rufo PA, Bousvaros A. Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis. World J Gastroenterol 2017; 23(18): 3322-3329 [PMID: 28566893 DOI: 10.3748/wjg.v23.i18.3322] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 375 |
Turner D, Yerushalmi B, Kori M, Broide E, Mozer-Glassberg Y, Shaoul R, Kolho KL, Shteyer E, Shamaly H, Ledder O, Cohen S, Peleg S, On A, Levine A. Once- Versus Twice-daily Mesalazine to Induce Remission in Paediatric Ulcerative Colitis: A Randomised Controlled Trial. J Crohns Colitis 2017;11:527-33. [PMID: 28453754 DOI: 10.1093/ecco-jcc/jjw180] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 376 |
Varni JW, Shulman RJ, Self MM, Saeed SA, Patel AS, Nurko S, Neigut DA, Saps M, Zacur GM, Dark CV, Bendo CB, Pohl JF. Patient Health Communication Mediating Effects Between Gastrointestinal Symptoms and Gastrointestinal Worry in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2017;23:704-11. [PMID: 28394807 DOI: 10.1097/MIB.0000000000001077] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 377 |
Stocco G, Martelossi S, Arrigo S, Barabino A, Aloi M, Martinelli M, Miele E, Knafelz D, Romano C, Naviglio S, Favretto D, Cuzzoni E, Franca R, Decorti G, Ventura A. Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2017;23:628-34. [PMID: 28296824 DOI: 10.1097/MIB.0000000000001051] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 378 |
Knoll RL, Forslund K, Kultima JR, Meyer CU, Kullmer U, Sunagawa S, Bork P, Gehring S. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis. Am J Physiol Gastrointest Liver Physiol 2017;312:G327-39. [PMID: 28039159 DOI: 10.1152/ajpgi.00293.2016] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 379 |
Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, Nakstad B, Vatn MH, Perminow G. Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy. Scand J Gastroenterol 2017;52:414-9. [PMID: 27887202 DOI: 10.1080/00365521.2016.1259653] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 380 |
Yamamoto-furusho J, Bosques-padilla F, Daffra P, De Paula J, Etchevers J, Galiano M, Ibañez P, Juliao F, Kotze P, Marroquín de la Garza J, Monreal Robles R, Rocha J, Steinwurz F, Vázquez-frías R, Veitia G, Zaltman C. Special situations in inflammatory bowel disease: First Latin American consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) (Second part). Revista de Gastroenterología de México (English Edition) 2017;82:134-155. [DOI: 10.1016/j.rgmxen.2016.07.004] [Reference Citation Analysis]
|
| 381 |
Diederen K, Hoekman DR, Leek A, Wolters VM, Hummel TZ, de Meij TG, Koot BG, Tabbers MM, Benninga MA, Kindermann A. Raised faecal calprotectin is associated with subsequent symptomatic relapse, in children and adolescents with inflammatory bowel disease in clinical remission. Aliment Pharmacol Ther 2017;45:951-60. [PMID: 28138990 DOI: 10.1111/apt.13950] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 382 |
Samson CM, Mager D, Frazee S, Yu F. Remission in Pediatric Inflammatory Bowel Disease Correlates With Prescription Refill Adherence Rates. J Pediatr Gastroenterol Nutr 2017;64:575-9. [PMID: 27299424 DOI: 10.1097/MPG.0000000000001304] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 383 |
Seong Y, Lazarus NH, Sutherland L, Habtezion A, Abramson T, He XS, Greenberg HB, Butcher EC. Trafficking receptor signatures define blood plasmablasts responding to tissue-specific immune challenge. JCI Insight 2017;2:e90233. [PMID: 28352656 DOI: 10.1172/jci.insight.90233] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 384 |
Yamamoto-Furusho JK, Bosques-Padilla F, Daffra P, De Paula JA, Etchevers J, Galiano MT, Ibañez P, Juliao F, Kotze PG, Marroquín de la Garza JM, Monreal Robles R, Rocha JL, Steinwurz F, Vázquez-Frías R, Veitia G, Zaltman C. Special situations in inflammatory bowel disease: First Latin American consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) (Second part). Rev Gastroenterol Mex 2017;82:134-55. [PMID: 28318706 DOI: 10.1016/j.rgmx.2016.07.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 385 |
Ankersen DV, Carlsen K, Marker D, Munkholm P, Burisch J. Using eHealth strategies in delivering dietary and other therapies in patients with irritable bowel syndrome and inflammatory bowel disease. J Gastroenterol Hepatol 2017;32 Suppl 1:27-31. [PMID: 28244677 DOI: 10.1111/jgh.13691] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 386 |
Carlsen K, Jakobsen C, Houen G, Kallemose T, Paerregaard A, Riis LB, Munkholm P, Wewer V. Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease: A Randomized Controlled Trial. Inflamm Bowel Dis 2017;23:357-65. [PMID: 28221247 DOI: 10.1097/MIB.0000000000001026] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 387 |
Marcovitch L, Nissan A, Mack D, Otley A, Hussey S, Mclean B, Lewis M, Croft N, Barakat FM, Griffiths AM, Turner D. Item Generation and Reduction Toward Developing a Patient-reported Outcome for Pediatric Ulcerative Colitis (TUMMY-UC). J Pediatr Gastroenterol Nutr 2017;64:373-7. [PMID: 27159210 DOI: 10.1097/MPG.0000000000001259] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 388 |
Bornaun HA, Yılmaz N, Kutluk G, Dedeoğlu R, Öztarhan K, Keskindemirci G, Tulunoğlu A, Şap F. Prolonged P-Wave and QT Dispersion in Children with Inflammatory Bowel Disease in Remission. Biomed Res Int 2017;2017:6960810. [PMID: 28316985 DOI: 10.1155/2017/6960810] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 389 |
Werner H, Landolt MA, Buehr P, Koller R, Nydegger A, Spalinger J, Heyland K, Schibli S, Braegger CP; The Swiss IBD Cohort Study Group. Changes in health-related quality of life over a 1-year follow-up period in children with inflammatory bowel disease. Qual Life Res 2017;26:1617-26. [DOI: 10.1007/s11136-017-1513-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 390 |
Chouliaras G, Margoni D, Dimakou K, Fessatou S, Panayiotou I, Roma-Giannikou E. Disease impact on the quality of life of children with inflammatory bowel disease. World J Gastroenterol 2017; 23(6): 1067-1075 [PMID: 28246481 DOI: 10.3748/wjg.v23.i6.1067] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 391 |
Minar P, Dykes DM, Arce-clachar AC, Saeed SA. Infliximab Therapy for Pediatric Crohn Disease and Ulcerative Colitis. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_32] [Reference Citation Analysis]
|
| 392 |
Kaplan JL, Winter HS. Treatment of Acute Severe Ulcerative Colitis. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_37] [Reference Citation Analysis]
|
| 393 |
Mack DR. Probiotic Therapy. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_28] [Reference Citation Analysis]
|
| 394 |
Uchida K, Ohtsuka Y, Yoden A, Tajiri H, Kimura H, Isihige T, Yamada H, Arai K, Tomomasa T, Ushijima K, Aomatsu T, Nagata S, Otake K, Matsushita K, Inoue M, Kudo T, Hosoi K, Takeuchi K, Shimizu T. Immunosuppressive medication is not associated with surgical site infection after surgery for intractable ulcerative colitis in children. Intractable Rare Dis Res 2017;6:106-13. [PMID: 28580210 DOI: 10.5582/irdr.2017.01012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 395 |
Boyle B, Hyams JS. Pediatric Aspects of Inflammatory Bowel Disease. Crohn's Disease and Ulcerative Colitis 2017. [DOI: 10.1007/978-3-319-33703-6_58] [Reference Citation Analysis]
|
| 396 |
El-Matary W, Abej E, Deora V, Singh H, Bernstein CN. Impact of Fecal Calprotectin Measurement on Decision-making in Children with Inflammatory Bowel Disease. Front Pediatr 2017;5:7. [PMID: 28180127 DOI: 10.3389/fped.2017.00007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 397 |
Alsabban Z, Church P, Moineddin R, Navarro OM, Greer M, Walters T, Chavhan GB. Accuracy and interobserver agreement of diffusion-weighted imaging in pediatric inflammatory bowel disease. Clinical Imaging 2017;41:14-22. [DOI: 10.1016/j.clinimag.2016.09.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 398 |
Turner D, Ledder O. Clinical Indices for Pediatric Inflammatory Bowel Disease Research. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_46] [Reference Citation Analysis]
|
| 399 |
Carlsen K, Munkholm P, Burisch J. Evaluation of Quality of Life in Crohn’s Disease and Ulcerative Colitis: What Is Health-Related Quality of Life? Crohn's Disease and Ulcerative Colitis 2017. [DOI: 10.1007/978-3-319-33703-6_25] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 400 |
Sherlock ME, Benchimol EI. Classification of Inflammatory Bowel Disease in Children. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 401 |
Varni JW, Shulman RJ, Self MM, Saeed SA, Patel AS, Nurko S, Neigut DA, Saps M, Franciosi JP, Denham JM, Zacur GM, Dark CV, Bendo CB, Pohl JF; Pediatric Quality of Life Inventory Gastrointestinal Symptoms Module Testing Study Consortium. Gastrointestinal Symptoms Predictors of Health-Related Quality of Life in Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2016;63:e186-92. [PMID: 27749610 DOI: 10.1097/MPG.0000000000001428] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 402 |
Keerthy D, Youk A, Srinath AI, Malas N, Bujoreanu S, Bousvaros A, Keljo D, DeMaso DR, Szigethy EM. Effect of Psychotherapy on Health Care Utilization in Children With Inflammatory Bowel Disease and Depression. J Pediatr Gastroenterol Nutr 2016;63:658-64. [PMID: 27035372 DOI: 10.1097/MPG.0000000000001207] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 403 |
Zaidi D, Bording-Jorgensen M, Huynh HQ, Carroll MW, Turcotte JF, Sergi C, Liu J, Wine E. Increased Epithelial Gap Density in the Noninflamed Duodenum of Children With Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr 2016;63:644-50. [PMID: 26933801 DOI: 10.1097/MPG.0000000000001182] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 404 |
Mottawea W, Chiang CK, Mühlbauer M, Starr AE, Butcher J, Abujamel T, Deeke SA, Brandel A, Zhou H, Shokralla S, Hajibabaei M, Singleton R, Benchimol EI, Jobin C, Mack DR, Figeys D, Stintzi A. Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's disease. Nat Commun 2016;7:13419. [PMID: 27876802 DOI: 10.1038/ncomms13419] [Cited by in Crossref: 213] [Cited by in F6Publishing: 221] [Article Influence: 30.4] [Reference Citation Analysis]
|
| 405 |
Aydemir Y, Pınar A, Hızal G, Demir H, Saltık Temizel İN, Özen H, Akbıyık F, Yüce A. Neutrophil volume distribution width as a new marker in detecting inflammatory bowel disease activation. Int Jnl Lab Hem 2017;39:51-7. [DOI: 10.1111/ijlh.12574] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 406 |
Larsen L, Jensen MD, Larsen MD, Nielsen RG, Thorsgaard N, Vind I, Wildt S, Kjeldsen J. The Danish National Registry for Biological Therapy in Inflammatory Bowel Disease. Clin Epidemiol. 2016;8:607-612. [PMID: 27822107 DOI: 10.2147/clep.s99478] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 407 |
Sznurkowska K, Żawrocki A, Sznurkowski J, Zieliński M, Landowski P, Plata-Nazar K, Iżycka-Świeszewska E, Trzonkowski P, Szlagatys-Sidorkiewicz A, Kamińska B. Peripheral and Intestinal T-regulatory Cells are Upregulated in Children with Inflammatory Bowel Disease at Onset of Disease. Immunol Invest 2016;45:787-96. [PMID: 27759462 DOI: 10.1080/08820139.2016.1214961] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 408 |
Conrad MA, Stein RE, Maxwell EC, Albenberg L, Baldassano RN, Dawany N, Grossman AB, Mamula P, Piccoli DA, Kelsen JR. Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:2425-31. [PMID: 27598742 DOI: 10.1097/MIB.0000000000000918] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 409 |
Hartman C, Marderfeld L, Davidson K, Mozer-Glassberg Y, Poraz I, Silbermintz A, Zevit N, Shamir R. Food Intake Adequacy in Children and Adolescents With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2016;63:437-44. [PMID: 26925608 DOI: 10.1097/MPG.0000000000001170] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 410 |
Kolho KL. Assessment of disease activity in pediatric ulcerative colitis. Expert Rev Gastroenterol Hepatol 2016;10:1127-34. [PMID: 27145213 DOI: 10.1080/17474124.2016.1185364] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 411 |
Walsh AJ, Bryant RV, Travis SP. Current best practice for disease activity assessment in IBD. Nat Rev Gastroenterol Hepatol 2016;13:567-79. [PMID: 27580684 DOI: 10.1038/nrgastro.2016.128] [Cited by in Crossref: 128] [Cited by in F6Publishing: 112] [Article Influence: 18.3] [Reference Citation Analysis]
|
| 412 |
Hagin S, Lobato DJ, Sands BE, Korzenik JR, Merrick M, Shah SA, Bancroft B, Bright R, Law M, Moniz H, Shapiro J, Leleiko NS. Dietary behaviors in newly diagnosed youth with inflammatory bowel disease. Children's Health Care 2016;46:408-20. [DOI: 10.1080/02739615.2016.1227935] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 413 |
Nambu R, Hagiwara S, Kubota M, Kagimoto S. Difference between early onset and late-onset pediatric ulcerative colitis. Pediatr Int 2016;58:862-6. [PMID: 26833925 DOI: 10.1111/ped.12935] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 414 |
Levy RL, van Tilburg MA, Langer SL, Romano JM, Walker LS, Mancl LA, Murphy TB, Claar RL, Feld SI, Christie DL, Abdullah B, DuPen MM, Swanson KS, Baker MD, Stoner SA, Whitehead WE. Effects of a Cognitive Behavioral Therapy Intervention Trial to Improve Disease Outcomes in Children with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:2134-48. [PMID: 27542131 DOI: 10.1097/MIB.0000000000000881] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 415 |
Taleban S, Stewart KO, Li DK, Singh P, Pardi DS, Sturgeon HC, Yajnik V, Xavier RJ, Ananthakrishnan AN, Khalili H. Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn's Disease Phenotypes. Dig Dis Sci 2016;61:2627-35. [PMID: 27142671 DOI: 10.1007/s10620-016-4180-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 416 |
Martin FP, Ezri J, Cominetti O, Da Silva L, Kussmann M, Godin JP, Nydegger A. Urinary Metabolic Phenotyping Reveals Differences in the Metabolic Status of Healthy and Inflammatory Bowel Disease (IBD) Children in Relation to Growth and Disease Activity. Int J Mol Sci. 2016;17. [PMID: 27529220 DOI: 10.3390/ijms17081310] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 417 |
Yammine S, Nyilas S, Casaulta C, Schibli S, Latzin P, Sokollik C. Function and Ventilation of Large and Small Airways in Children and Adolescents with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:1915-22. [PMID: 27120569 DOI: 10.1097/MIB.0000000000000779] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 418 |
Shaw KA, Bertha M, Hofmekler T, Chopra P, Vatanen T, Srivatsa A, Prince J, Kumar A, Sauer C, Zwick ME, Satten GA, Kostic AD, Mulle JG, Xavier RJ, Kugathasan S. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease. Genome Med 2016;8:75. [PMID: 27412252 DOI: 10.1186/s13073-016-0331-y] [Cited by in Crossref: 154] [Cited by in F6Publishing: 161] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 419 |
Kim DH, Cheon JH. Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis? Yonsei Med J 2016;57:22-32. [PMID: 26632379 DOI: 10.3349/ymj.2016.57.1.22] [Cited by in Crossref: 54] [Cited by in F6Publishing: 84] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 420 |
Choshen S, Finnamore H, Auth MK, Bdolah-Abram T, Shteyer E, Mack D, Hyams J, Leleiko N, Griffiths A, Turner D. Corticosteroid Dosing in Pediatric Acute Severe Ulcerative Colitis: A Propensity Score Analysis. J Pediatr Gastroenterol Nutr 2016;63:58-64. [PMID: 26756874 DOI: 10.1097/MPG.0000000000001079] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 421 |
Diederen K, Hoekman DR, Hummel TZ, de Meij TG, Koot BG, Tabbers MM, Vlieger AM, Kindermann A, Benninga MA. The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity. Aliment Pharmacol Ther 2016;44:181-8. [PMID: 27110920 DOI: 10.1111/apt.13636] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 422 |
Aloi M, DʼArcangelo G, Bramuzzo M, Gasparetto M, Martinelli M, Alvisi P, Illiceto MT, Valenti S, Distante M, Pellegrino S, Gatti S, Arrigo S, Civitelli F, Martelossi S; SIGENP IBD Working Group. Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis. Inflamm Bowel Dis 2016;22:1647-54. [PMID: 27271489 DOI: 10.1097/MIB.0000000000000828] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 423 |
Kolho KL, Ainamo A. Progress in the treatment and outcome of pediatric inflammatory bowel disease patients. Expert Rev Clin Immunol. 2016;12:1337-1345. [PMID: 27322874 DOI: 10.1080/1744666x.2016.1201422] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 424 |
Negroni A, Colantoni E, Vitali R, Palone F, Pierdomenico M, Costanzo M, Cesi V, Cucchiara S, Stronati L. NOD2 induces autophagy to control AIEC bacteria infectiveness in intestinal epithelial cells. Inflamm Res. 2016;65:803-813. [PMID: 27335178 DOI: 10.1007/s00011-016-0964-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 425 |
Gut G, Ben-Tov A, Lahad A, Soferman R, Cohen S, Tauman R, Sivan Y. Pulmonary functions in children with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2016;28:708-13. [PMID: 26862933 DOI: 10.1097/MEG.0000000000000606] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 426 |
Pini Prato A, Pio L, Leonelli L, Pistorio A, Crocco M, Arrigo S, Gandullia P, Mazzola C, Sanfilippo F, Barabino A, Mattioli G. Morbidity and Risk Factors of Laparoscopic-Assisted Ileostomies in Children With Ulcerative Colitis. J Pediatr Gastroenterol Nutr 2016;62:858-62. [PMID: 26529347 DOI: 10.1097/MPG.0000000000001025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 427 |
Capriati T, Cardile S, Papadatou B, Romano C, Knafelz D, Bracci F, Diamanti A. Pediatric inflammatory bowel disease: specificity of very early onset. Expert Review of Clinical Immunology 2016;12:963-72. [DOI: 10.1080/1744666x.2016.1184571] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 428 |
Ruuska T, Küster P, Grahnquist L, Lindgren F, Wewer AV. Efficacy and safety of granulocyte, monocyte/macrophage adsorptive in pediatric ulcerative colitis. World J Gastroenterol 2016; 22(17): 4389-4396 [PMID: 27158208 DOI: 10.3748/wjg.v22.i17.4389] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 429 |
Fell JM, Muhammed R, Spray C, Crook K, Russell RK; BSPGHAN IBD working group. Management of ulcerative colitis. Arch Dis Child 2016;101:469-74. [PMID: 26553909 DOI: 10.1136/archdischild-2014-307218] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 430 |
Martinelli M, Strisciuglio C, Alessandrella A, Rossi F, Auricchio R, Campostrini N, Girelli D, Nobili B, Staiano A, Perrotta S, Miele E. Serum Hepcidin and Iron Absorption in Paediatric Inflammatory Bowel Disease. J Crohns Colitis 2016;10:566-74. [PMID: 26733407 DOI: 10.1093/ecco-jcc/jjv242] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 431 |
Sadi G, Yang Q, Dufault B, Stefanovici C, Stoffman J, El-Matary W. Prevalence of Peripheral Eosinophilia at Diagnosis in Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2016;62:573-6. [PMID: 26308316 DOI: 10.1097/MPG.0000000000000957] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 432 |
Reed-Knight B, Lee JL, Greenley RN, Lewis JD, Blount RL. Disease Activity Does Not Explain It All: How Internalizing Symptoms and Caregiver Depressive Symptoms Relate to Health-related Quality of Life Among Youth with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:963-7. [PMID: 26818418 DOI: 10.1097/MIB.0000000000000686] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 433 |
Hoekman DR, Brandse JF, de Meij TG, Hummel TZ, Löwenberg M, Benninga MA, D'Haens GR, Kindermann A. The association of infliximab trough levels with disease activity in pediatric inflammatory bowel disease. Scand J Gastroenterol 2015;50:1110-7. [PMID: 25865965 DOI: 10.3109/00365521.2015.1027264] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 434 |
van den Brink G, Stapersma L, El Marroun H, Henrichs J, Szigethy EM, Utens EM, Escher JC. Effectiveness of disease-specific cognitive-behavioural therapy on depression, anxiety, quality of life and the clinical course of disease in adolescents with inflammatory bowel disease: study protocol of a multicentre randomised controlled trial (HAPPY-IBD). BMJ Open Gastroenterol 2016;3:e000071. [PMID: 26966551 DOI: 10.1136/bmjgast-2015-000071] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 435 |
deBruyn J, Fonseca K, Ghosh S, Panaccione R, Gasia MF, Ueno A, Kaplan GG, Seow CH, Wrobel I. Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized Trial. Inflamm Bowel Dis 2016;22:638-47. [PMID: 26595551 DOI: 10.1097/MIB.0000000000000615] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 436 |
Huntington JT, Boomer LA, Pepper VK, Diefenbach KA, Dotson JL, Nwomeh BC. Minimally Invasive Ileal Pouch-Anal Anastomosis with Rectal Eversion Allows for Equivalent Outcomes in Continence in Pediatric Patients. Journal of Laparoendoscopic & Advanced Surgical Techniques 2016;26:222-5. [DOI: 10.1089/lap.2015.0429] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 437 |
Livshits A, Fisher D, Hadas I, Bdolah-Abram T, Mack D, Hyams J, Crandall W, Griffiths AM, Turner D. Abdominal X-ray in Pediatric Acute Severe Colitis and Radiographic Predictors of Response to Intravenous Steroids. J Pediatr Gastroenterol Nutr 2016;62:259-63. [PMID: 26196204 DOI: 10.1097/MPG.0000000000000910] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 438 |
Pierdomenico M, Cesi V, Cucchiara S, Vitali R, Prete E, Costanzo M, Aloi M, Oliva S, Stronati L. NOD2 Is Regulated By Mir-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:315-26. [PMID: 26752466 DOI: 10.1097/MIB.0000000000000659] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 439 |
Buderus S, Scholz D, Behrens R, Classen M, De Laffolie J, Keller KM, Zimmer KP, Koletzko S; CEDATA-GPGE Study Group. Inflammatory bowel disease in pediatric patients: Characteristics of newly diagnosed patients from the CEDATA-GPGE Registry. Dtsch Arztebl Int 2015;112:121-7. [PMID: 25759978 DOI: 10.3238/arztebl.2015.0121] [Cited by in Crossref: 11] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 440 |
Müller KE, Lakatos PL, Kovacs JB, Arato A, Varkonyi A, Nemes E, Tarnok A, Toth G, Papp M, Solyom E, Horvath A, Guthy I, Kovacs M, Veres G; Hungarian Pediatric IBD Registry Group. Baseline Characteristics and Disease Phenotype in Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2016;62:50-5. [PMID: 26192700 DOI: 10.1097/MPG.0000000000000885] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 441 |
Higuchi LM, Regan BP, Bousvaros A. Ulcerative Colitis. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition 2016. [DOI: 10.1007/978-3-319-17169-2_30] [Reference Citation Analysis]
|
| 442 |
Hoekman DR, Diederen K, Koot BG, Tabbers MM, Kindermann A, Benninga MA. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease. Eur J Pediatr 2016;175:1335-42. [PMID: 27573259 DOI: 10.1007/s00431-016-2762-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 443 |
Guinet-Charpentier C, Champigneulle J, Williet N, Peyrin-Biroulet L, Morali A. The association of autoimmune diseases with pediatric ulcerative colitis does not influence its disease course. Scand J Gastroenterol 2016;51:33-40. [PMID: 26152794 DOI: 10.3109/00365521.2015.1058415] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 444 |
Kahn SA, Kaplan JL. Fecal Microbial Transplant: For Whom, How, and When. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition 2016. [DOI: 10.1007/978-3-319-17169-2_35] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 445 |
Dolinšek J, Rižnik P, Sabath L, Mičetić-turk D. Fecal calprotectin as a marker of the severity of mucosal inflammation in children with inflammatory bowel disease. Wien Klin Wochenschr 2016;128:253-9. [DOI: 10.1007/s00508-015-0915-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 446 |
Volonaki E, Mutalib M, Kiparissi F, Shah N, Lindley KJ, Elawad M. Adalimumab as a second-line biological therapy in children with refractory ulcerative colitis. Eur J Gastroenterol Hepatol 2015;27:1425-8. [PMID: 26426835 DOI: 10.1097/MEG.0000000000000470] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 447 |
Obih C, Wahbeh G, Lee D, Braly K, Giefer M, Shaffer ML, Nielson H, Suskind DL. Specific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD center. Nutrition. 2016;32:418-425. [PMID: 26655069 DOI: 10.1016/j.nut.2015.08.025] [Cited by in Crossref: 97] [Cited by in F6Publishing: 103] [Article Influence: 12.1] [Reference Citation Analysis]
|
| 448 |
Sherlock ME, MacDonald JK, Griffiths AM, Steinhart AH, Seow CH. Oral budesonide for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2015;26:CD007698. [PMID: 26497719 DOI: 10.1002/14651858.cd007698.pub3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 449 |
Wiernicka A, Szymanska S, Cielecka-Kuszyk J, Dadalski M, Kierkus J. Histological healing after infliximab induction therapy in children with ulcerative colitis. World J Gastroenterol 2015; 21(37): 10654-10661 [PMID: 26457025 DOI: 10.3748/wjg.v21.i37.10654] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 450 |
van Tilburg MA, Claar RL, Romano JM, Langer SL, Walker LS, Whitehead WE, Abdullah B, Christie DL, Levy RL. Role of Coping With Symptoms in Depression and Disability: Comparison Between Inflammatory Bowel Disease and Abdominal Pain. J Pediatr Gastroenterol Nutr 2015;61:431-6. [PMID: 25944213 DOI: 10.1097/MPG.0000000000000841] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 451 |
Lev-Tzion R, Renbaum P, Beeri R, Ledder O, Mevorach R, Karban A, Koifman E, Efrati E, Muise AM, Chowers Y, Turner D. Rac1 Polymorphisms and Thiopurine Efficacy in Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2015;61:404-7. [PMID: 25885881 DOI: 10.1097/MPG.0000000000000820] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 452 |
Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, D'Haens G, Dotan I, Dubinsky M, Feagan B, Fiorino G, Gearry R, Krishnareddy S, Lakatos PL, Loftus EV Jr, Marteau P, Munkholm P, Murdoch TB, Ordás I, Panaccione R, Riddell RH, Ruel J, Rubin DT, Samaan M, Siegel CA, Silverberg MS, Stoker J, Schreiber S, Travis S, Van Assche G, Danese S, Panes J, Bouguen G, O'Donnell S, Pariente B, Winer S, Hanauer S, Colombel JF. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. Am J Gastroenterol 2015;110:1324-38. [PMID: 26303131 DOI: 10.1038/ajg.2015.233] [Cited by in Crossref: 1160] [Cited by in F6Publishing: 1034] [Article Influence: 145.0] [Reference Citation Analysis]
|
| 453 |
Akobeng AK, O'Leary N, Vail A, Brown N, Widiatmoko D, Fagbemi A, Thomas AG. Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease: Randomised Controlled Trial and Economic Evaluation. EBioMedicine 2015;2:1251-6. [PMID: 26501125 DOI: 10.1016/j.ebiom.2015.08.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 454 |
Arora K, Sinha C, Zhang W, Moon CS, Ren A, Yarlagadda S, Dostmann WR, Adebiyi A, Haberman Y, Denson LA, Wang X, Naren AP. Altered cGMP dynamics at the plasma membrane contribute to diarrhea in ulcerative colitis. Am J Pathol 2015;185:2790-804. [PMID: 26261085 DOI: 10.1016/j.ajpath.2015.06.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 455 |
Nusman CM, Hemke R, Benninga MA, Schonenberg-Meinema D, Kindermann A, van Rossum MA, van den Berg JM, Maas M, Kuijpers TW. Contrast-enhanced MRI of the knee in children unaffected by clinical arthritis compared to clinically active juvenile idiopathic arthritis patients. Eur Radiol 2016;26:1141-8. [PMID: 26233246 DOI: 10.1007/s00330-015-3912-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 456 |
Chehoud C, Albenberg LG, Judge C, Hoffmann C, Grunberg S, Bittinger K, Baldassano RN, Lewis JD, Bushman FD, Wu GD. Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2015;21:1948-56. [PMID: 26083617 DOI: 10.1097/MIB.0000000000000454] [Cited by in Crossref: 152] [Cited by in F6Publishing: 147] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 457 |
Kawai T, Arai K, Harayama S, Nakazawa Y, Goto F, Maekawa T, Tamura E, Uchiyama T, Onodera M. Severe and Rapid Progression in Very Early-Onset Chronic Granulomatous Disease-Associated Colitis. J Clin Immunol 2015;35:583-8. [DOI: 10.1007/s10875-015-0180-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 458 |
Lazzerini M, Martelossi S, Magazzù G, Pellegrino S, Lucanto MC, Barabino A, Calvi A, Arrigo S, Lionetti P, Lorusso M, Mangiantini F, Fontana M, Zuin G, Palla G, Maggiore G, Bramuzzo M, Pellegrin MC, Maschio M, Villanacci V, Manenti S, Decorti G, De Iudicibus S, Paparazzo R, Montico M, Ventura A. Effect of Thalidomide on Clinical Remission in Children and Adolescents with Ulcerative Colitis Refractory to Other Immunosuppressives: Pilot Randomized Clinical Trial. Inflamm Bowel Dis 2015;21:1739-49. [PMID: 26185909 DOI: 10.1097/MIB.0000000000000437] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 459 |
Faus AL, Turchi RM, Polansky M, Berez A, Leibowitz KL. Health-Related Quality of Life in Overweight/Obese Children Compared With Children With Inflammatory Bowel Disease. Clin Pediatr (Phila) 2015;54:775-82. [PMID: 25520367 DOI: 10.1177/0009922814562555] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 460 |
Thangarajah D, Hyde MJ, Konteti VK, Santhakumaran S, Frost G, Fell JM. Systematic review: Body composition in children with inflammatory bowel disease. Aliment Pharmacol Ther 2015;42:142-57. [PMID: 26043941 DOI: 10.1111/apt.13218] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 461 |
Mattioli G, Barabino A, Aloi M, Arrigo S, Caldaro T, Carlucci M, Cucchiara S, De Angelis P, Di Leo G, Illiceto MT, Impellizzeri P, Leonelli L, Lisi G, Lombardi G, Martelossi S, Martinelli M, Miele E, Randazzo A, Romano C, Romeo C, Romeo E, Selvaggi F, Valenti S, Dall'Oglio L. Paediatric ulcerative colitis surgery: Italian survey. J Crohns Colitis 2015;9:558-64. [PMID: 25895877 DOI: 10.1093/ecco-jcc/jjv065] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 462 |
Strisciuglio C, Miele E, Giugliano FP, Vitale S, Andreozzi M, Vitale A, Catania MR, Staiano A, Troncone R, Gianfrani C. Bifidobacteria Enhance Antigen Sampling and Processing by Dendritic Cells in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2015;21:1491-8. [PMID: 25895109 DOI: 10.1097/MIB.0000000000000389] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 463 |
Aloi M, Tromba L, Rizzo V, D'Arcangelo G, Dilillo A, Blasi S, Civitelli F, Kiltzanidi D, Redler A, Viola F. Aortic Intima-Media Thickness as an Early Marker of Atherosclerosis in Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2015;61:41-6. [PMID: 26039941 DOI: 10.1097/MPG.0000000000000771] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 464 |
Heida A, Dijkstra A, Groen H, Muller Kobold A, Verkade H, van Rheenen P. Comparing the efficacy of a web-assisted calprotectin-based treatment algorithm (IBD-live) with usual practices in teenagers with inflammatory bowel disease: study protocol for a randomized controlled trial. Trials 2015;16:271. [PMID: 26073770 DOI: 10.1186/s13063-015-0787-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 465 |
Baillie CT, Smith JA. Surgical strategies in paediatric inflammatory bowel disease. World J Gastroenterol 2015; 21(20): 6101-6116 [PMID: 26034347 DOI: 10.3748/wjg.v21.i20.6101] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 466 |
Hommel KA, Gray WN, Hente E, Loreaux K, Ittenbach RF, Maddux M, Baldassano R, Sylvester F, Crandall W, Doarn C, Heyman MB, Keljo D, Denson LA. The Telehealth Enhancement of Adherence to Medication (TEAM) in pediatric IBD trial: Design and methodology. Contemp Clin Trials 2015;43:105-13. [PMID: 26003436 DOI: 10.1016/j.cct.2015.05.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 467 |
Varni JW, Franciosi JP, Shulman RJ, Saeed S, Nurko S, Neigut DA, Bendo CB, Patel AS, Self MM, Saps M, Zacur GM, Denham J, Dark CV, Pohl JF; Pediatric Quality of Life Inventory Gastrointestinal Symptoms Module Testing Study Consortium. PedsQL gastrointestinal symptoms scales and gastrointestinal worry scales in pediatric patients with inflammatory bowel disease in comparison with healthy controls. Inflamm Bowel Dis 2015;21:1115-24. [PMID: 25793327 DOI: 10.1097/MIB.0000000000000351] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 468 |
Martinelli M, Strisciuglio C, Illiceto MT, Cardile S, Guariso G, Vignola S, Aloi M, D'Altilia MR, Alvisi P, Salvatore S, Staiano A, Cucchiara S, Miele E; IMIBD Group of the Italian Society for Paediatric Gastroenterology, Hepatology and Nutrition. Natural history of pancreatic involvement in paediatric inflammatory bowel disease. Dig Liver Dis 2015;47:384-9. [PMID: 25704068 DOI: 10.1016/j.dld.2015.01.155] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 469 |
Pusateri AJ, Kim SC, Dotson JL, Balint JP, Potter CJ, Boyle BM, Crandall WV. Incidence, pattern, and etiology of elevated liver enzymes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2015;60:592-7. [PMID: 25493346 DOI: 10.1097/MPG.0000000000000672] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 470 |
Kim MJ, Lee SY, Choe YH. Monitoring thiopurine metabolites in korean pediatric patients with inflammatory bowel disease. Yonsei Med J 2014;55:1289-96. [PMID: 25048487 DOI: 10.3349/ymj.2014.55.5.1289] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 471 |
Abdovic S, Pavic AM, Milosevic M, Persic M, Senecic-Cala I, Kolacek S. Short health scale: a valid, reliable, and responsive measure of health-related quality of life in children with inflammatory bowel disease. Inflamm Bowel Dis 2015;21:818-23. [PMID: 25742398 DOI: 10.1097/MIB.0000000000000324] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 472 |
Gatti S, Brennan M, Heuschkel R, Zilbauer M. Assessing quality of care in paediatric inflammatory bowel disease: focusing on self-reported outcomes. Dig Liver Dis 2015;47:347-8. [PMID: 25540908 DOI: 10.1016/j.dld.2014.11.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 473 |
Schechter A, Griffiths C, Gana JC, Shaoul R, Shamir R, Shteyer E, Bdolah-Abram T, Ledder O, Turner D. Early endoscopic, laboratory and clinical predictors of poor disease course in paediatric ulcerative colitis. Gut 2015;64:580-8. [PMID: 24848266 DOI: 10.1136/gutjnl-2014-306999] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 474 |
Engelmann G, Erhard D, Petersen M, Parzer P, Schlarb AA, Resch F, Brunner R, Hoffmann GF, Lenhartz H, Richterich A. Health-related quality of life in adolescents with inflammatory bowel disease depends on disease activity and psychiatric comorbidity. Child Psychiatry Hum Dev 2015;46:300-7. [PMID: 24838299 DOI: 10.1007/s10578-014-0471-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 475 |
Ventham NT, Kalla R, Kennedy NA, Satsangi J, Arnott ID. Predicting outcomes in acute severe ulcerative colitis. Expert Rev Gastroenterol Hepatol 2015;9:405-15. [PMID: 25494666 DOI: 10.1586/17474124.2015.992880] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 476 |
Cameron FL, Wilson ML, Basheer N, Jamison A, McGrogan P, Bisset WM, Gillett PM, Russell RK, Wilson DC. Anti-TNF therapy for paediatric IBD: the Scottish national experience. Arch Dis Child 2015;100:399-405. [PMID: 25678594 DOI: 10.1136/archdischild-2013-305812] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 477 |
Arcos-machancoses J, Donat-aliaga E, Polo-miquel B, Masip-simó E, Ribes-koninckx C, Pereda-pérez A. Retraso diagnóstico en la enfermedad inflamatoria intestinal pediátrica. Descripción y estudio de los factores de riesgo. Anales de Pediatría 2015;82:247-54. [DOI: 10.1016/j.anpedi.2014.05.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 478 |
Arcos-machancoses J, Donat-aliaga E, Polo-miquel B, Masip-simó E, Ribes-koninckx C, Pereda-pérez A. Description and study of risk factors for the diagnostic delay of paediatric inflammatory bowel disease. Anales de Pediatría (English Edition) 2015;82:247-254. [DOI: 10.1016/j.anpede.2015.03.004] [Reference Citation Analysis]
|
| 479 |
Henderson P, Kennedy NA, Van Limbergen JE, Cameron FL, Satsangi J, Russell RK, Wilson DC. Serum C-reactive protein and CRP genotype in pediatric inflammatory bowel disease: influence on phenotype, natural history, and response to therapy. Inflamm Bowel Dis 2015;21:596-605. [PMID: 25636121 DOI: 10.1097/MIB.0000000000000296] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 480 |
Varni JW, Bendo CB, Shulman RJ, Self MM, Nurko S, Franciosi JP, Saps M, Saeed S, Zacur GM, Vaughan Dark C. Interpretability of the PedsQL™ Gastrointestinal Symptoms Scales and Gastrointestinal Worry Scales in Pediatric Patients With Functional and Organic Gastrointestinal Diseases. J Pediatr Psychol. 2015;40:591-601. [PMID: 25682210 DOI: 10.1093/jpepsy/jsv005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 481 |
Zitomersky NL, Atkinson BJ, Fournier K, Mitchell PD, Stern JB, Butler MC, Ashworth L, Hauenstein S, Heiner L, Chuang E, Singh S, Bousvaros A. Antibodies to infliximab are associated with lower infliximab levels and increased likelihood of surgery in pediatric IBD. Inflamm Bowel Dis 2015;21:307-14. [PMID: 25569737 DOI: 10.1097/MIB.0000000000000284] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 482 |
Dotson JL, Crandall WV, Zhang P, Forrest CB, Bailey LC, Colletti RB, Kappelman MD. Feasibility and validity of the pediatric ulcerative colitis activity index in routine clinical practice. J Pediatr Gastroenterol Nutr 2015;60:200-4. [PMID: 25221935 DOI: 10.1097/MPG.0000000000000568] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 483 |
Giraldo Escobar L, Crespo Madrid N, Vila Miravet V, Pujol Muncunill G, Varea Calderón V, Martín de Carpi J. Colitis ulcerosa asociada a hepatitis autoinmune: ¿una forma diferencial de enfermedad inflamatoria intestinal? Anales de Pediatría 2015;82:e78-81. [DOI: 10.1016/j.anpedi.2013.11.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 484 |
Werner H, Braegger C, Buehr P, Koller R, Nydegger A, Spalinger J, Heyland K, Schibli S, Landolt M; Swiss IBD Cohort Study Group. Shorter time since inflammatory bowel disease diagnosis in children is associated with lower mental health in parents. Acta Paediatr 2015;104:e32-8. [PMID: 25164428 DOI: 10.1111/apa.12781] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 485 |
Ghouri YA, Richards DM, Rahimi EF, Krill JT, Jelinek KA, DuPont AW. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clin Exp Gastroenterol. 2014;7:473-487. [PMID: 25525379 DOI: 10.2147/ceg.s27530] [Cited by in Crossref: 58] [Cited by in F6Publishing: 124] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 486 |
Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, Mantzaris G, Reinisch W, Colombel JF, Vermeire S, Travis S, Lindsay JO, van Assche G. [Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis (Spanish version)]. Rev Gastroenterol Mex 2014;79:263-89. [PMID: 25487134 DOI: 10.1016/j.rgmx.2014.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 487 |
Krenke K, Peradzyńska J, Lange J, Banaszkiewicz A, Łazowska-Przeorek I, Grzela K, Radzikowski A, Kulus M. Inflammatory cytokines in exhaled breath condensate in children with inflammatory bowel diseases. Pediatr Pulmonol 2014;49:1190-5. [PMID: 24339443 DOI: 10.1002/ppul.22953] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 488 |
Martinelli M, Strisciuglio C, Veres G, Paerregaard A, Pavic AM, Aloi M, Martín-de-Carpi J, Levine A, Turner D, Del Pezzo M, Staiano A, Miele E; Porto IBD Working Group of European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). Clostridium difficile and pediatric inflammatory bowel disease: a prospective, comparative, multicenter, ESPGHAN study. Inflamm Bowel Dis 2014;20:2219-25. [PMID: 25268634 DOI: 10.1097/MIB.0000000000000219] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 489 |
Winter HS, Krzeski P, Heyman MB, Ibarguen-Secchia E, Iwanczak B, Kaczmarski M, Kierkus J, Kolaček S, Osuntokun B, Quiros JA, Shah M, Yacyshyn B, Dunnmon PM. High- and low-dose oral delayed-release mesalamine in children with mild-to-moderately active ulcerative colitis. J Pediatr Gastroenterol Nutr 2014;59:767-72. [PMID: 25419597 DOI: 10.1097/MPG.0000000000000530] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 490 |
Turner D, Levine A, Kolho KL, Shaoul R, Ledder O. Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: a preliminary report. J Crohns Colitis 2014;8:1464-70. [PMID: 24958064 DOI: 10.1016/j.crohns.2014.05.010] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 491 |
Adis Medical Writers. Consider disease severity and response to corticosteroids when selecting agents to manage ulcerative colitis in children. Drugs Ther Perspect 2014;30:390-394. [DOI: 10.1007/s40267-014-0150-4] [Reference Citation Analysis]
|
| 492 |
Reigada LC, Mcgovern A, Tudor ME, Walder DJ, Warner CM. Collaborating With Pediatric Gastroenterologists to Treat Co-Occurring Inflammatory Bowel Disease and Anxiety in Pediatric Medical Settings. Cognitive and Behavioral Practice 2014;21:372-85. [DOI: 10.1016/j.cbpra.2014.03.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 493 |
Stenke E, Hussey S. Ulcerative colitis: management in adults, children and young people (NICE Clinical Guideline CG166). Arch Dis Child Educ Pract Ed 2014;99:194-7. [PMID: 24821990 DOI: 10.1136/archdischild-2013-305512] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 494 |
Walsh CM, Ling SC, Walters TD, Mamula P, Lightdale JR, Carnahan H. Development of the gastrointestinal endoscopy competency assessment tool for pediatric colonoscopy (GiECAT KIDS). J Pediatr Gastroenterol Nutr 2014;59:480-6. [PMID: 24590220 DOI: 10.1097/MPG.0000000000000358] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 495 |
Loreaux KL, Gray WN, Denson LA, Hommel KA. Health-Related Quality of Life in Adolescents With Inflammatory Bowel Disease: The Relation of Parent and Adolescent Depressive Symptoms. Children's Health Care 2014;44:119-35. [DOI: 10.1080/02739615.2014.912943] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 496 |
Pappa HM, Mitchell PD, Jiang H, Kassiff S, Filip-Dhima R, DiFabio D, Quinn N, Lawton RC, Bronzwaer ME, Koenen M, Gordon CM. Maintenance of optimal vitamin D status in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing two regimens. J Clin Endocrinol Metab 2014;99:3408-17. [PMID: 24926949 DOI: 10.1210/jc.2013-4218] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 497 |
Gothe F, Beigel F, Rust C, Hajji M, Koletzko S, Freudenberg F. Bile acid malabsorption assessed by 7 alpha-hydroxy-4-cholesten-3-one in pediatric inflammatory bowel disease: correlation to clinical and laboratory findings. J Crohns Colitis 2014;8:1072-8. [PMID: 24666974 DOI: 10.1016/j.crohns.2014.02.027] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 498 |
Negroni A, Prete E, Vitali R, Cesi V, Aloi M, Civitelli F, Cucchiara S, Stronati L. Endoplasmic reticulum stress and unfolded protein response are involved in paediatric inflammatory bowel disease. Dig Liver Dis 2014;46:788-94. [PMID: 24953208 DOI: 10.1016/j.dld.2014.05.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 499 |
Patel N, Alkhouri N, Eng K, Cikach F, Mahajan L, Yan C, Grove D, Rome ES, Lopez R, Dweik RA. Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study. Aliment Pharmacol Ther 2014;40:498-507. [PMID: 25041596 DOI: 10.1111/apt.12861] [Cited by in Crossref: 16] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 500 |
Weidlich S, Bulau AM, Schwerd T, Althans J, Kappler R, Koletzko S, Mayr D, Bufler P. Intestinal expression of the anti-inflammatory interleukin-1 homologue IL-37 in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2014;59:e18-26. [PMID: 24732025 DOI: 10.1097/MPG.0000000000000387] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 501 |
Srinath AI, Goyal A, Zimmerman LA, Newara MC, Kirshner MA, McCarthy FN, Keljo D, Binion D, Bousvaros A, DeMaso DR, Youk A, Szigethy EM. Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients. Inflamm Bowel Dis 2014;20:1329-40. [PMID: 24983975 DOI: 10.1097/MIB.0000000000000104] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 502 |
Mälkönen T, Wikström A, Heiskanen K, Merras-Salmio L, Mustonen H, Sipponen T, Kolho KL. Skin reactions during anti-TNFα therapy for pediatric inflammatory bowel disease: a 2-year prospective study. Inflamm Bowel Dis 2014;20:1309-15. [PMID: 24918318 DOI: 10.1097/MIB.0000000000000088] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 503 |
Gomollón F, García-López S, Sicilia B, Gisbert JP, Hinojosa J; en representació del Grupo Espa˜nol de Trabajode Enfermedad de Crohn y Colitis Ulcerosa or Spanish Group for Working on Crohn’sDisease and Ulcerative Colitis (GETECCU). [Therapeutic guidelines on ulcerative colitis: a GRADE methodology based effort of GETECCU]. Gastroenterol Hepatol 2013;36:e1-47. [PMID: 24215088 DOI: 10.1016/j.gastrohep.2012.11.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 504 |
Mosli MH, Sandborn WJ, Kim RB, Khanna R, Al-Judaibi B, Feagan BG. Toward a personalized medicine approach to the management of inflammatory bowel disease. Am J Gastroenterol 2014;109:994-1004. [PMID: 24842338 DOI: 10.1038/ajg.2014.110] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 505 |
Inoue K, Aomatsu T, Yoden A, Okuhira T, Kaji E, Tamai H. Usefulness of a novel and rapid assay system for fecal calprotectin in pediatric patients with inflammatory bowel diseases. J Gastroenterol Hepatol 2014;29:1406-12. [PMID: 24635100 DOI: 10.1111/jgh.12578] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 506 |
Szigethy E, Bujoreanu SI, Youk AO, Weisz J, Benhayon D, Fairclough D, Ducharme P, Gonzalez-Heydrich J, Keljo D, Srinath A, Bousvaros A, Kirshner M, Newara M, Kupfer D, DeMaso DR. Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry 2014;53:726-35. [PMID: 24954822 DOI: 10.1016/j.jaac.2014.04.014] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 507 |
Ihekweazu FD, Kellermayer R. Allopurinol: a useful adjunct to thiopurine therapy for pediatric ulcerative colitis in the biologic era. J Pediatr Gastroenterol Nutr 2014;59:22-4. [PMID: 24590210 DOI: 10.1097/MPG.0000000000000344] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 508 |
Civitelli F, Di Nardo G, Oliva S, Nuti F, Ferrari F, Dilillo A, Viola F, Pallotta N, Cucchiara S, Aloi M. Ultrasonography of the colon in pediatric ulcerative colitis: a prospective, blind, comparative study with colonoscopy. J Pediatr 2014;165:78-84.e2. [PMID: 24725581 DOI: 10.1016/j.jpeds.2014.02.055] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 509 |
Werner H, Landolt MA, Buehr P, Koller R, Nydegger A, Spalinger J, Heyland K, Schibli S, Braegger CP; Swiss IBD Cohort Study Group. Validation of the IMPACT-III quality of life questionnaire in Swiss children with inflammatory bowel disease. J Crohns Colitis 2014;8:641-8. [PMID: 24342766 DOI: 10.1016/j.crohns.2013.11.025] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 510 |
Samuel BP, Crumb TL, Duba MM. What nurses need to know about fecal microbiota transplantation: education, assessment, and care for children and young adults. J Pediatr Nurs 2014;29:354-61. [PMID: 24582649 DOI: 10.1016/j.pedn.2014.01.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 511 |
Navas-lópez VM, Blasco-alonso J, Girón Fernández-crehuet F, Serrano Nieto MJ, Gallego-gutiérrez S, Luque Pérez S, Sierra Salinas C. Successful treatment for ulcerative proctitis with rectal tacrolimus in an 8-year-old girl with intolerance to mesalamine. Clin J Gastroenterol 2014;7:320-3. [DOI: 10.1007/s12328-014-0506-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 512 |
Harris RA, Nagy-Szakal D, Mir SA, Frank E, Szigeti R, Kaplan JL, Bronsky J, Opekun A, Ferry GD, Winter H, Kellermayer R. DNA methylation-associated colonic mucosal immune and defense responses in treatment-naïve pediatric ulcerative colitis. Epigenetics 2014;9:1131-7. [PMID: 24937444 DOI: 10.4161/epi.29446] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 513 |
Rosh JR, Hyams JS. Pediatric UC drug development: a GREAT idea now needs a GRAND conversation. J Pediatr Gastroenterol Nutr 2014;58:677-8. [PMID: 24625967 DOI: 10.1097/MPG.0000000000000367] [Reference Citation Analysis]
|
| 514 |
Laakso S, Valta H, Verkasalo M, Toiviainen-Salo S, Mäkitie O. Compromised peak bone mass in patients with inflammatory bowel disease--a prospective study. J Pediatr 2014;164:1436-43.e1. [PMID: 24650398 DOI: 10.1016/j.jpeds.2014.01.073] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 515 |
Sun H, Vesely R, Taminiau J, Szitanyi P, Papadopoulos EJ, Isaac M, Klein A, Uzu S, Griebel D, Mulberg AE; International Inflammatory Bowel Disease Working Group. Steps toward harmonization for clinical development of medicines in pediatric ulcerative colitis-a global scientific discussion, part 1: efficacy endpoints and disease outcome assessments. J Pediatr Gastroenterol Nutr 2014;58:679-83. [PMID: 24866781 DOI: 10.1097/MPG.0000000000000306] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 516 |
Huang JS, Terrones L, Tompane T, Dillon L, Pian M, Gottschalk M, Norman GJ, Bartholomew LK. Preparing adolescents with chronic disease for transition to adult care: a technology program. Pediatrics 2014;133:e1639-46. [PMID: 24843066 DOI: 10.1542/peds.2013-2830] [Cited by in Crossref: 147] [Cited by in F6Publishing: 154] [Article Influence: 16.3] [Reference Citation Analysis]
|
| 517 |
Sun H, Vesely R, Nelson RM, Taminiau J, Szitanyi P, Isaac M, Klein A, Uzu S, Griebel D, Mulberg AE; International Inflammatory Bowel Disease Working Group. Steps toward harmonization for clinical development of medicines in pediatric ulcerative colitis-a global scientific discussion, part 2: data extrapolation, trial design, and pharmacokinetics. J Pediatr Gastroenterol Nutr 2014;58:684-8. [PMID: 24866782 DOI: 10.1097/MPG.0000000000000322] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 518 |
Regan BP, Bousvaros A. Pediatric ulcerative colitis: a practical guide to management. Paediatr Drugs 2014;16:189-98. [PMID: 24723200 DOI: 10.1007/s40272-014-0070-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 519 |
Szigethy EM, Youk AO, Benhayon D, Fairclough DL, Newara MC, Kirshner MA, Bujoreanu SI, Mrakotsky C, Bousvaros A, Srinath AI, Keljo DJ, Kupfer DJ, DeMaso DR. Depression subtypes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2014;58:574-81. [PMID: 24345836 DOI: 10.1097/MPG.0000000000000262] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 520 |
Rogler D, Fournier N, Pittet V, Bühr P, Heyland K, Friedt M, Koller R, Rueger V, Herzog D, Nydegger A, Schäppi M, Schibli S, Spalinger J, Rogler G, Braegger CP; Swiss IBD Cohort Study Group. Coping is excellent in Swiss Children with inflammatory bowel disease: results from the Swiss IBD cohort study. J Crohns Colitis 2014;8:409-20. [PMID: 24230970 DOI: 10.1016/j.crohns.2013.10.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 521 |
Nowak JK, Grzybowska-Chlebowczyk U, Landowski P, Szaflarska-Poplawska A, Klincewicz B, Adamczak D, Banasiewicz T, Plawski A, Walkowiak J. Prevalence and correlates of vitamin K deficiency in children with inflammatory bowel disease. Sci Rep. 2014;4:4768. [PMID: 24759680 DOI: 10.1038/srep04768] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 522 |
Lee JJ, Mitchell PD, Hood HC, Grand RJ, Cohen LE. Potential role of IGF-1 z score to predict permanent linear growth impairment in children with IBD. J Pediatr Gastroenterol Nutr 2014;58:472-6. [PMID: 24663033 DOI: 10.1097/MPG.0000000000000234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 523 |
Reed-Knight B, Lobato D, Hagin S, McQuaid EL, Seifer R, Kopel SJ, Boergers J, Nassau JH, Suorsa K, Bancroft B, Shapiro J, Leleiko NS. Depressive symptoms in youth with inflammatory bowel disease compared with a community sample. Inflamm Bowel Dis 2014;20:614-21. [PMID: 24518604 DOI: 10.1097/01.MIB.0000442678.62674.b7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 524 |
Kolho KL, Sipponen T. The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease. Scand J Gastroenterol 2014;49:434-41. [PMID: 24597837 DOI: 10.3109/00365521.2014.886719] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 525 |
Aloi M, Lionetti P, Barabino A, Guariso G, Costa S, Fontana M, Romano C, Lombardi G, Miele E, Alvisi P, Diaferia P, Baldi M, Romagnoli V, Gasparetto M, Di Paola M, Muraca M, Pellegrino S, Cucchiara S, Martelossi S; SIGENP IBD Group. Phenotype and disease course of early-onset pediatric inflammatory bowel disease. Inflamm Bowel Dis 2014;20:597-605. [PMID: 24569242 DOI: 10.1097/01.MIB.0000442921.77945.09] [Cited by in Crossref: 97] [Cited by in F6Publishing: 70] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 526 |
Gallo J, Grant A, Otley AR, Orsi M, MacIntyre B, Gauvry S, Lifschitz C. Do parents and children agree? Quality-of-life assessment of children with inflammatory bowel disease and their parents. J Pediatr Gastroenterol Nutr 2014;58:481-5. [PMID: 24663034 DOI: 10.1097/MPG.0000000000000236] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 527 |
Hradsky O, Ohem J, Zarubova K, Mitrova K, Durilova M, Kotalova R, Nevoral J, Zemanova I, Dryak P, Bronsky J. Disease activity is an important factor for indeterminate interferon-γ release assay results in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2014;58:320-4. [PMID: 24126833 DOI: 10.1097/MPG.0000000000000205] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 528 |
Khanna P, Agarwal N, Khanna D, Hays RD, Chang L, Bolus R, Melmed G, Whitman CB, Kaplan RM, Ogawa R, Snyder B, Spiegel BM. Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database. Am J Gastroenterol 2014;109:234-48. [PMID: 24343547 DOI: 10.1038/ajg.2013.401] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 529 |
Pierdomenico M, Negroni A, Stronati L, Vitali R, Prete E, Bertin J, Gough PJ, Aloi M, Cucchiara S. Necroptosis is active in children with inflammatory bowel disease and contributes to heighten intestinal inflammation. Am J Gastroenterol 2014;109:279-87. [PMID: 24322838 DOI: 10.1038/ajg.2013.403] [Cited by in Crossref: 139] [Cited by in F6Publishing: 231] [Article Influence: 15.4] [Reference Citation Analysis]
|
| 530 |
Aloi M, Nuti F, Stronati L, Cucchiara S. Advances in the medical management of paediatric IBD. Nat Rev Gastroenterol Hepatol 2014;11:99-108. [PMID: 23958601 DOI: 10.1038/nrgastro.2013.158] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 531 |
Conrad K, Roggenbuck D, Laass MW. Diagnosis and classification of ulcerative colitis. Autoimmun Rev. 2014;13:463-466. [PMID: 24424198 DOI: 10.1016/j.autrev.2014.01.028] [Cited by in Crossref: 174] [Cited by in F6Publishing: 152] [Article Influence: 19.3] [Reference Citation Analysis]
|
| 532 |
Reed-Knight B, Lobato D, Hagin S, McQuaid EL, Seifer R, Kopel SJ, Boergers J, Nassau JH, Suorsa K, Bancroft B, LeLeiko NS. Stability of Emotional and Behavioral Functioning in Youth with Inflammatory Bowel Disease. Child Health Care 2014;43:151-68. [PMID: 29497228 DOI: 10.1080/02739615.2013.837824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 533 |
Navas-López VM, Blasco Alonso J, Serrano Nieto MJ, Girón Fernández-Crehuet F, Argos Rodriguez MD, Sierra Salinas C. Oral tacrolimus for pediatric steroid-resistant ulcerative colitis. J Crohns Colitis 2014;8:64-9. [PMID: 23582736 DOI: 10.1016/j.crohns.2013.03.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 534 |
Tanner T, Zwintscher NP, Cusick RA, Azarow KS. The Pediatric Patient. Complexities in Colorectal Surgery 2014. [DOI: 10.1007/978-1-4614-9022-7_27] [Reference Citation Analysis]
|
| 535 |
Sun H, Lee JJ, Papadopoulos EJ, Lee CS, Nelson RM, Sachs HC, Rodriguez WJ, Mulberg AE. Alternate endpoints and clinical outcome assessments in pediatric ulcerative colitis registration trials. J Pediatr Gastroenterol Nutr 2014;58:12-7. [PMID: 24121142 DOI: 10.1097/MPG.0000000000000186] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 536 |
Kolho KL, Sipponen T, Valtonen E, Savilahti E. Fecal calprotectin, MMP-9, and human beta-defensin-2 levels in pediatric inflammatory bowel disease. Int J Colorectal Dis 2014;29:43-50. [PMID: 24077667 DOI: 10.1007/s00384-013-1775-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 537 |
Palmer R, Walsh A, Travis S. Assessment of Disease Activity in Ulcerative Colitis. Medical Therapy of Ulcerative Colitis 2014. [DOI: 10.1007/978-1-4939-1677-1_32] [Reference Citation Analysis]
|
| 538 |
Albenberg L, Baldassano RN, Kelsen J. Pediatric Issues in Treating Ulcerative Colitis. Medical Therapy of Ulcerative Colitis 2014. [DOI: 10.1007/978-1-4939-1677-1_25] [Reference Citation Analysis]
|
| 539 |
Adedokun OJ, Xu Z, Padgett L, Blank M, Johanns J, Griffiths A, Ford J, Zhou H, Guzzo C, Davis HM, Hyams J. Pharmacokinetics of infliximab in children with moderate-to-severe ulcerative colitis: results from a randomized, multicenter, open-label, phase 3 study. Inflamm Bowel Dis 2013;19:2753-62. [PMID: 24193155 DOI: 10.1097/01.MIB.0000435438.84365.f7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 540 |
Aloi M, D'Arcangelo G, Pofi F, Vassallo F, Rizzo V, Nuti F, Di Nardo G, Pierdomenico M, Viola F, Cucchiara S. Presenting features and disease course of pediatric ulcerative colitis. J Crohns Colitis 2013;7:e509-15. [PMID: 23583691 DOI: 10.1016/j.crohns.2013.03.007] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 541 |
Wine E, Mack DR, Hyams J, Otley AR, Markowitz J, Crandall WV, Leleiko N, Muise AM, Griffiths AM, Turner D. Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis. J Crohns Colitis 2013;7:916-22. [PMID: 23339932 DOI: 10.1016/j.crohns.2012.12.012] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 542 |
Däbritz J, Bonkowski E, Chalk C, Trapnell BC, Langhorst J, Denson LA, Foell D. Granulocyte macrophage colony-stimulating factor auto-antibodies and disease relapse in inflammatory bowel disease. Am J Gastroenterol 2013;108:1901-10. [PMID: 24145675 DOI: 10.1038/ajg.2013.360] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 543 |
Hourigan SK, Chirumamilla SR, Ross T, Golub JE, Rabizadeh S, Saeed SA, Elson CO, Kelly CP, Carroll KC, Oliva-Hemker M, Sears C. Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease. Inflamm Bowel Dis 2013;19:2744-52. [PMID: 24145927 DOI: 10.1097/01.MIB.0000435434.53871.36] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 544 |
Abdovic S, Mocic Pavic A, Milosevic M, Persic M, Senecic-Cala I, Kolacek S. The IMPACT-III (HR) questionnaire: a valid measure of health-related quality of life in Croatian children with inflammatory bowel disease. J Crohns Colitis 2013;7:908-15. [PMID: 23333037 DOI: 10.1016/j.crohns.2012.12.010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 545 |
van Lierop PP, Swagemakers SM, de Bie CI, Middendorp S, van Baarlen P, Samsom JN, van Ijcken WF, Escher JC, van der Spek PJ, Nieuwenhuis EE. Gene expression analysis of peripheral cells for subclassification of pediatric inflammatory bowel disease in remission. PLoS One. 2013;8:e79549. [PMID: 24260248 DOI: 10.1371/journal.pone.0079549] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 546 |
Teitelbaum JE, Rajaraman RR, Jaeger J, Para S, Rakitt T. Correlation of health-related quality of life in children with inflammatory bowel disease, their parents, and physician as measured by a visual analog scale. J Pediatr Gastroenterol Nutr 2013;57:594-7. [PMID: 23752079 DOI: 10.1097/MPG.0b013e31829cf923] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 547 |
Turner D, Griffiths AM, Veerman G, Johanns J, Damaraju L, Blank M, Hyams J. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab. Clin Gastroenterol Hepatol 2013;11:1460-5. [PMID: 23672831 DOI: 10.1016/j.cgh.2013.04.049] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 548 |
Lee EH, Ko JS, Seo JK. Correlations of plasma citrulline levels with clinical and endoscopic score and blood markers according to small bowel involvement in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2013;57:570-5. [PMID: 23752073 DOI: 10.1097/MPG.0b013e31829e264e] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 549 |
Piram M, Koné-Paut I, Lachmann HJ, Frenkel J, Ozen S, Kuemmerle-Deschner J, Stojanov S, Simon A, Finetti M, Sormani MP, Martini A, Gattorno M, Ruperto N; EUROFEVER, EUROTRAPS and the Paediatric Rheumatology International Trials Organisation (PRINTO) networks. Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes. Ann Rheum Dis 2014;73:2168-73. [PMID: 24026675 DOI: 10.1136/annrheumdis-2013-203666] [Cited by in Crossref: 94] [Cited by in F6Publishing: 100] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 550 |
Berkowitz D, Peri R, Lavy A, Kessel A. Increased Toll-like receptor 9 expression by B cells from inflammatory bowel disease patients. Hum Immunol. 2013;74:1519-1523. [PMID: 24007656 DOI: 10.1016/j.humimm.2013.08.285] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 551 |
Arató A. Milestones in understanding of the pathogenesis of immunmediated intestinal disorders. Development of their diagnosis and therapy. Orvosi Hetilap 2013;154:1512-1523. [DOI: 10.1556/oh.2013.29710] [Reference Citation Analysis]
|
| 552 |
Dykes DM, Towbin AJ, Bonkowski E, Chalk C, Bezold R, Lake K, Kim MO, Heubi JE, Trapnell BC, Podberesky DJ, Denson LA. Increased prevalence of luminal narrowing and stricturing identified by enterography in pediatric Crohn's disease patients with elevated granulocyte-macrophage colony stimulating factor autoantibodies. Inflamm Bowel Dis 2013;19:2146-54. [PMID: 23893081 DOI: 10.1097/MIB.0b013e31829706e0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 553 |
El-Hodhod MA, Aly RH, Youssef SR, Mohamed SI. Enhanced blood lymphocytes apoptosis in children with inflammatory bowel disease. ISRN Gastroenterol 2013;2013:415417. [PMID: 24073337 DOI: 10.1155/2013/415417] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 554 |
Gomollón F, García-lópez S, Sicilia B, Gisbert JP, Hinojosa J. The GETECCU clinical guideline for the treatment of ulcerative colitis: A guideline created using GRADE methodology. Gastroenterología y Hepatología 2013;36:483.e1-483.e46. [DOI: 10.1016/j.gastrohep.2012.11.002] [Reference Citation Analysis]
|
| 555 |
Gray FL, Turner CG, Zurakowski D, Bousvaros A, Linden BC, Shamberger RC, Lillehei CW. Predictive value of the Pediatric Ulcerative Colitis Activity Index in the surgical management of ulcerative colitis. J Pediatr Surg 2013;48:1540-5. [PMID: 23895969 DOI: 10.1016/j.jpedsurg.2013.03.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 556 |
McAteer JP, Larison C, Wahbeh GT, Kronman MP, Goldin AB. Total colectomy for ulcerative colitis in children: when are we operating? Pediatr Surg Int 2013;29:689-96. [PMID: 23571824 DOI: 10.1007/s00383-013-3307-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 557 |
Zitomersky NL, Atkinson BJ, Franklin SW, Mitchell PD, Snapper SB, Comstock LE, Bousvaros A. Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease. PLoS One. 2013;8:e63686. [PMID: 23776434 DOI: 10.1371/journal.pone.0063686] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 558 |
Piekkala M, Hagström J, Tanskanen M, Rintala R, Haglund C, Kolho KL. Low trypsinogen-1 expression in pediatric ulcerative colitis patients who undergo surgery. World J Gastroenterol 2013; 19(21): 3272-3280 [PMID: 23745029 DOI: 10.3748/wjg.v19.i21.3272] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 559 |
Kunde S, Pham A, Bonczyk S, Crumb T, Duba M, Conrad H Jr, Cloney D, Kugathasan S. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr 2013;56:597-601. [PMID: 23542823 DOI: 10.1097/MPG.0b013e318292fa0d] [Cited by in Crossref: 212] [Cited by in F6Publishing: 220] [Article Influence: 21.2] [Reference Citation Analysis]
|
| 560 |
Strisciuglio C, Giannetti E, Martinelli M, Sciorio E, Staiano A, Miele E. Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis? Acta Paediatr 2013;102:e273-8. [PMID: 23445275 DOI: 10.1111/apa.12215] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 561 |
Jacobson DL, Bousvaros A, Ashworth L, Carey R, Shrier LA, Burchett SK, Renna H, Lu Y. Immunogenicity and tolerability to human papillomavirus-like particle vaccine in girls and young women with inflammatory bowel disease. Inflamm Bowel Dis 2013;19:1441-9. [PMID: 23567780 DOI: 10.1097/MIB.0b013e318281341b] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 562 |
Russell RK, Protheroe A, Roughton M, Croft NM, Murphy MS, Spray C, Rodrigues AF, Wilson DC, Puntis J, Cosgrove M, Tamok A, Rao P, Down C, Arnott ID, Mitton SG. Contemporary outcomes for ulcerative colitis inpatients admitted to pediatric hospitals in the United Kingdom. Inflamm Bowel Dis 2013;19:1434-40. [PMID: 23624885 DOI: 10.1097/MIB.0b013e31828133d6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 563 |
Gray WN, Graef DM, Schuman SS, Janicke DM, Hommel KA. Parenting stress in pediatric IBD: relations with child psychopathology, family functioning, and disease severity. J Dev Behav Pediatr 2013;34:237-44. [PMID: 23669870 DOI: 10.1097/DBP.0b013e318290568a] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 564 |
Däbritz J, Langhorst J, Lügering A, Heidemann J, Mohr M, Wittkowski H, Krummenerl T, Foell D. Improving relapse prediction in inflammatory bowel disease by neutrophil-derived S100A12. Inflamm Bowel Dis 2013;19:1130-8. [PMID: 23377171 DOI: 10.1097/MIB.0b013e318280b1cd] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 565 |
Spiegel BM. Patient-reported outcomes in gastroenterology: clinical and research applications. J Neurogastroenterol Motil 2013;19:137-48. [PMID: 23667745 DOI: 10.5056/jnm.2013.19.2.137] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 566 |
Hill RJ, Davies PS. You look all right to me: compromised nutritional status in paediatric patients with ulcerative colitis. J Pediatr Gastroenterol Nutr 2013;56:385-9. [PMID: 23201705 DOI: 10.1097/MPG.0b013e31827e1f25] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 567 |
Reigada LC, Benkov KJ, Bruzzese JM, Hoogendoorn C, Szigethy E, Briggie A, Walder DJ, Warner CM. Integrating illness concerns into cognitive behavioral therapy for children and adolescents with inflammatory bowel disease and co-occurring anxiety. J Spec Pediatr Nurs 2013;18:133-43. [PMID: 23560585 DOI: 10.1111/jspn.12019] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 568 |
Hommel KA, Hente E, Herzer M, Ingerski LM, Denson LA. Telehealth behavioral treatment for medication nonadherence: a pilot and feasibility study. Eur J Gastroenterol Hepatol 2013;25:469-73. [PMID: 23325274 DOI: 10.1097/MEG.0b013e32835c2a1b] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 569 |
Deutschmann A, Schlagenhauf A, Leschnik B, Hoffmann KM, Hauer A, Muntean W. Increased procoagulant function of microparticles in pediatric inflammatory bowel disease: role in increased thrombin generation. J Pediatr Gastroenterol Nutr 2013;56:401-7. [PMID: 23164759 DOI: 10.1097/MPG.0b013e31827daf72] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 570 |
Urganci N, Kalyoncu D. Immunogenecity of hepatitis A and B vaccination in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013;56:412-15. [PMID: 23841120 DOI: 10.1097/MPG.0b013e31827dd87d] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 571 |
Yanagi T, Mizuochi T, Seki Y, Yagi M, Matsuishi T. Ulcerative colitis with rare chromosomal abnormalities: report of 2 patients. Inflamm Bowel Dis 2013;19:E68-9. [PMID: 23435400 DOI: 10.1097/MIB.0b013e31827fec5a] [Reference Citation Analysis]
|
| 572 |
Kawai T, Watanabe N, Yokoyama M, Arai K, Oana S, Harayama S, Yasui K, Oh-Ishi T, Onodera M. Thalidomide attenuates excessive inflammation without interrupting lipopolysaccharide-driven inflammatory cytokine production in chronic granulomatous disease. Clin Immunol 2013;147:122-8. [PMID: 23583898 DOI: 10.1016/j.clim.2013.03.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 573 |
Kovacs M, Papp M, Lakatos PL, Jacobsen S, Nemes E, Polgar M, Solyom E, Bodi P, Horvath A, Molnar K, Szabo D, Cseh A, Muller KE, Dezsofi A, Arato A, Veres G. Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease. J Crohns Colitis 2013;7:134-41. [PMID: 22504031 DOI: 10.1016/j.crohns.2012.03.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 574 |
Bollegala N, Brill H, Marshall JK. Resource utilization during pediatric to adult transfer of care in IBD. J Crohns Colitis 2013;7:e55-60. [PMID: 22677118 DOI: 10.1016/j.crohns.2012.05.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 575 |
Suskind DL, Wahbeh G, Burpee T, Cohen M, Christie D, Weber W. Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study. J Pediatr Gastroenterol Nutr 2013;56:277-9. [PMID: 23059643 DOI: 10.1097/MPG.0b013e318276977d] [Cited by in Crossref: 74] [Cited by in F6Publishing: 72] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 576 |
Kolho KL, Turner D. Fecal calprotectin and clinical disease activity in pediatric ulcerative colitis. ISRN Gastroenterol 2013;2013:179024. [PMID: 23533791 DOI: 10.1155/2013/179024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 577 |
Kim EJ, Nam D, Ahn BJ, Lee SD, Lee JD, Kim KS. Study to establish Ojeok-San (Five Accumulation Powder: wu ji san) administration criteria and a questionnaire to evaluate the holistic effects of Ojeok-San on patients with low back pain. J Altern Complement Med 2013;19:891-7. [PMID: 23373442 DOI: 10.1089/acm.2011.0312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 578 |
Schoepfer AM, Beglinger C, Straumann A, Safroneeva E, Romero Y, Armstrong D, Schmidt C, Trummler M, Pittet V, Vavricka SR. Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes. Inflamm Bowel Dis 2013;19:332-41. [PMID: 23328771 DOI: 10.1097/MIB.0b013e3182810066] [Cited by in Crossref: 191] [Cited by in F6Publishing: 167] [Article Influence: 19.1] [Reference Citation Analysis]
|
| 579 |
Uzzan M, Treton X. Rectocolite hémorragique: épidémiologie et diagnostic. Colon Rectum 2013;7:4-10. [DOI: 10.1007/s11725-013-0435-5] [Reference Citation Analysis]
|
| 580 |
Aomatsu T, Imaeda H, Fujimoto T, Takahashi K, Yoden A, Tamai H, Fujiyama Y, Andoh A. Terminal restriction fragment length polymorphism analysis of the gut microbiota profiles of pediatric patients with inflammatory bowel disease. Digestion 2012;86:129-35. [PMID: 22846404 DOI: 10.1159/000339777] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 581 |
Puthoor PR, de Zoeten EF. Pediatric Ulcerative Colitis: The Therapeutic Road to Infliximab. Biol Ther. 2013;3:1-14. [PMID: 24392300 DOI: 10.1007/s13554-012-0006-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 582 |
Zeisler B, Lerer T, Markowitz J, Mack D, Griffiths A, Bousvaros A, Keljo D, Rosh J, Evans J, Kappelman M, Otley A, Kay M, Grossman A, Saeed S, Carvalho R, Oliva-Hemker M, Faubion W, Sudel B, Pfefferkorn M, Ashai-Khan F, Leleiko N, Hyams J; Pediatric Inflammatory Bowel Disease Collaborative Research Group. Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis. J Pediatr Gastroenterol Nutr 2013;56:12-8. [PMID: 22847466 DOI: 10.1097/MPG.0b013e31826ac41a] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 583 |
Friedt M, Braegger CP. Chronisch-entzündliche Darmerkrankungen (CED). Pädiatrische Gastroenterologie, Hepatologie und Ernährung 2013. [DOI: 10.1007/978-3-642-24710-1_11] [Reference Citation Analysis]
|
| 584 |
Cucchiara S, Di Nardo G, Aloi M. Clinical Trials (Clinician Perspective). Pediatric Inflammatory Bowel Disease 2013. [DOI: 10.1007/978-1-4614-5061-0_42] [Reference Citation Analysis]
|
| 585 |
Mack DR. Probiotic Therapy. Pediatric Inflammatory Bowel Disease 2013. [DOI: 10.1007/978-1-4614-5061-0_29] [Reference Citation Analysis]
|
| 586 |
Reed-knight B, Lewis JD, Blount RL. Behavioral Functioning in Youth With Inflammatory Bowel Disease: Perceived Barriers as Mediator of Medication Adherence. Journal of Pediatric Psychology 2013;38:309-20. [DOI: 10.1093/jpepsy/jss122] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 587 |
Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, Mantzaris G, Reinisch W, Colombel JF, Vermeire S, Travis S, Lindsay JO, Van Assche G. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis 2012;6:965-90. [PMID: 23040452 DOI: 10.1016/j.crohns.2012.09.003] [Cited by in Crossref: 602] [Cited by in F6Publishing: 610] [Article Influence: 54.7] [Reference Citation Analysis]
|
| 588 |
Tarlton NJ, Green CM, Lazarus NH, Rott L, Wong AP, Abramson ON, Bremer M, Butcher EC, Abramson T. Plasmablast frequency and trafficking receptor expression are altered in pediatric ulcerative colitis. Inflamm Bowel Dis 2012;18:2381-91. [PMID: 22488927 DOI: 10.1002/ibd.22962] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 589 |
Kronman MP, Gerber JS, Prasad PA, Adler AL, Bass JA, Newland JG, Shah KM, Zerr DM, Feng R, Coffin SE, Zaoutis TE. Variation in Antibiotic Use for Children Hospitalized With Inflammatory Bowel Disease Exacerbation: A Multicenter Validation Study. J Pediatric Infect Dis Soc 2012;1:306-13. [PMID: 23687581 DOI: 10.1093/jpids/pis053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 590 |
Samson CM, Morgan P, Williams E, Beck L, Addie-Carson R, McIntire S, Booth A, Mendez E, Luzader C, Tomer G, Saeed S, Donovan E, Bucuvalas J, Denson LA. Improved outcomes with quality improvement interventions in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2012;55:679-88. [PMID: 22699837 DOI: 10.1097/MPG.0b013e318262de16] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 591 |
Bradley GM, Oliva-Hemker M. Infliximab for the treatment of pediatric ulcerative colitis. Expert Rev Gastroenterol Hepatol 2012;6:659-65. [PMID: 23237250 DOI: 10.1586/egh.12.53] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 592 |
Kelley-Quon LI, Jen HC, Ziring DA, Gupta N, Kirschner BS, Ferry GD, Cohen SA, Winter HS, Heyman MB, Gold BD, Shew SB. Predictors of proctocolectomy in children with ulcerative colitis. J Pediatr Gastroenterol Nutr 2012;55:534-40. [PMID: 22684351 DOI: 10.1097/MPG.0b013e3182619d26] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 593 |
van Rheenen PF. Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control. Inflamm Bowel Dis 2012;18:2018-25. [PMID: 22275341 DOI: 10.1002/ibd.22896] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 594 |
Tsang J, Sikora S, Spady D, El-Matary W. Histopathological changes in anatomical distribution of inflammatory bowel disease in children: a retrospective cohort study. BMC Pediatr 2012;12:162. [PMID: 23061647 DOI: 10.1186/1471-2431-12-162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 595 |
La Scaleia R, Stoppacciaro A, Oliva S, Morrone S, Di Nardo G, Santoni A, Cucchiara S, Palmieri G. NKG2D/Ligand dysregulation and functional alteration of innate immunity cell populations in pediatric IBD. Inflamm Bowel Dis 2012;18:1910-22. [PMID: 22294522 DOI: 10.1002/ibd.22899] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 596 |
Aloi M, Tromba L, Di Nardo G, Dilillo A, Del Giudice E, Marocchi E, Viola F, Civitelli F, Berni A, Cucchiara S. Premature subclinical atherosclerosis in pediatric inflammatory bowel disease. J Pediatr 2012;161:589-94.e1. [PMID: 22579000 DOI: 10.1016/j.jpeds.2012.03.043] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 597 |
Michail S, Durbin M, Turner D, Griffiths AM, Mack DR, Hyams J, Leleiko N, Kenche H, Stolfi A, Wine E. Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis 2012;18:1799-808. [PMID: 22170749 DOI: 10.1002/ibd.22860] [Cited by in Crossref: 198] [Cited by in F6Publishing: 186] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 598 |
Kovacs M, Lakatos PL, Papp M, Jacobsen S, Nemes E, Polgar M, Solyom E, Bodi P, Horvath A, Muller KE, Molnar K, Szabo D, Cseh A, Dezsofi A, Arato A, Veres G. Pancreatic autoantibodies and autoantibodies against goblet cells in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2012;55:429-35. [PMID: 22465933 DOI: 10.1097/MPG.0b013e318256b516] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 599 |
Park KT, Tsai R, Perez F, Cipriano LE, Bass D, Garber AM. Cost-effectiveness of early colectomy with ileal pouch-anal anastamosis versus standard medical therapy in severe ulcerative colitis. Ann Surg. 2012;256:117-124. [PMID: 22270693 DOI: 10.1097/sla.0b013e3182445321] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 600 |
Turner D, Levine A, Escher JC, Griffiths AM, Russell RK, Dignass A, Dias JA, Bronsky J, Braegger CP, Cucchiara S, de Ridder L, Fagerberg UL, Hussey S, Hugot JP, Kolacek S, Kolho KL, Lionetti P, Paerregaard A, Potapov A, Rintala R, Serban DE, Staiano A, Sweeny B, Veerman G, Veres G, Wilson DC, Ruemmele FM; European Crohn's and Colitis Organization, European Society for Paediatric Gastroenterology, Hepatology, and Nutrition. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr 2012;55:340-61. [PMID: 22773060 DOI: 10.1097/MPG.0b013e3182662233] [Cited by in Crossref: 279] [Cited by in F6Publishing: 294] [Article Influence: 25.4] [Reference Citation Analysis]
|
| 601 |
Sidoroff M, Kolho KL. Glucocorticoid sensitivity in inflammatory bowel disease. Ann Med 2012;44:578-87. [PMID: 21992564 DOI: 10.3109/07853890.2011.590521] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 602 |
Dayan B, Turner D. Role of surgery in severe ulcerative colitis in the era of medical rescue therapy. World J Gastroenterol 2012; 18(29): 3833-3838 [PMID: 22876035 DOI: 10.3748/wjg.v18.i29.3833] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 603 |
Sherlock ME, Griffiths AM. Medical therapy for pediatric inflammatory bowel disease. Curr Gastroenterol Rep. 2012;14:166-173. [PMID: 22350842 DOI: 10.1007/s11894-012-0249-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 604 |
Werkstetter KJ, Ullrich J, Schatz SB, Prell C, Koletzko B, Koletzko S. Lean body mass, physical activity and quality of life in paediatric patients with inflammatory bowel disease and in healthy controls. J Crohns Colitis 2012;6:665-73. [PMID: 22398103 DOI: 10.1016/j.crohns.2011.11.017] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 605 |
Laakso S, Valta H, Verkasalo M, Toiviainen-Salo S, Viljakainen H, Mäkitie O. Impaired bone health in inflammatory bowel disease: a case-control study in 80 pediatric patients. Calcif Tissue Int. 2012;91:121-130. [PMID: 22729560 DOI: 10.1007/s00223-012-9617-2] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 606 |
Bradley GM, Oliva-Hemker M. Pediatric ulcerative colitis: current treatment approaches including role of infliximab. Biologics 2012;6:125-34. [PMID: 22740771 DOI: 10.2147/BTT.S31833] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 607 |
Pappa HM, Mitchell PD, Jiang H, Kassiff S, Filip-Dhima R, DiFabio D, Quinn N, Lawton RC, Varvaris M, Van Straaten S, Gordon CM. Treatment of vitamin D insufficiency in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing three regimens. J Clin Endocrinol Metab 2012;97:2134-42. [PMID: 22456619 DOI: 10.1210/jc.2011-3182] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 608 |
Huang JS, Tobin A, Tompane T. Clinicians poorly assess health literacy-related readiness for transition to adult care in adolescents with inflammatory bowel disease. Clin Gastroenterol Hepatol 2012;10:626-32. [PMID: 22387250 DOI: 10.1016/j.cgh.2012.02.017] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 609 |
El-Hodhod MA, Hamdy AM, Abbas AA, Moftah SG, Ramadan AA. Fibroblast growth factor 23 contributes to diminished bone mineral density in childhood inflammatory bowel disease. BMC Gastroenterol 2012;12:44. [PMID: 22551310 DOI: 10.1186/1471-230X-12-44] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 610 |
Negroni A, Costanzo M, Vitali R, Superti F, Bertuccini L, Tinari A, Minelli F, Di Nardo G, Nuti F, Pierdomenico M, Cucchiara S, Stronati L. Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2012;18:913-24. [PMID: 21994005 DOI: 10.1002/ibd.21899] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 611 |
Hyams J, Damaraju L, Blank M, Johanns J, Guzzo C, Winter HS, Kugathasan S, Cohen S, Markowitz J, Escher JC, Veereman-Wauters G, Crandall W, Baldassano R, Griffiths A; T72 Study Group. Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitis. Clin Gastroenterol Hepatol 2012;10:391-9.e1. [PMID: 22155755 DOI: 10.1016/j.cgh.2011.11.026] [Cited by in Crossref: 186] [Cited by in F6Publishing: 189] [Article Influence: 16.9] [Reference Citation Analysis]
|
| 612 |
Cangemi G, Barabino A, Barco S, Parodi A, Arrigo S, Melioli G. A Validated HPLC Method for the Monitoring of Thiopurine Metabolites in Whole Blood in Paediatric Patients with Inflammatory Bowel Disease. Int J Immunopathol Pharmacol 2012;25:435-44. [DOI: 10.1177/039463201202500213] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 613 |
Lin K, Chen H, Chen C, Wang T, Wu C, Hsieh Y, Wu L. Validity, responsiveness, minimal detectable change, and minimal clinically important change of the Pediatric Motor Activity Log in children with cerebral palsy. Research in Developmental Disabilities 2012;33:570-7. [DOI: 10.1016/j.ridd.2011.10.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 614 |
Kovacs M, Muller KE, Arato A, Lakatos PL, Kovacs JB, Varkonyi A, Solyom E, Polgar M, Nemes E, Guthy I, Tokodi I, Toth G, Horvath A, Tarnok A, Tomsits E, Csoszánszky N, Balogh M, Vass N, Bodi P, Dezsofi A, Gardos L, Micskey E, Papp M, Szucs D, Cseh A, Molnar K, Szabo D, Veres G; Hungarian IBD Registry Group (HUPIR). Diagnostic yield of upper endoscopy in paediatric patients with Crohn's disease and ulcerative colitis. Subanalysis of the HUPIR registry. J Crohns Colitis 2012;6:86-94. [PMID: 22261532 DOI: 10.1016/j.crohns.2011.07.008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 615 |
Turner D, Griffiths AM, Walters TD, Seah T, Markowitz J, Pfefferkorn M, Keljo D, Waxman J, Otley A, LeLeiko NS, Mack D, Hyams J, Levine A. Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions. Inflamm Bowel Dis 2012;18:55-62. [PMID: 21351206 DOI: 10.1002/ibd.21649] [Cited by in Crossref: 157] [Cited by in F6Publishing: 99] [Article Influence: 14.3] [Reference Citation Analysis]
|
| 616 |
deBruyn JC, Hilsden R, Fonseca K, Russell ML, Kaplan GG, Vanderkooi O, Wrobel I. Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease. Inflamm Bowel Dis 2012;18:25-33. [PMID: 21472826 DOI: 10.1002/ibd.21706] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 617 |
Hyams JS. Pediatric Aspects in Inflammatory Bowel Disease. Crohn's Disease and Ulcerative Colitis 2012. [DOI: 10.1007/978-1-4614-0998-4_53] [Reference Citation Analysis]
|
| 618 |
Hommel KA, Hente EA, Odell S, Herzer M, Ingerski LM, Guilfoyle SM, Denson LA. Evaluation of a group-based behavioral intervention to promote adherence in adolescents with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2012;24:64-9. [PMID: 21989119 DOI: 10.1097/MEG.0b013e32834d09f1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 619 |
Willot S, Noble A, Deslandres C. Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center. Inflamm Bowel Dis 2011;17:2521-6. [PMID: 21337668 DOI: 10.1002/ibd.21653] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 620 |
Kudo T, Nagata S, Ohtani K, Fujii T, Wada M, Haruna H, Shoji H, Ohtsuka Y, Shimizu T, Yamashiro Y. Pulse steroids as induction therapy for children with ulcerative colitis. Pediatr Int 2011;53:974-9. [PMID: 21624004 DOI: 10.1111/j.1442-200X.2011.03405.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 621 |
Park KT, Perez F, Tsai R, Honkanen A, Bass D, Garber A. Cost-effectiveness analysis of adjunct VSL#3 therapy versus standard medical therapy in pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr 2011;53:489-96. [PMID: 21694634 DOI: 10.1097/MPG.0b013e3182293a5e] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 622 |
Huang JS, Tobin A, Harvey L, Nelson TR. Diagnostic medical radiation in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011;53:502-6. [PMID: 22020539 DOI: 10.1097/MPG.0b013e31820d5d84] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 623 |
Vitali R, Stronati L, Negroni A, Di Nardo G, Pierdomenico M, del Giudice E, Rossi P, Cucchiara S. Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease. Am J Gastroenterol 2011;106:2029-40. [PMID: 21788990 DOI: 10.1038/ajg.2011.231] [Cited by in Crossref: 87] [Cited by in F6Publishing: 91] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 624 |
Ross SC, Strachan J, Russell RK, Wilson SL. Psychosocial functioning and health-related quality of life in paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011;53:480-8. [PMID: 21822149 DOI: 10.1097/MPG.0b013e31822f2c32] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 625 |
Turner D, Mack DR, Hyams J, LeLeiko N, Otley A, Markowitz J, Kasirer Y, Muise A, Seow CH, Silverberg MS, Crandall W, Griffiths AM. C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis. J Crohns Colitis 2011;5:423-9. [PMID: 21939916 DOI: 10.1016/j.crohns.2011.05.003] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 626 |
Hommel KA, Herzer M, Ingerski LM, Hente E, Denson LA. Individually tailored treatment of medication nonadherence. J Pediatr Gastroenterol Nutr 2011;53:435-9. [PMID: 21519282 DOI: 10.1097/MPG.0b013e3182203a91] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 627 |
Aomatsu T, Imaeda H, Matsumoto K, Kimura E, Yoden A, Tamai H, Fujiyama Y, Mizoguchi E, Andoh A. Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease. Aliment Pharmacol Ther 2011;34:941-8. [PMID: 21848856 DOI: 10.1111/j.1365-2036.2011.04805.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 628 |
Tsampalieros A, Griffiths AM, Barrowman N, Mack DR. Use of C-reactive protein in children with newly diagnosed inflammatory bowel disease. J Pediatr 2011;159:340-2. [PMID: 21645909 DOI: 10.1016/j.jpeds.2011.04.028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 629 |
Sylvester FA, Turner D, Draghi A 2nd, Uuosoe K, McLernon R, Koproske K, Mack DR, Crandall WV, Hyams JS, Leleiko NS, Griffiths AM. Fecal osteoprotegerin may guide the introduction of second-line therapy in hospitalized children with ulcerative colitis. Inflamm Bowel Dis 2011;17:1726-30. [PMID: 21744427 DOI: 10.1002/ibd.21561] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 630 |
Burisch J, Cukovic-Cavka S, Kaimakliotis I, Shonová O, Andersen V, Dahlerup JF, Elkjaer M, Langholz E, Pedersen N, Salupere R, Kolho KL, Manninen P, Lakatos PL, Shuhaibar M, Odes S, Martinato M, Mihu I, Magro F, Belousova E, Fernandez A, Almer S, Halfvarson J, Hart A, Munkholm P. Construction and validation of a web-based epidemiological database for inflammatory bowel diseases in Europe An EpiCom study. J Crohns Colitis 2011;5:342-9. [PMID: 21683305 DOI: 10.1016/j.crohns.2011.02.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 631 |
Aomatsu T, Yoden A, Matsumoto K, Kimura E, Inoue K, Andoh A, Tamai H. Fecal calprotectin is a useful marker for disease activity in pediatric patients with inflammatory bowel disease. Dig Dis Sci 2011;56:2372-7. [PMID: 21394462 DOI: 10.1007/s10620-011-1633-y] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 632 |
Pappa HM, Saslowsky TM, Filip-Dhima R, DiFabio D, Hassani Lahsinoui H, Akkad A, Grand RJ, Gordon CM. Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial. Am J Gastroenterol 2011;106:1527-43. [PMID: 21519359 DOI: 10.1038/ajg.2011.129] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 633 |
Hill RJ, Lewindon PJ, Withers GD, Connor FL, Ee LC, Cleghorn GJ, Davies PS. Ability of commonly used prediction equations to predict resting energy expenditure in children with inflammatory bowel disease. Inflamm Bowel Dis 2011;17:1587-93. [PMID: 21674716 DOI: 10.1002/ibd.21518] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 634 |
Tomomasa T, Tajiri H, Kagimoto S, Shimizu T, Yoden A, Ushijima K, Uchida K, Kaneko H, Abukawa D, Konno M, Maisawa S, Kohsaka T, Kobayashi A; Japanese Study Group for Pediatric Ulcerative Colitis. Leukocytapheresis in pediatric patients with ulcerative colitis. J Pediatr Gastroenterol Nutr 2011;53:34-9. [PMID: 21694533 DOI: 10.1097/MPG.0b013e31821058bc] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 635 |
Gray WN, Denson LA, Baldassano RN, Hommel KA. Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2011;17:1581-6. [PMID: 21674715 DOI: 10.1002/ibd.21520] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 636 |
Lee JJ, Colman RJ, Mitchell PD, Atmadja ML, Bousvaros A, Lightdale JR. Agreement between patient- and physician-completed Pediatric Ulcerative Colitis Activity Index scores. J Pediatr Gastroenterol Nutr 2011;52:708-13. [PMID: 21593644 DOI: 10.1097/MPG.0b013e3182099018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 637 |
Thia KT, Loftus EV Jr, Pardi DS, Kane SV, Faubion WA, Tremaine WJ, Schroeder KW, Harmsen SW, Zinsmeister AR, Sandborn WJ. Measurement of disease activity in ulcerative colitis: interobserver agreement and predictors of severity. Inflamm Bowel Dis 2011;17:1257-64. [PMID: 20878712 DOI: 10.1002/ibd.21480] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 638 |
Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, Fell J, Ruemmele FM, Walters T, Sherlock M, Dubinsky M, Hyams JS. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011;17:1314-21. [PMID: 21560194 DOI: 10.1002/ibd.21493] [Cited by in Crossref: 932] [Cited by in F6Publishing: 680] [Article Influence: 77.7] [Reference Citation Analysis]
|
| 639 |
Werkstetter KJ, Pozza SB, Filipiak-Pittroff B, Schatz SB, Prell C, Bufler P, Koletzko B, Koletzko S. Long-term development of bone geometry and muscle in pediatric inflammatory bowel disease. Am J Gastroenterol 2011;106:988-98. [PMID: 21224841 DOI: 10.1038/ajg.2010.495] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 640 |
Ploeger HE, Takken T, Wilk B, Issenman RM, Sears R, Suri S, Timmons BW. Exercise capacity in pediatric patients with inflammatory bowel disease. J Pediatr 2011;158:814-9. [PMID: 21146188 DOI: 10.1016/j.jpeds.2010.10.020] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 641 |
Hyams JS, Lerer T, Mack D, Bousvaros A, Griffiths A, Rosh J, Otley A, Evans J, Stephens M, Kay M, Keljo D, Pfefferkorn M, Saeed S, Crandall W, Michail S, Kappelman MD, Grossman A, Samson C, Sudel B, Oliva-Hemker M, Leleiko N, Markowitz J; Pediatric Infl ammatory Bowel Disease Collaborative Research Group Registry. Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study. Am J Gastroenterol 2011;106:981-7. [PMID: 21224840 DOI: 10.1038/ajg.2010.493] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 642 |
Turner D, Travis SP, Griffiths AM, Ruemmele FM, Levine A, Benchimol EI, Dubinsky M, Alex G, Baldassano RN, Langer JC, Shamberger R, Hyams JS, Cucchiara S, Bousvaros A, Escher JC, Markowitz J, Wilson DC, van Assche G, Russell RK; European Crohn's and Colitis Organization, Porto IBD Working Group, European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol 2011;106:574-88. [PMID: 21224839 DOI: 10.1038/ajg.2010.481] [Cited by in Crossref: 150] [Cited by in F6Publishing: 144] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 643 |
Hommel KA, Denson LA, Baldassano RN. Oral medication adherence and disease severity in pediatric inflammatory bowel disease. Eur J Gastroenterol Hepatol 2011;23:250-4. [PMID: 21304318 DOI: 10.1097/MEG.0b013e328344019c] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 644 |
Pierdomenico M, Stronati L, Costanzo M, Vitali R, Di Nardo G, Nuti F, Oliva S, Cucchiara S, Negroni A. New insights into the pathogenesis of inflammatory bowel disease: transcription factors analysis in bioptic tissues from pediatric patients. J Pediatr Gastroenterol Nutr 2011;52:271-9. [PMID: 21336161 DOI: 10.1097/MPG.0b013e3182034d08] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 645 |
El-Matary W, Sikora S, Spady D. Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease. Dig Dis Sci 2011;56:825-9. [PMID: 20725784 DOI: 10.1007/s10620-010-1380-5] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 646 |
Sierra Salinas C, Blasco Alonso J, Navas López VM, Serrano Nieto J, Unda Freire A, Argos Rodríguez MD. [Colectomy in paediatric patients with ulcerative colitis]. An Pediatr (Barc) 2011;74:293-7. [PMID: 21333618 DOI: 10.1016/j.anpedi.2010.11.011] [Reference Citation Analysis]
|
| 647 |
Cakir M, Ozgenc F, Yusekkaya HA, Ecevit CO, Yagci RV. Steroid response in moderate to severe pediatric ulcerative colitis: a single center's experience. World J Pediatr 2011;7:50-3. [PMID: 21191776 DOI: 10.1007/s12519-011-0245-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 648 |
Sherlock ME, Bandsma R, Ota K, Kirby-Allen M, Griffiths AM. Severe neutropenia following infliximab treatment in a child with ulcerative colitis. Inflamm Bowel Dis 2011;17:E17-8. [PMID: 20824816 DOI: 10.1002/ibd.21466] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 649 |
Jones NP, Siegle GJ, Proud L, Silk JS, Hardy D, Keljo DJ, Dahl RE, Szigethy E. Impact of inflammatory bowel disease and high-dose steroid exposure on pupillary responses to negative information in pediatric depression. Psychosom Med 2011;73:151-7. [PMID: 21217099 DOI: 10.1097/PSY.0b013e318207ffea] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 650 |
Cheon JH, Han DS, Park JY, Ye BD, Jung SA, Park YS, Kim YS, Kim JS, Nam CM, Kim YN, Yang SK, Kim WH; Korean IBD Study Group. Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet's disease. Inflamm Bowel Dis 2011;17:605-13. [PMID: 20848515 DOI: 10.1002/ibd.21313] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 651 |
Picco M. Predicting the need for colectomy in severe ulcerative colitis: a critical appraisal of clinical parameters and currently available biomarkers. Yearbook of Gastroenterology 2011;2011:172-175. [DOI: 10.1016/j.ygas.2011.07.122] [Reference Citation Analysis]
|
| 652 |
Moore JC, Thompson K, Lafleur B, Book LS, Jackson WD, O'Gorman MA, Black RE, Downey E Jr, Johnson DG, Matlak ME, Meyers RL, Scaife E, Guthery SL. Clinical variables as prognostic tools in pediatric-onset ulcerative colitis: a retrospective cohort study. Inflamm Bowel Dis 2011;17:15-21. [PMID: 20629099 DOI: 10.1002/ibd.21393] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 653 |
Rosh JR. Assessing disease risk in pediatric ulcerative colitis. Inflamm Bowel Dis 2011;17:13-4. [PMID: 20629182 DOI: 10.1002/ibd.21392] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 654 |
Turner D, Griffiths AM. Acute severe ulcerative colitis in children: a systematic review. Inflamm Bowel Dis 2011;17:440-9. [PMID: 20645317 DOI: 10.1002/ibd.21383] [Cited by in Crossref: 72] [Cited by in F6Publishing: 52] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 655 |
Watson S, Pensabene L, Mitchell P, Bousvaros A. Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis. Inflamm Bowel Dis 2011;17:22-9. [PMID: 20722055 DOI: 10.1002/ibd.21418] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 656 |
Hugot J, Martinez-vinson C, Viala J, Cézard J. Particularités des MICI chez l’enfant. Post’U FMC-HGE 2011. [DOI: 10.1007/978-2-8178-0237-4_11] [Reference Citation Analysis]
|
| 657 |
Stronati L, Negroni A, Pierdomenico M, D'Ottavio C, Tirindelli D, Di Nardo G, Oliva S, Viola F, Cucchiara S. Altered expression of innate immunity genes in different intestinal sites of children with ulcerative colitis. Dig Liver Dis 2010;42:848-53. [PMID: 20452301 DOI: 10.1016/j.dld.2010.04.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 658 |
Pels LP, Van de Vijver E, Waalkens HJ, Uitentuis J, JGonera-de ong G, van Overbeek LA, Norbruis OF, Rings EH, van Rheenen PF. Slow hematological recovery in children with IBD-associated anemia in cases of "expectant management". J Pediatr Gastroenterol Nutr 2010;51:708-13. [PMID: 20683207 DOI: 10.1097/MPG.0b013e3181da4d8b] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 659 |
Uslu N, Yüce A, Demir H, Saltik-Temizel IN, Usta Y, Yilmaz E, Beşbaş N, Gürakan F, Ozen H, Ozen S. The association of inflammatory bowel disease and Mediterranean fever gene (MEFV) mutations in Turkish children. Dig Dis Sci 2010;55:3488-94. [PMID: 20306331 DOI: 10.1007/s10620-010-1178-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 660 |
La Scaleia R, Morrone S, Stoppacciaro A, Scarpino S, Antonelli M, Bianchi E, Di Nardo G, Oliva S, Viola F, Cucchiara S, Santoni A, Palmieri G, Uccini S. Peripheral and intestinal CD4+ T cells with a regulatory phenotype in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2010;51:563-72. [PMID: 20890221 DOI: 10.1097/MPG.0b013e3181e4d323] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 661 |
Sherlock ME, Seow CH, Steinhart AH, Griffiths AM. Oral budesonide for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2010;:CD007698. [PMID: 20927762 DOI: 10.1002/14651858.CD007698.pub2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 662 |
Aloi M, Di Nardo G, Conte F, Mazzeo L, Cavallari N, Nuti F, Cucchiara S, Stronati L. Methotrexate in paediatric ulcerative colitis: a retrospective survey at a single tertiary referral centre. Aliment Pharmacol Ther 2010;32:1017-22. [PMID: 20937047 DOI: 10.1111/j.1365-2036.2010.04433.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 663 |
Ohtsuka Y, Arai K, Aoyagi Y, Fujii T, Yamakawa Y, Ohtani K, Ikuse T, Baba Y, Inage E, Kudo T, Suzuki R, Nagata S, Shimizu T. Monitoring 6-thioguanine nucleotide concentrations in Japanese children and adolescents with inflammatory bowel disease. J Gastroenterol Hepatol 2010;25:1626-30. [PMID: 20880170 DOI: 10.1111/j.1440-1746.2010.06364.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 664 |
Lillehei CW, Masek BJ, Shamberger RC. Prospective study of health-related quality of life and restorative proctocolectomy in children. Dis Colon Rectum 2010;53:1388-92. [PMID: 20847620 DOI: 10.1007/DCR.0b013e3181e8efc5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 665 |
Lee JJ, Escher JC, Shuman MJ, Forbes PW, Delemarre LC, Harr BW, Kruijer M, Moret M, Allende-Richter S, Grand RJ. Final adult height of children with inflammatory bowel disease is predicted by parental height and patient minimum height Z-score. Inflamm Bowel Dis 2010;16:1669-77. [PMID: 20127995 DOI: 10.1002/ibd.21214] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 666 |
Kabakchiev B, Turner D, Hyams J, Mack D, Leleiko N, Crandall W, Markowitz J, Otley AR, Xu W, Hu P, Griffiths AM, Silverberg MS. Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis. PLoS One 2010;5:e13085. [PMID: 20941359 DOI: 10.1371/journal.pone.0013085] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 667 |
Turner D, Griffiths AM, Walters TD, Seah T, Markowitz J, Pfefferkorn M, Keljo D, Otley A, Leleiko NS, Mack D, Hyams J, Levine A. Appraisal of the pediatric Crohn's disease activity index on four prospectively collected datasets: recommended cutoff values and clinimetric properties. Am J Gastroenterol 2010;105:2085-92. [PMID: 20372111 DOI: 10.1038/ajg.2010.143] [Cited by in Crossref: 101] [Cited by in F6Publishing: 94] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 668 |
Van Limbergen J, Griffiths AM. Pediatric Inflammatory Bowel Disease in the Emergency Department. Clinical Pediatric Emergency Medicine 2010;11:189-197. [DOI: 10.1016/j.cpem.2010.06.004] [Reference Citation Analysis]
|
| 669 |
Dotson JL, Hyams JS, Markowitz J, LeLeiko NS, Mack DR, Evans JS, Pfefferkorn MD, Griffiths AM, Otley AR, Bousvaros A, Kugathasan S, Rosh JR, Keljo D, Carvalho RS, Tomer G, Mamula P, Kay MH, Kerzner B, Oliva-Hemker M, Langton CR, Crandall W. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. J Pediatr Gastroenterol Nutr 2010;51:140-5. [PMID: 20453677 DOI: 10.1097/MPG.0b013e3181ca4db4] [Cited by in Crossref: 111] [Cited by in F6Publishing: 107] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 670 |
Claßen M. Ernährung und Chirurgie als Säulen der CED-Behandlung. Monatsschr Kinderheilkd 2010;158:752-758. [DOI: 10.1007/s00112-010-2197-1] [Reference Citation Analysis]
|
| 671 |
Schwiertz A, Jacobi M, Frick JS, Richter M, Rusch K, Köhler H. Microbiota in pediatric inflammatory bowel disease. J Pediatr 2010;157:240-244.e1. [PMID: 20400104 DOI: 10.1016/j.jpeds.2010.02.046] [Cited by in Crossref: 114] [Cited by in F6Publishing: 125] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 672 |
Turner D, Guyatt G. Reflections on the minimal important difference: research is the ultimate goal, not the anchor. Journal of Clinical Epidemiology 2010;63:806. [DOI: 10.1016/j.jclinepi.2010.01.006] [Reference Citation Analysis]
|
| 673 |
Sidoroff M, Karikoski R, Raivio T, Savilahti E, Kolho KL. High-sensitivity C-reactive protein in paediatric inflammatory bowel disease. World J Gastroenterol 2010; 16(23): 2901-2906 [PMID: 20556836 DOI: 10.3748/wjg.v16.i23.2901] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 674 |
Jyonouchi H, Geng L, Cushing-Ruby A, Monteiro IM. Aberrant responses to TLR agonists in pediatric IBD patients; the possible association with increased production of Th1/Th17 cytokines in response to candida, a luminal antigen. Pediatr Allergy Immunol 2010;21:e747-55. [PMID: 19725895 DOI: 10.1111/j.1399-3038.2009.00923.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 675 |
Turner D, Mack D, Leleiko N, Walters TD, Uusoue K, Leach ST, Day AS, Crandall W, Silverberg MS, Markowitz J, Otley AR, Keljo D, Mamula P, Kugathasan S, Hyams J, Griffiths AM. Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response. Gastroenterology 2010;138:2282-91. [PMID: 20193683 DOI: 10.1053/j.gastro.2010.02.047] [Cited by in Crossref: 180] [Cited by in F6Publishing: 190] [Article Influence: 13.8] [Reference Citation Analysis]
|
| 676 |
Tiemi J, Komati S, Sdepanian VL. Effectiveness of infliximab in Brazilian children and adolescents with Crohn disease and ulcerative colitis according to clinical manifestations, activity indices of inflammatory bowel disease, and corticosteroid use. J Pediatr Gastroenterol Nutr 2010;50:628-33. [PMID: 20386321 DOI: 10.1097/MPG.0b013e3181bbf481] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 677 |
Schurman JV, Cushing CC, Carpenter E, Christenson K. Volitional and accidental nonadherence to pediatric inflammatory bowel disease treatment plans: initial investigation of associations with quality of life and disease activity. J Pediatr Psychol 2011;36:116-25. [PMID: 20498007 DOI: 10.1093/jpepsy/jsq046] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 678 |
Romano C, Famiani A, Comito D, Rossi P, Raffa V, Fries W. Oral beclomethasone dipropionate in pediatric active ulcerative colitis: a comparison trial with mesalazine. J Pediatr Gastroenterol Nutr 2010;50:385-9. [PMID: 20179636 DOI: 10.1097/MPG.0b013e3181bb3457] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 679 |
Turner D, Griffiths AM, Mack D, Otley AR, Seow CH, Steinhart AH, Silverberg MS, Hyams J, Guyatt GH. Assessing disease activity in ulcerative colitis: patients or their physicians? Inflamm Bowel Dis 2010;16:651-6. [PMID: 19708058 DOI: 10.1002/ibd.21088] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 680 |
Turner D, Kolho KL, Mack DR, Raivio T, Leleiko N, Crandall W, Markowitz J, Silverberg MS, Jänne OA, Stempak J, Hyams J, Griffiths AM. Glucocorticoid bioactivity does not predict response to steroid therapy in severe pediatric ulcerative colitis. Inflamm Bowel Dis 2010;16:469-73. [PMID: 19714760 DOI: 10.1002/ibd.21070] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 681 |
Sandhu BK, Fell JM, Beattie RM, Mitton SG, Wilson DC, Jenkins H; IBD Working Group of the British Society of Paediatric Gastroenterology, Hepatology, and Nutrition. Guidelines for the management of inflammatory bowel disease in children in the United Kingdom. J Pediatr Gastroenterol Nutr 2010;50 Suppl 1:S1-13. [PMID: 20081543 DOI: 10.1097/MPG.0b013e3181c92c53] [Cited by in Crossref: 109] [Cited by in F6Publishing: 107] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 682 |
Sauer CG, Kugathasan S. Pediatric inflammatory bowel disease: highlighting pediatric differences in IBD. Med Clin North Am. 2010;94:35-52. [PMID: 19944797 DOI: 10.1016/j.mcna.2009.10.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 683 |
Sauer CG, Kugathasan S. Pediatric inflammatory bowel disease: highlighting pediatric differences in IBD. Gastroenterol Clin North Am 2009;38:611-28. [PMID: 19913205 DOI: 10.1016/j.gtc.2009.07.010] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 684 |
Turner D, Seow CH, Greenberg GR, Griffiths AM, Silverberg MS, Steinhart AH. A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis. Clin Gastroenterol Hepatol 2009;7:1081-8. [PMID: 19577010 DOI: 10.1016/j.cgh.2009.06.024] [Cited by in Crossref: 124] [Cited by in F6Publishing: 126] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 685 |
Turner D, Schünemann HJ, Griffith LE, Beaton DE, Griffiths AM, Critch JN, Guyatt GH. The minimal detectable change cannot reliably replace the minimal important difference. J Clin Epidemiol 2010;63:28-36. [PMID: 19800198 DOI: 10.1016/j.jclinepi.2009.01.024] [Cited by in Crossref: 226] [Cited by in F6Publishing: 204] [Article Influence: 16.1] [Reference Citation Analysis]
|
| 686 |
Turner D, Hyams J, Markowitz J, Lerer T, Mack DR, Evans J, Pfefferkorn M, Rosh J, Kay M, Crandall W, Keljo D, Otley AR, Kugathasan S, Carvalho R, Oliva-Hemker M, Langton C, Mamula P, Bousvaros A, LeLeiko N, Griffiths AM; Pediatric IBD Collaborative Research Group. Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis 2009;15:1218-23. [PMID: 19161178 DOI: 10.1002/ibd.20867] [Cited by in Crossref: 181] [Cited by in F6Publishing: 126] [Article Influence: 12.9] [Reference Citation Analysis]
|
| 687 |
Turner D, Griffiths AM, Steinhart AH, Otley AR, Beaton DE. Mathematical weighting of a clinimetric index (Pediatric Ulcerative Colitis Activity Index) was superior to the judgmental approach. Journal of Clinical Epidemiology 2009;62:738-44. [DOI: 10.1016/j.jclinepi.2008.09.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 688 |
Perminow G, Brackmann S, Lyckander LG, Franke A, Borthne A, Rydning A, Aamodt G, Schreiber S, Vatn MH; IBSEN-II Group. A characterization in childhood inflammatory bowel disease, a new population-based inception cohort from South-Eastern Norway, 2005-07, showing increased incidence in Crohn's disease. Scand J Gastroenterol 2009;44:446-56. [PMID: 19117240 DOI: 10.1080/00365520802647434] [Cited by in Crossref: 87] [Cited by in F6Publishing: 94] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 689 |
Ward LM, Rauch F, Matzinger MA, Benchimol EI, Boland M, Mack DR. Iliac bone histomorphometry in children with newly diagnosed inflammatory bowel disease. Osteoporos Int 2010;21:331-7. [DOI: 10.1007/s00198-009-0969-z] [Cited by in Crossref: 58] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 690 |
Schippa S, Conte MP, Borrelli O, Iebba V, Aleandri M, Seganti L, Longhi C, Chiarini F, Osborn J, Cucchiara S. Dominant genotypes in mucosa-associated Escherichia coli strains from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2009;15:661-72. [PMID: 19067417 DOI: 10.1002/ibd.20818] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 691 |
Marcus SB, Strople JA, Neighbors K, Weissberg-Benchell J, Nelson SP, Limbers C, Varni JW, Alonso EM. Fatigue and health-related quality of life in pediatric inflammatory bowel disease. Clin Gastroenterol Hepatol 2009;7:554-61. [PMID: 19418604 DOI: 10.1016/j.cgh.2009.01.022] [Cited by in Crossref: 89] [Cited by in F6Publishing: 90] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 692 |
Sherlock ME, Seow CH, Steinhart AH, Griffiths AM. Oral budesonide for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2009. [DOI: 10.1002/14651858.cd007698] [Reference Citation Analysis]
|
| 693 |
Otley A. Evaluating health utilities in adolescents: raising the profile of an alternative method for assessing health-related quality of life. J Pediatr 2009;154:476-8. [PMID: 19324215 DOI: 10.1016/j.jpeds.2008.11.039] [Reference Citation Analysis]
|
| 694 |
Turner D, Schünemann HJ, Griffith LE, Beaton DE, Griffiths AM, Critch JN, Guyatt GH. Using the entire cohort in the receiver operating characteristic analysis maximizes precision of the minimal important difference. Journal of Clinical Epidemiology 2009;62:374-9. [DOI: 10.1016/j.jclinepi.2008.07.009] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 695 |
Grossman AB, Mamula P. What is the optimal management approach for pediatric patients with severe ulcerative colitis? Nat Rev Gastroenterol Hepatol 2008;5:542-543. [DOI: 10.1038/ncpgasthep1234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 696 |
Rochon J, Protiva P, Seeff LB, Fontana RJ, Liangpunsakul S, Watkins PB, Davern T, McHutchison JG; Drug-Induced Liver Injury Network (DILIN). Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury. Hepatology 2008;48:1175-83. [PMID: 18798340 DOI: 10.1002/hep.22442] [Cited by in Crossref: 141] [Cited by in F6Publishing: 144] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 697 |
Brain O, Travis SP. Therapy of ulcerative colitis: state of the art. Current Opinion in Internal Medicine 2008;7:477-482. [DOI: 10.1097/mci.0b013e3283154e13] [Reference Citation Analysis]
|
| 698 |
Dittrich K, Richter M, Rascher W, Köhler H. Leukocytapheresis in a girl with severe ulcerative colitis refractory to corticosteroids, infliximab, and cyclosporine A. Inflamm Bowel Dis 2008;14:1466-7. [PMID: 18421764 DOI: 10.1002/ibd.20464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 699 |
Martín de Carpi J, Vilar Escrigas P, Varea Calderón V. Infliximab como terapia de rescate en colitis ulcerosa grave resistente al tratamiento corticoideo. Anales de Pediatría 2008;69:351-354. [DOI: 10.1157/13126560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 700 |
Guthery SL, Dong L, Dean JM, Holubkov R. US estimates of hospitalized pediatric patients with ulcerative colitis: implications for multicenter clinical studies. Inflamm Bowel Dis 2008;14:1253-8. [PMID: 18512244 DOI: 10.1002/ibd.20521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 701 |
Brain O, Travis SP. Therapy of ulcerative colitis: state of the art. Curr Opin Gastroenterol 2008;24:469-74. [PMID: 18622161 DOI: 10.1097/MOG.0b013e3282ff0dd5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 702 |
Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Dig Liver Dis 2008;40:547-53. [PMID: 18358796 DOI: 10.1016/j.dld.2008.01.017] [Cited by in Crossref: 123] [Cited by in F6Publishing: 121] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 703 |
Shi HY, Lee HH, Chiu CC, Chiu HC, Uen YH, Lee KT. Responsiveness and minimal clinically important differences after cholecystectomy: GIQLI versus SF-36. J Gastrointest Surg 2008;12:1275-82. [PMID: 18454301 DOI: 10.1007/s11605-008-0526-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 704 |
Benchimol EI, Turner D, Mann EH, Thomas KE, Gomes T, McLernon RA, Griffiths AM. Toxic megacolon in children with inflammatory bowel disease: clinical and radiographic characteristics. Am J Gastroenterol 2008;103:1524-31. [PMID: 18510624 DOI: 10.1111/j.1572-0241.2008.01807.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 705 |
Krzystek-Korpacka M, Neubauer K, Berdowska I, Boehm D, Zielinski B, Petryszyn P, Terlecki G, Paradowski L, Gamian A. Enhanced formation of advanced oxidation protein products in IBD. Inflamm Bowel Dis 2008;14:794-802. [PMID: 18213700 DOI: 10.1002/ibd.20383] [Cited by in Crossref: 44] |
